India's NavIC gets its 4th satellite back, a 22,600-qubit plan to break RSA, and 8 new frontier items
Today: a code-breaking estimate that shrinks the quantum threat timeline, India's navigation satellite launch, a faster FDA path for custom gene editing, a Chinese AI chip that skips HBM, Mistral's open trillion-parameter model, RBI's cyber push and a blind patient's vision implant. Each item has an analogy, a readiness score and a plain-words urgency badge.
Alice & Bob: about 22,600 'cat qubits' could break RSA-2048 encryption in about 3 days, on paper
Stage 1 · Lab physics
Every big cut in the number of qubits needed to break encryption pulls the 'upgrade your locks' deadline closer. This one maps Shor's algorithm to a full chip layout and lands at about 22,600 cat qubits. It is a paper estimate on assumed hardware, so Stage 1, but it matters to every bank and crypto holder.
🆕 New todayReadiness vs prev: 🆕 new · Updated 2026-10-31
Stage 1 · Lab physics👀 Too early: keep an eye on itQuantum code-breaking estimate
1. Alice & Bob: about 22,600 'cat qubits' could break RSA-2048 encryption in about 3 days, on paper
🧩 Like an engineer publishing full blueprints showing a bridge needs 40 times fewer steel beams than everyone assumed: the bridge is not built yet, but the cost e
QTUMDefiance Quantum ETFLAESSEALSQ
🏛 Alice & Bob (private, France) with Inria, CEA and the University of Edinburgh · 📅 2026-10-30
👀 Too early: keep an eye on itOur judgment · Not financial advice
1Lab physics
2Hardware demo
3Cloud access / customers
4Commercial advantage
💡 What it is
🔬 A preprint (IACR ePrint 2026/2665) maps Shor's code-breaking algorithm all the way down to a physical chip layout.
🧩 Like an engineer publishing full blueprints showing a bridge needs 40 times fewer steel beams than everyone assumed: the bridge is not built yet, but the cost estimate just shrank.
🚀 Why it matters
📈 Readiness 22/100 · Lab physics
⏳ 6-10 yrs to market (our judgment)
🎯 This is a paper estimate, not a working machine.
💰 Who gains
QTUMDefiance Quantum ETFLAESSEALSQ
🏷 Post-quantum security chip and software vendors (our judgment)
🏷 Cat-qubit hardware makers, if the hardware follows (our judgment)
⚠️ Risks
❌ Estimate rests on hardware assumptions not yet demonstrated
✅ What to do
👀 Too early: keep an eye on it · plan: keep watching
🔎 Watch for: Peer review of the preprint and Alice & Bob hardware milestones toward error-corrected cat qubits.
🗓 Timeline
1 yrBanks and governments speed up post-quantum upgrades
3 yrFirst small error-corrected cat-qubit demos
5 yr+Machines of this size remain uncertain
Timeline steps are our judgment unless marked as company plan.
What they found: A preprint (IACR ePrint 2026/2665) maps Shor's code-breaking algorithm all the way down to a physical chip layout. It estimates RSA-2048 could be factored with 22,593 physical cat qubits in 3.14 days, about 40 times fewer physical qubits than leading estimates for standard (transmon) qubits and less than half the team's own 2023 figure of 49,649. For the 256-bit elliptic-curve keys used by Bitcoin it estimates up to 29,588 qubits and about 62 minutes.
🧒 Like I'm 10: Scientists worked out that a future quantum computer may need far fewer parts than expected to crack the locks that protect bank websites, so those locks need upgrading sooner.
🧩 Think of it like: Like an engineer publishing full blueprints showing a bridge needs 40 times fewer steel beams than everyone assumed: the bridge is not built yet, but the cost estimate just shrank.
Readiness22/100
Years to market: 6-10
Our judgment
🎢 Hype vs Reality
Hype 80
Reality 22
Mostly hype so far (our judgment)
⚖️ Patent / IP risk
Quantum error-correction patents are crowded; no known dispute. (our judgment)
🔒 Patent risk noteIncluded in Pro & InstitutionalUnlock Premium
🏆 Who could win
Post-quantum security chip and software vendors (our judgment)Cat-qubit hardware makers, if the hardware follows (our judgment)
💰 Investor view👀 Too early: keep an eye on it
In plain words: Scientists worked out that a future quantum computer may need far fewer parts than expected to crack the locks that protect bank websites, so those locks need upgrading sooner.
Direct: Post-quantum security chips are its focus (our judgment)
Winner
Medium
Other possible winners: Post-quantum security chip and software vendors, Cat-qubit hardware makers, if the hardware follows (our judgment)
⚠️ Who could lose
Today's encryption vendors if quantum-safe upgrades lag (our judgment)
Over-hyped quantum stocks if timelines slip (our judgment)
✅ Why now
A preprint (IACR ePrint 2026/2665) maps Shor's code-breaking algorithm all the way down to a physical chip layout. It estimates RSA-2048 could be factored with 22,593 physical cat qubits in 3.14 days, about 40 times fewe…
Readiness 22/100, stage 1 on our ladder.
U=-5: ½×readiness 22 + 0 (no big event expected soon) − 8×2 kill-risk flag(s)
⛔ Why not yet
Estimate rests on hardware assumptions not yet demonstrated
Alice & Bob is private; listed exposure is indirect (our judgment)
Timeline to impact: about 6-10 years (our judgment)
⬆️ Upgrade triggers
Concrete date or release: Peer review of the preprint and Alice & Bob hardware milestones toward error-corrected cat qubits.
A named paying customer or order
Independent replication / outside test results
Readiness reaching 70+ with a dated catalyst within 90 days (our 🔥 rule)
⬇️ Downgrade signals
Delay or missed milestone (our judgment)
Independent tests fail to confirm the claim (our judgment)
A rival leapfrogs or rules/regulators block it (our judgment)
🧭 Simple plan for this item (👀 Too early: keep an eye on it)
Don't buy because of this item yet.
Add the tickers to a watchlist and check the triggers below each week.
Move to Build only if 2+ upgrade triggers happen.
Tiers: 👀 Too early: keep an eye on it = track triggers only · ⏳ Promising = small staged position · 🔥 Act = catalyst near, sized small. No return promises.
🗓 Timeline
1 yr (our judgment): Banks and governments speed up post-quantum upgrades
3 yr (our judgment): First small error-corrected cat-qubit demos
5 yr+ (our judgment): Machines of this size remain uncertain
📖 What these words mean
Readiness: our 0–100 score for how close an idea is to real products and sales. Higher = closer.
Conviction: how confident we are in a company's link to the idea (high, medium, low).
Ticker / stock code: the short code used to find a company's share on an exchange, e.g. NVDA.
Catalyst / next big event: a dated event (launch, approval, results) that could move the story.
Urgency: our badge for how time-sensitive it is: 🔥 strong signal, ⏳ promising, 👀 too early.
Our judgment · Not financial advice
🇮🇳 Indian investor angle
No NSE quantum pure play. Access via international funds (e.g. Nasdaq-100 fund-of-funds) or US ETFs like QTUM under LRS. (our judgment)
Our judgment · Not financial advice. Exposure notes are qualitative; we don't quote % of revenue unless sourced.
🐂 Bull case
A preprint (IACR ePrint 2026/2665) maps Shor's code-breaking algorithm all the way down to a physical chip layout.
Who could win: Post-quantum security chip and software vendors (our judgment), Cat-qubit hardware makers, if the hardware follows (our judgment)
🐻 What could go wrong
Estimate rests on hardware assumptions not yet demonstrated source
Alice & Bob is private; listed exposure is indirect (our judgment) (judgment)
📐 How we scored this
Criterion
Score
Weight
Points
Evidence level
1/5 — Lab demo
55%
5.5
Manufacturability
1/5
20%
4.0
Supply chain
2/5
10%
4.0
Corporate backing
3/5
10%
6.0
Independent groups
3/5
5%
3.0
Readiness
22/100
Hype = 10×claim boldness (4/5) + 10×attention (4/5) = 80. Patent/IP risk: Medium (crowding 3/5, litigation 1/5). Sub-scores are our judgment from the linked sources. Full method
👀 What to watch next: Peer review of the preprint and Alice & Bob hardware milestones toward error-corrected cat qubits.
⏰ Time Machinedrag: 1 → 3 → 5 years (our scenario, not a forecast)
In 1 year: 1 yr (our judgment): Banks and governments speed up post-quantum upgrades
📋 Executive briefing teaser free
This is a paper estimate, not a working machine.
This is a paper estimate, not a working machine. It assumes hardware that does not exist yet (1-microsecond error-correction cycles and almost no bit-flip errors); with hourly bit-flips the machine grows to about 45,000 qubits. Each such cut shortens the safe window for today's encryption. US NIST and the UK NCSC direct critical systems to move to post-quantum encryption by 2035.
🔒 Full executive briefingIncluded in Pro & InstitutionalUnlock Premium
🎬 30-second video script Premium
Alice & Bob: about 22,600 'cat qubits' could break RSA-2048 encryption in about 3 days, on paper. Like an engineer publishing full blueprints showing a bridge needs 40 times fewer steel beams than everyone assumed: the bridge is not built yet, but the cost estimate just shrank. Our judgment: watch. Sources on our page.
🔒 Video script with citationsIncluded in Pro & InstitutionalUnlock Premium
🆕 New todayReadiness vs prev: 🆕 new · Updated 2026-10-31
Stage 3 · Flight👀 Too early: keep an eye on itNavigation satellite launch
2. ISRO's GSLV-F18 puts NVS-03 in orbit, set to restore India's own GPS (NavIC)
🧩 Like lighthouses along a coast: a ship needs to see at least four lights to fix its position. One light had gone dark, and this launch relights it.
UFOProcure Space ETFMTARTECH.NSMTAR Technologies
🏛 ISRO (Indian Space Research Organisation) · 📅 2026-10-30
👀 Too early: keep an eye on itOur judgment · Not financial advice
1Design
2Testing
3Flight
4Operations
💡 What it is
🔬 GSLV-F18 lifted off from Sriharikota at 11:51 pm IST on Oct 30 and placed the 2,250 kg NVS-03 satellite in a transfer orbit about 18 minutes later.
🧩 Like lighthouses along a coast: a ship needs to see at least four lights to fix its position. One light had gone dark, and this launch relights it.
🚀 Why it matters
📈 Readiness 78/100 · Flight
⏳ 0-2 yrs to market (our judgment)
🎯 NavIC is India's regional navigation system, covering India and about 1,500 km around it.
💰 Who gains
UFOProcure Space ETFMTARTECH.NSMTAR Technologies
🏷 Indian space and defence suppliers (our judgment)
🏷 Phone, car and chip makers adding NavIC L1 support (our judgment)
⚠️ Risks
❌ Orbit-raising is the step where NVS-02 failed in 2025
✅ What to do
👀 Too early: keep an eye on it · plan: keep watching
🔎 Watch for: Orbit-raising and commissioning of NVS-03; launch dates for NVS-04/05; ISRO's next launches this financial year.
🗓 Timeline
1 yrNVS-03 commissioned; standalone NavIC positioning back
3 yrNVS-04/05 complete the new series
5 yrNavIC common in Indian phones and vehicles
Timeline steps are our judgment unless marked as company plan.
What they found: GSLV-F18 lifted off from Sriharikota at 11:51 pm IST on Oct 30 and placed the 2,250 kg NVS-03 satellite in a transfer orbit about 18 minutes later. It carries an Indian-made atomic clock plus bought-in clocks, and adds the L1 signal that common phone chips already use. ISRO's chairman said the launch restores the minimum four satellites NavIC needs for positioning; it had only three working after NVS-02 failed to reach its orbit in 2025.
🧒 Like I'm 10: India launched a new satellite for its own map-and-location system, so phones and ships in India can rely less on America's GPS.
🧩 Think of it like: Like lighthouses along a coast: a ship needs to see at least four lights to fix its position. One light had gone dark, and this launch relights it.
Readiness78/100
Years to market: 0-2
Our judgment
🎢 Hype vs Reality
Hype 40
Reality 78
Reality is catching up (our judgment)
⚖️ Patent / IP risk
Government programme; low patent risk. (our judgment)
🔒 Patent risk noteIncluded in Pro & InstitutionalUnlock Premium
🏆 Who could win
Indian space and defence suppliers (our judgment)Phone, car and chip makers adding NavIC L1 support (our judgment)
💰 Investor view👀 Too early: keep an eye on it
In plain words: India launched a new satellite for its own map-and-location system, so phones and ships in India can rely less on America's GPS.
Indirect: Precision engineering; ISRO engine parts are one segment (our judgment)
Supplier
Medium
Other possible winners: Indian space and defence suppliers, Phone, car and chip makers adding NavIC L1 support (our judgment)
⚠️ Who could lose
Higher-cost launch providers (our judgment)
✅ Why now
GSLV-F18 lifted off from Sriharikota at 11:51 pm IST on Oct 30 and placed the 2,250 kg NVS-03 satellite in a transfer orbit about 18 minutes later. It carries an Indian-made atomic clock plus bought-in clocks, and adds t…
Readiness 78/100, stage 3 on our ladder.
U=39: ½×readiness 78 + 0 (no big event expected soon)
⛔ Why not yet
Orbit-raising is the step where NVS-02 failed in 2025
Listed suppliers earn only a small part of revenue from ISRO (our judgment)
Timeline to impact: about 0-2 years (our judgment)
⬆️ Upgrade triggers
Concrete date or release: Orbit-raising and commissioning of NVS-03; launch dates for NVS-04/05; ISRO's next launches this financial year.
A named paying customer or order
Independent replication / outside test results
Readiness reaching 70+ with a dated catalyst within 90 days (our 🔥 rule)
⬇️ Downgrade signals
Delay or missed milestone (our judgment)
Independent tests fail to confirm the claim (our judgment)
A rival leapfrogs or rules/regulators block it (our judgment)
🧭 Simple plan for this item (👀 Too early: keep an eye on it)
Don't buy because of this item yet.
Add the tickers to a watchlist and check the triggers below each week.
Move to Build only if 2+ upgrade triggers happen.
Tiers: 👀 Too early: keep an eye on it = track triggers only · ⏳ Promising = small staged position · 🔥 Act = catalyst near, sized small. No return promises.
🗓 Timeline
1 yr (our judgment): NVS-03 commissioned; standalone NavIC positioning back
3 yr (our judgment): NVS-04/05 complete the new series
5 yr (our judgment): NavIC common in Indian phones and vehicles
📖 What these words mean
Readiness: our 0–100 score for how close an idea is to real products and sales. Higher = closer.
Conviction: how confident we are in a company's link to the idea (high, medium, low).
Ticker / stock code: the short code used to find a company's share on an exchange, e.g. NVDA.
Catalyst / next big event: a dated event (launch, approval, results) that could move the story.
Urgency: our badge for how time-sensitive it is: 🔥 strong signal, ⏳ promising, 👀 too early.
Our judgment · Not financial advice
🇮🇳 Indian investor angle
NSE: HAL, BEL, MTARTECH (MTAR, ISRO engine parts), DATAPATTNS (Data Patterns) are defence/space suppliers; US via UFO/LRS. (our judgment)
Our judgment · Not financial advice. Exposure notes are qualitative; we don't quote % of revenue unless sourced.
🐂 Bull case
GSLV-F18 lifted off from Sriharikota at 11:51 pm IST on Oct 30 and placed the 2,250 kg NVS-03 satellite in a transfer orbit about 18 minutes later.
Who could win: Indian space and defence suppliers (our judgment), Phone, car and chip makers adding NavIC L1 support (our judgment)
🐻 What could go wrong
Orbit-raising is the step where NVS-02 failed in 2025 source
Listed suppliers earn only a small part of revenue from ISRO (our judgment) (judgment)
📐 How we scored this
Criterion
Score
Weight
Points
Evidence level
4/5 — Volume production or orders
55%
41.2
Manufacturability
4/5
20%
16.0
Supply chain
4/5
10%
8.0
Corporate backing
5/5
10%
10.0
Independent groups
3/5
5%
3.0
Readiness
78/100
Hype = 10×claim boldness (1/5) + 10×attention (3/5) = 40. Patent/IP risk: Low (crowding 1/5, litigation 1/5). Sub-scores are our judgment from the linked sources. Full method
👀 What to watch next: Orbit-raising and commissioning of NVS-03; launch dates for NVS-04/05; ISRO's next launches this financial year.
⏰ Time Machinedrag: 1 → 3 → 5 years (our scenario, not a forecast)
In 1 year: 1 yr (our judgment): NVS-03 commissioned; standalone NavIC positioning back
📋 Executive briefing teaser free
NavIC is India's regional navigation system, covering India and about 1,500 km around it.
NavIC is India's regional navigation system, covering India and about 1,500 km around it. Without four working satellites it could not give positions on its own (timing still worked). The new L1 signal makes NavIC easier to use in everyday phones. The satellite still has to raise itself to its final orbit and be commissioned; NVS-04 and NVS-05 are in advanced stages.
🔒 Full executive briefingIncluded in Pro & InstitutionalUnlock Premium
🎬 30-second video script Premium
ISRO's GSLV-F18 puts NVS-03 in orbit, set to restore India's own GPS (NavIC). Like lighthouses along a coast: a ship needs to see at least four lights to fix its position. One light had gone dark, and this launch relights it. Our judgment: watch. Sources on our page.
🔒 Video script with citationsIncluded in Pro & InstitutionalUnlock Premium
🆕 New todayReadiness vs prev: 🆕 new · Updated 2026-10-31
Stage 2 · Early trial (Ph 1/2)👀 Too early: keep an eye on itGene-editing regulation
3. FDA draft rule would let one approval cover many personalised gene-editing treatments
🧩 Like a tailor approved once for a suit pattern who can then cut each customer's size without a fresh approval, as long as the measurements stay inside the appro
👀 Too early: keep an eye on itOur judgment · Not financial advice
1Preclinical
2Early trial (Ph 1/2)
3Late trial (Ph 3)
4Approved
💡 What it is
🔬 FDA's draft guidance creates an 'Individualized Feature Space': pre-set limits on how a gene-editing therapy may differ from patient to patient while staying inside one Biologics License Application.
🧩 Like a tailor approved once for a suit pattern who can then cut each customer's size without a fresh approval, as long as the measurements stay inside the approved range.
🚀 Why it matters
📈 Readiness 57/100 · Early trial (Ph 1/2)
⏳ 2-4 yrs to market (our judgment)
🎯 Until now, a custom edit for one family's ultra-rare mutation looked like a brand-new drug needing its own trials, which is unaffordable for tiny patient groups.
🏷 Gene-editing developers with platform approaches (our judgment)
🏷 Contract manufacturers for gene therapies (our judgment)
⚠️ Risks
❌ Draft only; not binding and may change
✅ What to do
👀 Too early: keep an eye on it · plan: keep watching
🔎 Watch for: Final guidance after the Nov 27 comment deadline, and the first application filed under this framework.
📅 Catalyst: 2026-11-27 FDA comment deadline: individualized gene-editing draft guidance
🗓 Timeline
1 yrGuidance finalised
3 yrFirst platform-style approvals
5 yrCustom edits become a routine path for rare diseases
Timeline steps are our judgment unless marked as company plan.
What they found: FDA's draft guidance creates an 'Individualized Feature Space': pre-set limits on how a gene-editing therapy may differ from patient to patient while staying inside one Biologics License Application. If a new patient-specific version stays inside those limits and lab tests show adequate safety and activity, it can be added without new clinical trials. Public comments are open until Nov 27, 2026. CMS also plans to widen its Cell and Gene Therapy Access Model.
🧒 Like I'm 10: America's medicine regulator wants to make it easier to approve gene fixes made specially for each child with a rare disease.
🧩 Think of it like: Like a tailor approved once for a suit pattern who can then cut each customer's size without a fresh approval, as long as the measurements stay inside the approved range.
Readiness57/100
Years to market: 2-4
Our judgment
🎢 Hype vs Reality
Hype 50
Reality 57
Reality is catching up (our judgment)
⚖️ Patent / IP risk
CRISPR patent disputes are long-running in this field. (our judgment)
🔒 Patent risk noteIncluded in Pro & InstitutionalUnlock Premium
🏆 Who could win
Gene-editing developers with platform approaches (our judgment)Contract manufacturers for gene therapies (our judgment)
💰 Investor view👀 Too early: keep an eye on it
In plain words: America's medicine regulator wants to make it easier to approve gene fixes made specially for each child with a rare disease.
Direct: Clinical-stage in-body gene-editing company (our judgment)
Winner
Medium
Other possible winners: Gene-editing developers with platform approaches, Contract manufacturers for gene therapies (our judgment)
⚠️ Who could lose
Older therapy makers in the same disease if this works (our judgment)
✅ Why now
FDA's draft guidance creates an 'Individualized Feature Space': pre-set limits on how a gene-editing therapy may differ from patient to patient while staying inside one Biologics License Application. If a new patient-spe…
Companies still need a first approval before adding variants (our judgment)
Timeline to impact: about 2-4 years (our judgment)
⬆️ Upgrade triggers
Concrete date or release: Final guidance after the Nov 27 comment deadline, and the first application filed under this framework.
A named paying customer or order
Independent replication / outside test results
Readiness reaching 70+ with a dated catalyst within 90 days (our 🔥 rule)
⬇️ Downgrade signals
Delay or missed milestone (our judgment)
Independent tests fail to confirm the claim (our judgment)
A rival leapfrogs or rules/regulators block it (our judgment)
🧭 Simple plan for this item (👀 Too early: keep an eye on it)
Don't buy because of this item yet.
Add the tickers to a watchlist and check the triggers below each week.
Move to Build only if 2+ upgrade triggers happen.
Tiers: 👀 Too early: keep an eye on it = track triggers only · ⏳ Promising = small staged position · 🔥 Act = catalyst near, sized small. No return promises.
🗓 Timeline
1 yr (our judgment): Guidance finalised
3 yr (our judgment): First platform-style approvals
5 yr (our judgment): Custom edits become a routine path for rare diseases
📖 What these words mean
Readiness: our 0–100 score for how close an idea is to real products and sales. Higher = closer.
Conviction: how confident we are in a company's link to the idea (high, medium, low).
Ticker / stock code: the short code used to find a company's share on an exchange, e.g. NVDA.
Catalyst / next big event: a dated event (launch, approval, results) that could move the story.
Urgency: our badge for how time-sensitive it is: 🔥 strong signal, ⏳ promising, 👀 too early.
Our judgment · Not financial advice
🇮🇳 Indian investor angle
Indian CDMOs (e.g. SYNGENE, DIVISLAB) are indirect; US biotech only via international funds/LRS. (our judgment)
Our judgment · Not financial advice. Exposure notes are qualitative; we don't quote % of revenue unless sourced.
🐂 Bull case
FDA's draft guidance creates an 'Individualized Feature Space': pre-set limits on how a gene-editing therapy may differ from patient to patient while staying inside one Biologics License Application.
Who could win: Gene-editing developers with platform approaches (our judgment), Contract manufacturers for gene therapies (our judgment)
Companies still need a first approval before adding variants (our judgment) (judgment)
📐 How we scored this
Criterion
Score
Weight
Points
Evidence level
3/5 — Customer samples / qualification
55%
24.8
Manufacturability
3/5
20%
12.0
Supply chain
3/5
10%
6.0
Corporate backing
5/5
10%
10.0
Independent groups
4/5
5%
4.0
Readiness
57/100
Hype = 10×claim boldness (2/5) + 10×attention (3/5) = 50. Patent/IP risk: High (crowding 4/5, litigation 3/5). Sub-scores are our judgment from the linked sources. Full method
👀 What to watch next: Final guidance after the Nov 27 comment deadline, and the first application filed under this framework.
⏰ Time Machinedrag: 1 → 3 → 5 years (our scenario, not a forecast)
In 1 year: 1 yr (our judgment): Guidance finalised
📋 Executive briefing teaser free
Until now, a custom edit for one family's ultra-rare mutation looked like a brand-new drug needing its own trials, which is unaffordable for tiny patient groups.
Until now, a custom edit for one family's ultra-rare mutation looked like a brand-new drug needing its own trials, which is unaffordable for tiny patient groups. This is a draft and non-binding; the final version may change.
🔒 Full executive briefingIncluded in Pro & InstitutionalUnlock Premium
🎬 30-second video script Premium
FDA draft rule would let one approval cover many personalised gene-editing treatments. Like a tailor approved once for a suit pattern who can then cut each customer's size without a fresh approval, as long as the measurements stay inside the approved range. Our judgment: watch. Sources on our page.
🔒 Video script with citationsIncluded in Pro & InstitutionalUnlock Premium
🆕 New todayReadiness vs prev: 🆕 new · Updated 2026-10-31
Stage 2 · Prototype👀 Too early: keep an eye on it3D memory-on-logic AI chip
4. China's DF1000 AI chip stacks memory directly on its logic, reaching 6.4 TB/s without HBM
🧩 Like building the warehouse directly above the shop floor, linked by thousands of lifts, instead of trucking goods in from a depot across town.
BESI.ASBesiADEAAdeia
🏛 Dongfang Suanxin (Orient Silicon), private, China · 📅 2026-10-30
👀 Too early: keep an eye on itOur judgment · Not financial advice
1Paper
2Prototype
3Factories & orders
4Revenue
💡 What it is
🔬 At the Chip China expo in Shanghai, Dongfang Suanxin said it delivered the first fully domestic training cluster built on its DF1000 chip: 128 cards ran 72 hours without a stop and adapted the 130-billion-parameter Step 130B model in 7 days.
🧩 Like building the warehouse directly above the shop floor, linked by thousands of lifts, instead of trucking goods in from a depot across town.
🚀 Why it matters
📈 Readiness 52/100 · Prototype
⏳ 2-4 yrs to market (our judgment)
🎯 Today's AI chips sit beside stacks of HBM memory, and the link between them is a bottleneck; HBM is also scarce and restricted for Chinese buyers.
💰 Who gains
BESI.ASBesiADEAAdeia
🏷 Hybrid-bonding tool and IP companies (sector read-across) (our judgment)
🏷 Chinese AI cloud operators seeking non-HBM supply (our judgment)
⚠️ Risks
❌ Performance figures are company claims, not independent tests
✅ What to do
👀 Too early: keep an eye on it · plan: keep watching
🔎 Watch for: Delivery of the planned 1,000-card cluster by end-2026 and any independent benchmark.
🗓 Timeline
1 yr1,000-card clusters tested
3 yrMemory-on-logic stacking spreads to more AI chips
5 yrCould reduce HBM's role in some inference chips
Timeline steps are our judgment unless marked as company plan.
What they found: At the Chip China expo in Shanghai, Dongfang Suanxin said it delivered the first fully domestic training cluster built on its DF1000 chip: 128 cards ran 72 hours without a stop and adapted the 130-billion-parameter Step 130B model in 7 days. The chip bonds a memory (DRAM) wafer straight onto the logic wafer, copper to copper, with no bumps or interposer. The company claims 6.4 TB/s memory bandwidth and 520 TFLOPS (BF16) on an older 14nm process, and plans a 1,000-card cluster by end-2026.
🧒 Like I'm 10: A Chinese company put the chip's memory right on top of its brain, so data travels a tiny distance and the chip does not need hard-to-buy memory.
🧩 Think of it like: Like building the warehouse directly above the shop floor, linked by thousands of lifts, instead of trucking goods in from a depot across town.
Readiness52/100
Years to market: 2-4
Our judgment
🎢 Hype vs Reality
Hype 70
Reality 52
Some hype; watch for proof (our judgment)
⚖️ Patent / IP risk
Hybrid-bonding patents are crowded; no known dispute. (our judgment)
🔒 Patent risk noteIncluded in Pro & InstitutionalUnlock Premium
🏆 Who could win
Hybrid-bonding tool and IP companies (sector read-across) (our judgment)Chinese AI cloud operators seeking non-HBM supply (our judgment)
💰 Investor view👀 Too early: keep an eye on it
In plain words: A Chinese company put the chip's memory right on top of its brain, so data travels a tiny distance and the chip does not need hard-to-buy memory.
Other possible winners: Hybrid-bonding tool and IP companies (sector read-across), Chinese AI cloud operators seeking non-HBM supply (our judgment)
⚠️ Who could lose
Makers of older copper/electrical interconnect and packaging may lose share (our judgment)
✅ Why now
At the Chip China expo in Shanghai, Dongfang Suanxin said it delivered the first fully domestic training cluster built on its DF1000 chip: 128 cards ran 72 hours without a stop and adapted the 130-billion-parameter Step …
Readiness 52/100, stage 2 on our ladder.
U=18: ½×readiness 52 + 0 (no big event expected soon) − 8×1 kill-risk flag(s)
⛔ Why not yet
Performance figures are company claims, not independent tests
Private company; no direct listed exposure (our judgment)
Timeline to impact: about 2-4 years (our judgment)
⬆️ Upgrade triggers
Concrete date or release: Delivery of the planned 1,000-card cluster by end-2026 and any independent benchmark.
A named paying customer or order
Independent replication / outside test results
Readiness reaching 70+ with a dated catalyst within 90 days (our 🔥 rule)
⬇️ Downgrade signals
Delay or missed milestone (our judgment)
Independent tests fail to confirm the claim (our judgment)
A rival leapfrogs or rules/regulators block it (our judgment)
🧭 Simple plan for this item (👀 Too early: keep an eye on it)
Don't buy because of this item yet.
Add the tickers to a watchlist and check the triggers below each week.
Move to Build only if 2+ upgrade triggers happen.
Tiers: 👀 Too early: keep an eye on it = track triggers only · ⏳ Promising = small staged position · 🔥 Act = catalyst near, sized small. No return promises.
🗓 Timeline
1 yr (our judgment): 1,000-card clusters tested
3 yr (our judgment): Memory-on-logic stacking spreads to more AI chips
5 yr (our judgment): Could reduce HBM's role in some inference chips
📖 What these words mean
Readiness: our 0–100 score for how close an idea is to real products and sales. Higher = closer.
Conviction: how confident we are in a company's link to the idea (high, medium, low).
Ticker / stock code: the short code used to find a company's share on an exchange, e.g. NVDA.
Catalyst / next big event: a dated event (launch, approval, results) that could move the story.
Urgency: our badge for how time-sensitive it is: 🔥 strong signal, ⏳ promising, 👀 too early.
Our judgment · Not financial advice
🇮🇳 Indian investor angle
NSE: KAYNES and CGPOWER (both started chip assembly/test, OSAT, production at Sanand in 2026); US names via Nasdaq-100 or US-tech funds under the LRS route (RBI scheme for investing abroad). (our judgment)
Our judgment · Not financial advice. Exposure notes are qualitative; we don't quote % of revenue unless sourced.
🐂 Bull case
At the Chip China expo in Shanghai, Dongfang Suanxin said it delivered the first fully domestic training cluster built on its DF1000 chip: 128 cards ran 72 hours without a stop and adapted the 130-billion-parameter Step 130B model in 7 days.
Who could win: Hybrid-bonding tool and IP companies (sector read-across) (our judgment), Chinese AI cloud operators seeking non-HBM supply (our judgment)
🐻 What could go wrong
Performance figures are company claims, not independent tests source
Private company; no direct listed exposure (our judgment) (judgment)
📐 How we scored this
Criterion
Score
Weight
Points
Evidence level
3/5 — Customer samples / qualification
55%
24.8
Manufacturability
3/5
20%
12.0
Supply chain
3/5
10%
6.0
Corporate backing
3/5
10%
6.0
Independent groups
3/5
5%
3.0
Readiness
52/100
Hype = 10×claim boldness (4/5) + 10×attention (3/5) = 70. Patent/IP risk: Medium (crowding 4/5, litigation 2/5). Sub-scores are our judgment from the linked sources. Full method
👀 What to watch next: Delivery of the planned 1,000-card cluster by end-2026 and any independent benchmark.
⏰ Time Machinedrag: 1 → 3 → 5 years (our scenario, not a forecast)
In 1 year: 1 yr (our judgment): 1,000-card clusters tested
📋 Executive briefing teaser free
Today's AI chips sit beside stacks of HBM memory, and the link between them is a bottleneck; HBM is also scarce and restricted for Chinese buyers.
Today's AI chips sit beside stacks of HBM memory, and the link between them is a bottleneck; HBM is also scarce and restricted for Chinese buyers. DF1000 swaps leading-edge transistors for a much shorter, denser memory link. All performance figures are company claims; no independent benchmark yet.
🔒 Full executive briefingIncluded in Pro & InstitutionalUnlock Premium
🎬 30-second video script Premium
China's DF1000 AI chip stacks memory directly on its logic, reaching 6.4 TB/s without HBM. Like building the warehouse directly above the shop floor, linked by thousands of lifts, instead of trucking goods in from a depot across town. Our judgment: watch. Sources on our page.
🔒 Video script with citationsIncluded in Pro & InstitutionalUnlock Premium
🆕 New todayReadiness vs prev: 🆕 new · Updated 2026-10-31
Stage 3 · Generally available👀 Too early: keep an eye on itOpen-weight frontier model
5. Mistral releases the weights of Large 4, a ~1-trillion-parameter open model aimed at coding and cyber defence
🧩 Like a carmaker publishing its full engine design so any garage can build and tune the engine, while taxi companies selling rides with it need a separate licenc
NVDANvidiaMSFTMicrosoft
🏛 Mistral AI (private, France) · 📅 2026-10-29
👀 Too early: keep an eye on itOur judgment · Not financial advice
1Paper / research
2Limited preview
3Generally available
4Widely adopted
💡 What it is
🔬 Mistral made the weights of Mistral Large 4 ('Le Chonk') free to download after a preview that began Oct 6.
🧩 Like a carmaker publishing its full engine design so any garage can build and tune the engine, while taxi companies selling rides with it need a separate licence.
🚀 Why it matters
📈 Readiness 81/100 · Generally available
⏳ 0-2 yrs to market (our judgment)
🎯 Most top models can only be rented through an online service.
💰 Who gains
NVDANvidiaMSFTMicrosoft
🏷 Cloud and GPU providers hosting open models (our judgment)
🏷 European banks and governments wanting self-hosted AI (our judgment)
⚠️ Risks
❌ Benchmarks are Mistral's own
✅ What to do
👀 Too early: keep an eye on it · plan: keep watching
🔎 Watch for: Independent benchmark results and the promised technical report.
🗓 Timeline
1 yrSelf-hosted use grows in banks and government
3 yrOpen models close more of the gap to closed ones
5 yrMost firms mix open and closed models
Timeline steps are our judgment unless marked as company plan.
What they found: Mistral made the weights of Mistral Large 4 ('Le Chonk') free to download after a preview that began Oct 6. Mistral says it leads open-weight models on Cognition's FrontierCode 2.0 (19.7%) and Terminal-Bench 4.0 (41%), scores 51% on the Artificial Analysis Cyber Index and refuses 96.6% of malicious cyber requests on average. API price: $0.70 per million input tokens and $2.10 per million output tokens. Anyone may use and modify it, but companies selling it as a hosted service need a separate licence. It is also offered through Microsoft Foundry and NVIDIA NIM.
🧒 Like I'm 10: A French company shared its giant AI so anyone can run it on their own computers instead of renting it.
🧩 Think of it like: Like a carmaker publishing its full engine design so any garage can build and tune the engine, while taxi companies selling rides with it need a separate licence.
Readiness81/100
Years to market: 0-2
Our judgment
🎢 Hype vs Reality
Hype 60
Reality 81
Reality is catching up (our judgment)
⚖️ Patent / IP risk
AI copyright litigation is industry-wide. (our judgment)
🔒 Patent risk noteIncluded in Pro & InstitutionalUnlock Premium
🏆 Who could win
Cloud and GPU providers hosting open models (our judgment)European banks and governments wanting self-hosted AI (our judgment)
💰 Investor view👀 Too early: keep an eye on it
In plain words: A French company shared its giant AI so anyone can run it on their own computers instead of renting it.
Indirect: Owns a stake in and sells OpenAI models via Azure (our judgment)
Winner
Low (watchlist)
Other possible winners: Cloud and GPU providers hosting open models, European banks and governments wanting self-hosted AI (our judgment)
⚠️ Who could lose
Rival model labs and paid software that AI can replace (e.g. some IT-services work) (our judgment)
✅ Why now
Mistral made the weights of Mistral Large 4 ('Le Chonk') free to download after a preview that began Oct 6. Mistral says it leads open-weight models on Cognition's FrontierCode 2.0 (19.7%) and Terminal-Bench 4.0 (41%), s…
Readiness 81/100, stage 3 on our ladder.
U=32: ½×readiness 81 + 0 (no big event expected soon) − 8×1 kill-risk flag(s)
⛔ Why not yet
Benchmarks are Mistral's own
Mistral is private; listed exposure is indirect via Microsoft and Nvidia (our judgment)
Timeline to impact: about 0-2 years (our judgment)
⬆️ Upgrade triggers
Concrete date or release: Independent benchmark results and the promised technical report.
A named paying customer or order
Independent replication / outside test results
Readiness reaching 70+ with a dated catalyst within 90 days (our 🔥 rule)
⬇️ Downgrade signals
Delay or missed milestone (our judgment)
Independent tests fail to confirm the claim (our judgment)
A rival leapfrogs or rules/regulators block it (our judgment)
🧭 Simple plan for this item (👀 Too early: keep an eye on it)
Don't buy because of this item yet.
Add the tickers to a watchlist and check the triggers below each week.
Move to Build only if 2+ upgrade triggers happen.
Tiers: 👀 Too early: keep an eye on it = track triggers only · ⏳ Promising = small staged position · 🔥 Act = catalyst near, sized small. No return promises.
🗓 Timeline
1 yr (our judgment): Self-hosted use grows in banks and government
3 yr (our judgment): Open models close more of the gap to closed ones
5 yr (our judgment): Most firms mix open and closed models
📖 What these words mean
Readiness: our 0–100 score for how close an idea is to real products and sales. Higher = closer.
Conviction: how confident we are in a company's link to the idea (high, medium, low).
Ticker / stock code: the short code used to find a company's share on an exchange, e.g. NVDA.
Catalyst / next big event: a dated event (launch, approval, results) that could move the story.
Urgency: our badge for how time-sensitive it is: 🔥 strong signal, ⏳ promising, 👀 too early.
Our judgment · Not financial advice
🇮🇳 Indian investor angle
Nasdaq-100 fund-of-funds/ETFs on NSE (e.g. Nasdaq-100 ETF) hold GOOGL, MSFT, AMZN, META, NVDA; Indian IT is the local 'at risk/adopter' angle. (our judgment)
Mistral is private; listed exposure is indirect via Microsoft and Nvidia (our judgment) (judgment)
📐 How we scored this
Criterion
Score
Weight
Points
Evidence level
4/5 — Volume production or orders
55%
41.2
Manufacturability
5/5
20%
20.0
Supply chain
4/5
10%
8.0
Corporate backing
4/5
10%
8.0
Independent groups
4/5
5%
4.0
Readiness
81/100
Hype = 10×claim boldness (3/5) + 10×attention (3/5) = 60. Patent/IP risk: Medium (crowding 3/5, litigation 3/5). Sub-scores are our judgment from the linked sources. Full method
👀 What to watch next: Independent benchmark results and the promised technical report.
⏰ Time Machinedrag: 1 → 3 → 5 years (our scenario, not a forecast)
In 1 year: 1 yr (our judgment): Self-hosted use grows in banks and government
📋 Executive briefing teaser free
Most top models can only be rented through an online service.
Most top models can only be rented through an online service. Open weights let banks, governments and companies run AI on their own servers ('sovereign AI'). The benchmarks are Mistral's own, and on its human-preference coding test it still ranks behind a closed leader (Claude Opus 5.5).
🔒 Full executive briefingIncluded in Pro & InstitutionalUnlock Premium
🎬 30-second video script Premium
Mistral releases the weights of Large 4, a ~1-trillion-parameter open model aimed at coding and cyber defence. Like a carmaker publishing its full engine design so any garage can build and tune the engine, while taxi companies selling rides with it need a separate licence. Our judgment: watch. Sources on our page.
🔒 Video script with citationsIncluded in Pro & InstitutionalUnlock Premium
🆕 New todayReadiness vs prev: 🆕 new · Updated 2026-10-31
Stage 2 · Pilot👀 Too early: keep an eye on itRegTech / bank cybersecurity
6. RBI presses banks to prove cyber defences as AI-assisted API attacks hit Indian lenders
🧩 Like a housing society discovering thieves are coming in through the service lift that delivery partners use, so the guard now checks every partner's key card.
🏛 Reserve Bank of India (per Reuters sources) · 📅 2026-10-30
👀 Too early: keep an eye on itOur judgment · Not financial advice
1Research / sandbox
2Pilot
3Live launch
4Scaled & regulated
💡 What it is
🔬 Reuters, citing three people familiar with the matter, reports the RBI asked banks to probe weaknesses in APIs, the software links to non-bank lenders and fintechs, and to show proof of compliance and readiness for AI-related risks.
🧩 Like a housing society discovering thieves are coming in through the service lift that delivery partners use, so the guard now checks every partner's key card.
🚀 Why it matters
📈 Readiness 60/100 · Pilot
⏳ 2-4 yrs to market (our judgment)
🎯 Banks connect to fintechs and non-bank lenders through APIs, and smaller partners are 'softer targets'.
🏷 Cybersecurity and API-security vendors (our judgment)
🏷 Large banks with bigger security budgets (our judgment)
⚠️ Risks
❌ Based on unnamed sources; RBI did not comment
✅ What to do
👀 Too early: keep an eye on it · plan: keep watching
🔎 Watch for: Any formal RBI circular or penalties, and banks' disclosures on cyber spending.
🗓 Timeline
1 yrTighter API security checks
3 yrHigher bank cybersecurity spending
5 yrAI-versus-AI fraud defence becomes standard
Timeline steps are our judgment unless marked as company plan.
What they found: Reuters, citing three people familiar with the matter, reports the RBI asked banks to probe weaknesses in APIs, the software links to non-bank lenders and fintechs, and to show proof of compliance and readiness for AI-related risks. Two Mumbai non-bank lenders lost about $2 million in more than 700 unauthorised instant transfers on Oct 8-9 after hackers compromised an API link to ICICI Bank, according to a police complaint. SBI said data of 3,900 customers leaked. CERT-In warned on Oct 9 that hackers steal banks' API credentials, possibly with AI tools.
🧒 Like I'm 10: Hackers are sneaking money out through the digital doors banks share with apps, so India's central bank is telling banks to lock those doors better.
🧩 Think of it like: Like a housing society discovering thieves are coming in through the service lift that delivery partners use, so the guard now checks every partner's key card.
Readiness60/100
Years to market: 2-4
Our judgment
🎢 Hype vs Reality
Hype 50
Reality 60
Reality is catching up (our judgment)
⚖️ Patent / IP risk
Policy and security risk, not patent risk. (our judgment)
🔒 Patent risk noteIncluded in Pro & InstitutionalUnlock Premium
🏆 Who could win
Cybersecurity and API-security vendors (our judgment)Large banks with bigger security budgets (our judgment)
💰 Investor view👀 Too early: keep an eye on it
In plain words: Hackers are sneaking money out through the digital doors banks share with apps, so India's central bank is telling banks to lock those doors better.
Direct: Cybersecurity software is its core business (our judgment)
Winner
Medium
Other possible winners: Cybersecurity and API-security vendors, Large banks with bigger security budgets (our judgment)
⚠️ Who could lose
Incumbent banks/payment firms slow to adopt (our judgment)
✅ Why now
Reuters, citing three people familiar with the matter, reports the RBI asked banks to probe weaknesses in APIs, the software links to non-bank lenders and fintechs, and to show proof of compliance and readiness for AI-re…
Readiness 60/100, stage 2 on our ladder.
U=30: ½×readiness 60 + 0 (no big event expected soon)
⛔ Why not yet
Based on unnamed sources; RBI did not comment
Higher compliance cost for small lenders (our judgment)
Timeline to impact: about 2-4 years (our judgment)
⬆️ Upgrade triggers
Concrete date or release: Any formal RBI circular or penalties, and banks' disclosures on cyber spending.
A named paying customer or order
Independent replication / outside test results
Readiness reaching 70+ with a dated catalyst within 90 days (our 🔥 rule)
⬇️ Downgrade signals
Delay or missed milestone (our judgment)
Independent tests fail to confirm the claim (our judgment)
A rival leapfrogs or rules/regulators block it (our judgment)
🧭 Simple plan for this item (👀 Too early: keep an eye on it)
Don't buy because of this item yet.
Add the tickers to a watchlist and check the triggers below each week.
Move to Build only if 2+ upgrade triggers happen.
Tiers: 👀 Too early: keep an eye on it = track triggers only · ⏳ Promising = small staged position · 🔥 Act = catalyst near, sized small. No return promises.
🗓 Timeline
1 yr (our judgment): Tighter API security checks
3 yr (our judgment): Higher bank cybersecurity spending
5 yr (our judgment): AI-versus-AI fraud defence becomes standard
📖 What these words mean
Readiness: our 0–100 score for how close an idea is to real products and sales. Higher = closer.
Conviction: how confident we are in a company's link to the idea (high, medium, low).
Ticker / stock code: the short code used to find a company's share on an exchange, e.g. NVDA.
Catalyst / next big event: a dated event (launch, approval, results) that could move the story.
Urgency: our badge for how time-sensitive it is: 🔥 strong signal, ⏳ promising, 👀 too early.
Our judgment · Not financial advice
🇮🇳 Indian investor angle
NSE: PAYTM, BAJFINANCE, POLICYBZR, CAMS, HDFCBANK are the closest local plays. (our judgment)
Our judgment · Not financial advice. Exposure notes are qualitative; we don't quote % of revenue unless sourced.
🐂 Bull case
Reuters, citing three people familiar with the matter, reports the RBI asked banks to probe weaknesses in APIs, the software links to non-bank lenders and fintechs, and to show proof of compliance and readiness for AI-related risks.
Who could win: Cybersecurity and API-security vendors (our judgment), Large banks with bigger security budgets (our judgment)
🐻 What could go wrong
Based on unnamed sources; RBI did not comment source
Higher compliance cost for small lenders (our judgment) (judgment)
📐 How we scored this
Criterion
Score
Weight
Points
Evidence level
3/5 — Customer samples / qualification
55%
24.8
Manufacturability
4/5
20%
16.0
Supply chain
4/5
10%
8.0
Corporate backing
4/5
10%
8.0
Independent groups
3/5
5%
3.0
Readiness
60/100
Hype = 10×claim boldness (2/5) + 10×attention (3/5) = 50. Patent/IP risk: Low (crowding 1/5, litigation 1/5). Sub-scores are our judgment from the linked sources. Full method
👀 What to watch next: Any formal RBI circular or penalties, and banks' disclosures on cyber spending.
⏰ Time Machinedrag: 1 → 3 → 5 years (our scenario, not a forecast)
In 1 year: 1 yr (our judgment): Tighter API security checks
📋 Executive briefing teaser free
Banks connect to fintechs and non-bank lenders through APIs, and smaller partners are 'softer targets'.
Banks connect to fintechs and non-bank lenders through APIs, and smaller partners are 'softer targets'. RBI already has cyber rules, but sources say banks lag in applying them. This is based on unnamed sources, not an official RBI circular.
🔒 Full executive briefingIncluded in Pro & InstitutionalUnlock Premium
🎬 30-second video script Premium
RBI presses banks to prove cyber defences as AI-assisted API attacks hit Indian lenders. Like a housing society discovering thieves are coming in through the service lift that delivery partners use, so the guard now checks every partner's key card. Our judgment: watch. Sources on our page.
🔒 Video script with citationsIncluded in Pro & InstitutionalUnlock Premium
🆕 New todayReadiness vs prev: 🆕 new · Updated 2026-10-31
Stage 2 · Pilot / feasibility👀 Too early: keep an eye on itVisual brain implant
7. A wireless brain implant for artificial vision goes into a third blind patient
🧩 Like a stadium light board: each electrode switches on one bulb, and a pattern of bulbs draws a rough picture even when the TV camera (the eye) is broken.
No listed ticker linked
🏛 Illinois Tech (lead) with Rush University Medical Center and partners · 📅 2026-10-29
👀 Too early: keep an eye on itOur judgment · Not financial advice
1Lab study
2Pilot / feasibility
3Pivotal trial
4Approved device
💡 What it is
🔬 Rush surgeons implanted the Intracortical Visual Prosthesis (ICVP) in a third participant: 34 wireless stimulators carrying 544 electrodes in total, placed in the brain's vision area.
🧩 Like a stadium light board: each electrode switches on one bulb, and a pattern of bulbs draws a rough picture even when the TV camera (the eye) is broken.
🚀 Why it matters
📈 Readiness 33/100 · Pilot / feasibility
⏳ 3-6 yrs to market (our judgment)
🎯 Most sight aids need a working optic nerve.
💰 Who gains
No listed pure-play linked (private or small part of a big company)
❌ Only three participants and no published outcomes yet
✅ What to do
👀 Too early: keep an eye on it · plan: Wait
🔎 Watch for: Published results on what participants can see and do.
🗓 Timeline
1 yrFirst results on what participants perceive
3 yrLarger trial if results hold
5 yr+Possible path toward device approval
Timeline steps are our judgment unless marked as company plan.
What they found: Rush surgeons implanted the Intracortical Visual Prosthesis (ICVP) in a third participant: 34 wireless stimulators carrying 544 electrodes in total, placed in the brain's vision area. It bypasses the eye and optic nerve. The study tests whether people who went blind as adults can use it to move around and do simple visually guided tasks, following each person for one to three years.
🧒 Like I'm 10: Doctors put tiny wireless parts in a blind person's brain that may let them see dots of light to help them get around.
🧩 Think of it like: Like a stadium light board: each electrode switches on one bulb, and a pattern of bulbs draws a rough picture even when the TV camera (the eye) is broken.
Readiness33/100
Years to market: 3-6
Our judgment
🎢 Hype vs Reality
Hype 40
Reality 33
Reality is catching up (our judgment)
⚖️ Patent / IP risk
Neural-implant patents are moderately crowded; no known dispute. (our judgment)
🔒 Patent risk noteIncluded in Pro & InstitutionalUnlock Premium
🏆 Who could win
Makers of neural-implant parts (our judgment)Low-vision rehabilitation services (our judgment)
💰 Investor view👀 Too early: keep an eye on it
In plain words: Doctors put tiny wireless parts in a blind person's brain that may let them see dots of light to help them get around.
📊 Stocks tied to this
Company
Stock code
How it is linked
Role
Conviction
No listed company directly tied yet. Developer: Illinois Tech (lead) with Rush University Medical Center and partners. Watch for a listed partner or IPO.
Other possible winners: Makers of neural-implant parts, Low-vision rehabilitation services (our judgment)
⚠️ Who could lose
Older assistive-device makers (our judgment)
✅ Why now
Rush surgeons implanted the Intracortical Visual Prosthesis (ICVP) in a third participant: 34 wireless stimulators carrying 544 electrodes in total, placed in the brain's vision area. It bypasses the eye and optic nerve.…
Readiness 33/100, stage 2 on our ladder.
U=16: ½×readiness 33 + 0 (no big event expected soon) · no listed ticker linked → 👀 too early
⛔ Why not yet
Only three participants and no published outcomes yet
Partners are mostly private; no listed exposure (our judgment)
Timeline to impact: about 3-6 years (our judgment)
⬆️ Upgrade triggers
Concrete date or release: Published results on what participants can see and do.
A named paying customer or order
Independent replication / outside test results
Readiness reaching 70+ with a dated catalyst within 90 days (our 🔥 rule)
⬇️ Downgrade signals
Delay or missed milestone (our judgment)
Independent tests fail to confirm the claim (our judgment)
A rival leapfrogs or rules/regulators block it (our judgment)
🧭 Simple plan for this item (👀 Too early: keep an eye on it)
Don't buy because of this item yet.
Add the tickers to a watchlist and check the triggers below each week.
Move to Build only if 2+ upgrade triggers happen.
Tiers: 👀 Too early: keep an eye on it = track triggers only · ⏳ Promising = small staged position · 🔥 Act = catalyst near, sized small. No return promises.
🗓 Timeline
1 yr (our judgment): First results on what participants perceive
3 yr (our judgment): Larger trial if results hold
5 yr+ (our judgment): Possible path toward device approval
📖 What these words mean
Readiness: our 0–100 score for how close an idea is to real products and sales. Higher = closer.
Conviction: how confident we are in a company's link to the idea (high, medium, low).
Ticker / stock code: the short code used to find a company's share on an exchange, e.g. NVDA.
Catalyst / next big event: a dated event (launch, approval, results) that could move the story.
Urgency: our badge for how time-sensitive it is: 🔥 strong signal, ⏳ promising, 👀 too early.
Our judgment · Not financial advice
🇮🇳 Indian investor angle
No Indian listed exposure; US access only via international funds/LRS. (our judgment)
Our judgment · Not financial advice. Exposure notes are qualitative; we don't quote % of revenue unless sourced.
🐂 Bull case
Rush surgeons implanted the Intracortical Visual Prosthesis (ICVP) in a third participant: 34 wireless stimulators carrying 544 electrodes in total, placed in the brain's vision area.
Who could win: Makers of neural-implant parts (our judgment), Low-vision rehabilitation services (our judgment)
🐻 What could go wrong
Only three participants and no published outcomes yet source
Partners are mostly private; no listed exposure (our judgment) (judgment)
📐 How we scored this
Criterion
Score
Weight
Points
Evidence level
2/5 — Working prototype chip
55%
13.8
Manufacturability
2/5
20%
8.0
Supply chain
2/5
10%
4.0
Corporate backing
2/5
10%
4.0
Independent groups
3/5
5%
3.0
Readiness
33/100
Hype = 10×claim boldness (2/5) + 10×attention (2/5) = 40. Patent/IP risk: Low (crowding 2/5, litigation 1/5). Sub-scores are our judgment from the linked sources. Full method
👀 What to watch next: Published results on what participants can see and do.
⏰ Time Machinedrag: 1 → 3 → 5 years (our scenario, not a forecast)
In 1 year: 1 yr (our judgment): First results on what participants perceive
📋 Executive briefing teaser free
Most sight aids need a working optic nerve.
Most sight aids need a working optic nerve. ICVP talks directly to the visual cortex, with fully implanted wireless parts. It is an early study with three people so far, and no results on what they can see have been published yet.
🔒 Full executive briefingIncluded in Pro & InstitutionalUnlock Premium
🎬 30-second video script Premium
A wireless brain implant for artificial vision goes into a third blind patient. Like a stadium light board: each electrode switches on one bulb, and a pattern of bulbs draws a rough picture even when the TV camera (the eye) is broken. Our judgment: wait. Sources on our page.
🔒 Video script with citationsIncluded in Pro & InstitutionalUnlock Premium
🆕 New todayReadiness vs prev: 🆕 new · Updated 2026-10-31
Stage 2 · Prototype system👀 Too early: keep an eye on itDNA synthesis chip
8. AtlasBase unveils 'Thalia', a DNA-writing chip with 5.6 billion sites, 700× earlier chips
🧩 Like going from one printing press to a newspaper plant with billions of tiny presses printing side by side.
TWSTTwist Bioscience
🏛 AtlasBase (private) · 📅 2026-10-28
👀 Too early: keep an eye on itOur judgment · Not financial advice
1Lab proof
2Prototype system
3Pilot archives
4Commercial service
💡 What it is
🔬 AtlasBase announced a molecular computing platform built on Thalia, a CMOS chip with 5.6 billion electrochemical sites that write synthetic DNA.
🧩 Like going from one printing press to a newspaper plant with billions of tiny presses printing side by side.
🚀 Why it matters
📈 Readiness 36/100 · Prototype system
⏳ 3-6 yrs to market (our judgment)
🎯 Writing DNA is the slowest and costliest step of DNA storage.
💰 Who gains
TWSTTwist Bioscience
🏷 Foundries making biochips (our judgment)
🏷 Media and archive owners needing century-scale storage (our judgment)
⚠️ Risks
❌ Company announcement without speed or cost data
✅ What to do
👀 Too early: keep an eye on it · plan: Wait
🔎 Watch for: Published write speed, cost per gigabyte and first named customers.
🗓 Timeline
1 yrEarly-access pilots
3 yrFirst paid archive projects
5 yrNiche cold storage if costs fall
Timeline steps are our judgment unless marked as company plan.
What they found: AtlasBase announced a molecular computing platform built on Thalia, a CMOS chip with 5.6 billion electrochemical sites that write synthetic DNA. It calls this a 700-fold scale-up over earlier DNA synthesis chips. The platform targets archiving data in DNA and DNA-based computing for search and optimisation problems. Early-access programmes are open to selected partners.
🧒 Like I'm 10: A company built a computer chip that can write billions of DNA strands at once, a step toward saving files in DNA.
🧩 Think of it like: Like going from one printing press to a newspaper plant with billions of tiny presses printing side by side.
Readiness36/100
Years to market: 3-6
Our judgment
🎢 Hype vs Reality
Hype 60
Reality 36
Some hype; watch for proof (our judgment)
⚖️ Patent / IP risk
DNA synthesis patents are active; no known dispute. (our judgment)
🔒 Patent risk noteIncluded in Pro & InstitutionalUnlock Premium
🏆 Who could win
Foundries making biochips (our judgment)Media and archive owners needing century-scale storage (our judgment)
💰 Investor view👀 Too early: keep an eye on it
In plain words: A company built a computer chip that can write billions of DNA strands at once, a step toward saving files in DNA.
Direct: Makes synthetic DNA; DNA storage is a small side bet (our judgment)
Supplier
Low (watchlist)
Other possible winners: Foundries making biochips, Media and archive owners needing century-scale storage (our judgment)
⚠️ Who could lose
Tape/archive storage vendors, only in the very long run (our judgment)
✅ Why now
AtlasBase announced a molecular computing platform built on Thalia, a CMOS chip with 5.6 billion electrochemical sites that write synthetic DNA. It calls this a 700-fold scale-up over earlier DNA synthesis chips. The pla…
Readiness 36/100, stage 2 on our ladder.
U=10: ½×readiness 36 + 0 (no big event expected soon) − 8×1 kill-risk flag(s)
⛔ Why not yet
Company announcement without speed or cost data
Private; listed exposure only via rivals such as Twist (our judgment)
Timeline to impact: about 3-6 years (our judgment)
⬆️ Upgrade triggers
Concrete date or release: Published write speed, cost per gigabyte and first named customers.
A named paying customer or order
Independent replication / outside test results
Readiness reaching 70+ with a dated catalyst within 90 days (our 🔥 rule)
⬇️ Downgrade signals
Delay or missed milestone (our judgment)
Independent tests fail to confirm the claim (our judgment)
A rival leapfrogs or rules/regulators block it (our judgment)
🧭 Simple plan for this item (👀 Too early: keep an eye on it)
Don't buy because of this item yet.
Add the tickers to a watchlist and check the triggers below each week.
Move to Build only if 2+ upgrade triggers happen.
Tiers: 👀 Too early: keep an eye on it = track triggers only · ⏳ Promising = small staged position · 🔥 Act = catalyst near, sized small. No return promises.
🗓 Timeline
1 yr (our judgment): Early-access pilots
3 yr (our judgment): First paid archive projects
5 yr (our judgment): Niche cold storage if costs fall
📖 What these words mean
Readiness: our 0–100 score for how close an idea is to real products and sales. Higher = closer.
Conviction: how confident we are in a company's link to the idea (high, medium, low).
Ticker / stock code: the short code used to find a company's share on an exchange, e.g. NVDA.
Catalyst / next big event: a dated event (launch, approval, results) that could move the story.
Urgency: our badge for how time-sensitive it is: 🔥 strong signal, ⏳ promising, 👀 too early.
Our judgment · Not financial advice. Exposure notes are qualitative; we don't quote % of revenue unless sourced.
🐂 Bull case
AtlasBase announced a molecular computing platform built on Thalia, a CMOS chip with 5.6 billion electrochemical sites that write synthetic DNA.
Who could win: Foundries making biochips (our judgment), Media and archive owners needing century-scale storage (our judgment)
🐻 What could go wrong
Company announcement without speed or cost data source
Private; listed exposure only via rivals such as Twist (our judgment) (judgment)
📐 How we scored this
Criterion
Score
Weight
Points
Evidence level
2/5 — Working prototype chip
55%
13.8
Manufacturability
3/5
20%
12.0
Supply chain
2/5
10%
4.0
Corporate backing
2/5
10%
4.0
Independent groups
2/5
5%
2.0
Readiness
36/100
Hype = 10×claim boldness (4/5) + 10×attention (2/5) = 60. Patent/IP risk: Medium (crowding 3/5, litigation 1/5). Sub-scores are our judgment from the linked sources. Full method
👀 What to watch next: Published write speed, cost per gigabyte and first named customers.
⏰ Time Machinedrag: 1 → 3 → 5 years (our scenario, not a forecast)
In 1 year: 1 yr (our judgment): Early-access pilots
📋 Executive briefing teaser free
Writing DNA is the slowest and costliest step of DNA storage.
Writing DNA is the slowest and costliest step of DNA storage. A chip made on standard semiconductor lines could cut cost through massive parallel writing. No write speed, cost per gigabyte or error rate was disclosed.
🔒 Full executive briefingIncluded in Pro & InstitutionalUnlock Premium
🎬 30-second video script Premium
AtlasBase unveils 'Thalia', a DNA-writing chip with 5.6 billion sites, 700× earlier chips. Like going from one printing press to a newspaper plant with billions of tiny presses printing side by side. Our judgment: wait. Sources on our page.
🔒 Video script with citationsIncluded in Pro & InstitutionalUnlock Premium
Tracked since 2026-10-30Readiness vs prev: = no change · Updated 2026-10-30
History: 10-30 S1/28 → 10-31 S1/28
Stage 1 · Lab proof👀 Too early: keep an eye on itDNA storage codec
9. HKU's 'Gungnir' code recovers data from DNA damaged like 400-year-old archives
🧩 Like rebuilding a torn, faded letter by trying millions of guesses and checking each against a fingerprint until one fits.
TWSTTwist Bioscience
🏛 The University of Hong Kong (Faculty of Engineering) · 📅 2026-10-26
👀 Too early: keep an eye on itOur judgment · Not financial advice
1Lab proof
2Prototype system
3Pilot archives
4Commercial service
💡 What it is
🔬 A blockchain-inspired error-correction method uses computing power to guess and verify the original data.
🧩 Like rebuilding a torn, faded letter by trying millions of guesses and checking each against a fingerprint until one fits.
🚀 Why it matters
📈 Readiness 28/100 · Lab proof
⏳ 4-8 yrs to market (our judgment)
🎯 DNA can hold huge amounts of data for centuries, but the molecules decay and reading them adds errors.
💰 Who gains
TWSTTwist Bioscience
🏷 DNA synthesis and sequencing toolmakers (our judgment)
🏷 Archive and cloud storage providers (our judgment)
⚠️ Risks
❌ Result reported by the university; independent replication not yet shown
✅ What to do
👀 Too early: keep an eye on it · plan: Wait
🔎 Watch for: Independent tests and use with a commercial DNA-writing system.
🗓 Timeline
1 yrMore codec papers compare against it
3 yrPilot archives may test it
5 yrCould become a standard layer if DNA writing gets cheap
Timeline steps are our judgment unless marked as company plan.
What they found: A blockchain-inspired error-correction method uses computing power to guess and verify the original data. It tolerates error rates up to 20%, which HKU calls a fourfold improvement, and recovered data losslessly from DNA damaged to the level expected after about 400 years.
🧒 Like I'm 10: Scientists store files in DNA. This trick fixes the file even when the DNA gets very old and broken.
🧩 Think of it like: Like rebuilding a torn, faded letter by trying millions of guesses and checking each against a fingerprint until one fits.
Readiness28/100
Years to market: 4-8
Our judgment
🎢 Hype vs Reality
Hype 50
Reality 28
Some hype; watch for proof (our judgment)
⚖️ Patent / IP risk
Codec patents are active in DNA storage; no known litigation. (Our judgment)
🔒 Patent risk noteIncluded in Pro & InstitutionalUnlock Premium
🏆 Who could win
DNA synthesis and sequencing toolmakers (our judgment)Archive and cloud storage providers (our judgment)
💰 Investor view👀 Too early: keep an eye on it
In plain words: Scientists store files in DNA. This trick fixes the file even when the DNA gets very old and broken.
Direct: Makes synthetic DNA; DNA storage is a small side bet (our judgment)
Supplier
Low (watchlist)
Other possible winners: DNA synthesis and sequencing toolmakers, Archive and cloud storage providers (our judgment)
⚠️ Who could lose
Tape/archive storage vendors, only in the very long run (our judgment)
✅ Why now
A blockchain-inspired error-correction method uses computing power to guess and verify the original data. It tolerates error rates up to 20%, which HKU calls a fourfold improvement, and recovered data losslessly from DNA…
Readiness 28/100, stage 1 on our ladder.
U=6: ½×readiness 28 + 0 (no big event expected soon) − 8×1 kill-risk flag(s)
⛔ Why not yet
Result reported by the university; independent replication not yet shown
The real bottleneck, cost and speed of writing DNA, is not solved by a better code
Timeline to impact: about 4-8 years (our judgment)
⬆️ Upgrade triggers
Concrete date or release: Independent tests and use with a commercial DNA-writing system.
A named paying customer or order
Independent replication / outside test results
Readiness reaching 70+ with a dated catalyst within 90 days (our 🔥 rule)
⬇️ Downgrade signals
Delay or missed milestone (our judgment)
Independent tests fail to confirm the claim (our judgment)
A rival leapfrogs or rules/regulators block it (our judgment)
🧭 Simple plan for this item (👀 Too early: keep an eye on it)
Don't buy because of this item yet.
Add the tickers to a watchlist and check the triggers below each week.
Move to Build only if 2+ upgrade triggers happen.
Tiers: 👀 Too early: keep an eye on it = track triggers only · ⏳ Promising = small staged position · 🔥 Act = catalyst near, sized small. No return promises.
🗓 Timeline
1 yr (our judgment): More codec papers compare against it
3 yr (our judgment): Pilot archives may test it
5 yr (our judgment): Could become a standard layer if DNA writing gets cheap
📖 What these words mean
Readiness: our 0–100 score for how close an idea is to real products and sales. Higher = closer.
Conviction: how confident we are in a company's link to the idea (high, medium, low).
Ticker / stock code: the short code used to find a company's share on an exchange, e.g. NVDA.
Catalyst / next big event: a dated event (launch, approval, results) that could move the story.
Urgency: our badge for how time-sensitive it is: 🔥 strong signal, ⏳ promising, 👀 too early.
Our judgment · Not financial advice. Exposure notes are qualitative; we don't quote % of revenue unless sourced.
🐂 Bull case
A blockchain-inspired error-correction method uses computing power to guess and verify the original data.
Who could win: DNA synthesis and sequencing toolmakers (our judgment), Archive and cloud storage providers (our judgment)
🐻 What could go wrong
Result reported by the university; independent replication not yet shown source
The real bottleneck, cost and speed of writing DNA, is not solved by a better code (judgment)
📐 How we scored this
Criterion
Score
Weight
Points
Evidence level
1/5 — Lab demo
55%
5.5
Manufacturability
3/5
20%
12.0
Supply chain
2/5
10%
4.0
Corporate backing
2/5
10%
4.0
Independent groups
3/5
5%
3.0
Readiness
28/100
Hype = 10×claim boldness (3/5) + 10×attention (2/5) = 50. Patent/IP risk: Medium (crowding 3/5, litigation 1/5). Sub-scores are our judgment from the linked sources. Full method
👀 What to watch next: Independent tests and use with a commercial DNA-writing system.
⏰ Time Machinedrag: 1 → 3 → 5 years (our scenario, not a forecast)
In 1 year: 1 yr (our judgment): More codec papers compare against it
📋 Executive briefing teaser free
DNA can hold huge amounts of data for centuries, but the molecules decay and reading them adds errors.
DNA can hold huge amounts of data for centuries, but the molecules decay and reading them adds errors. Gungnir moves the burden to computers: more compute, stronger repair. Lab and computational result; writing DNA is still slow and costly.
🔒 Full executive briefingIncluded in Pro & InstitutionalUnlock Premium
🎬 30-second video script Premium
HKU's 'Gungnir' code recovers data from DNA damaged like 400-year-old archives. Like rebuilding a torn, faded letter by trying millions of guesses and checking each against a fingerprint until one fits. Our judgment: wait. Sources on our page.
🔒 Video script with citationsIncluded in Pro & InstitutionalUnlock Premium
Tracked since 2026-10-30Readiness vs prev: = no change · Updated 2026-10-30
History: 10-30 S1/28 → 10-31 S1/28
Stage 1 · Lab proof👀 Too early: keep an eye on itDNA storage system
10. DNA-SaM: a DNA storage system tested in the lab and in living cells with 100% recovery
🧩 Like a library that labels every shelf and refuses to print pages that would jam the photocopier.
No listed ticker linked
🏛 Research team publishing in Nature Communications · 📅 2026-10
👀 Too early: keep an eye on itOur judgment · Not financial advice
1Lab proof
2Prototype system
3Pilot archives
4Commercial service
💡 What it is
🔬 DNA-SaM combines fast encoding, checks that avoid problem DNA sequences, and a two-level index for large files.
🧩 Like a library that labels every shelf and refuses to print pages that would jam the photocopier.
🚀 Why it matters
📈 Readiness 28/100 · Lab proof
⏳ 4-8 yrs to market (our judgment)
🎯 Most DNA-storage codecs are slow or create sequences that break lab steps.
💰 Who gains
No listed pure-play linked (private or small part of a big company)
🏷 DNA synthesis and sequencing toolmakers (our judgment)
⚠️ Risks
❌ The 270 PB figure is a theoretical capacity, not data actually stored
✅ What to do
👀 Too early: keep an eye on it · plan: Wait
🔎 Watch for: Real-world archives beyond lab test files.
🗓 Timeline
1 yrBenchmarked against other codecs
3 yrUsed in larger lab demos
5 yrPart of a DNA-archive product stack if costs fall
Timeline steps are our judgment unless marked as company plan.
What they found: DNA-SaM combines fast encoding, checks that avoid problem DNA sequences, and a two-level index for large files. It was validated in vitro and in vivo with a 100% success rate and could theoretically hold more than 270 petabytes.
🧒 Like I'm 10: It is a smart filing system for storing computer files inside DNA, so even huge collections can be found again.
🧩 Think of it like: Like a library that labels every shelf and refuses to print pages that would jam the photocopier.
Readiness28/100
Years to market: 4-8
Our judgment
🎢 Hype vs Reality
Hype 50
Reality 28
Some hype; watch for proof (our judgment)
⚖️ Patent / IP risk
Crowded academic codec space. (Our judgment)
🔒 Patent risk noteIncluded in Pro & InstitutionalUnlock Premium
🏆 Who could win
DNA synthesis and sequencing toolmakers (our judgment)
💰 Investor view👀 Too early: keep an eye on it
In plain words: It is a smart filing system for storing computer files inside DNA, so even huge collections can be found again.
📊 Stocks tied to this
Company
Stock code
How it is linked
Role
Conviction
No listed company directly tied yet. Developer: Research team publishing in Nature Communications. Watch for a listed partner or IPO.
Other possible winners: DNA synthesis and sequencing toolmakers (our judgment)
⚠️ Who could lose
Tape/archive storage vendors, only in the very long run (our judgment)
✅ Why now
DNA-SaM combines fast encoding, checks that avoid problem DNA sequences, and a two-level index for large files. It was validated in vitro and in vivo with a 100% success rate and could theoretically hold more than 270 pe…
Readiness 28/100, stage 1 on our ladder.
U=6: ½×readiness 28 + 0 (no big event expected soon) − 8×1 kill-risk flag(s) · no listed ticker linked → 👀 too early
⛔ Why not yet
The 270 PB figure is a theoretical capacity, not data actually stored
Timeline to impact: about 4-8 years (our judgment)
⬆️ Upgrade triggers
Concrete date or release: Real-world archives beyond lab test files.
A named paying customer or order
Independent replication / outside test results
Readiness reaching 70+ with a dated catalyst within 90 days (our 🔥 rule)
⬇️ Downgrade signals
Delay or missed milestone (our judgment)
Independent tests fail to confirm the claim (our judgment)
A rival leapfrogs or rules/regulators block it (our judgment)
🧭 Simple plan for this item (👀 Too early: keep an eye on it)
Don't buy because of this item yet.
Add the tickers to a watchlist and check the triggers below each week.
Move to Build only if 2+ upgrade triggers happen.
Tiers: 👀 Too early: keep an eye on it = track triggers only · ⏳ Promising = small staged position · 🔥 Act = catalyst near, sized small. No return promises.
🗓 Timeline
1 yr (our judgment): Benchmarked against other codecs
3 yr (our judgment): Used in larger lab demos
5 yr (our judgment): Part of a DNA-archive product stack if costs fall
📖 What these words mean
Readiness: our 0–100 score for how close an idea is to real products and sales. Higher = closer.
Conviction: how confident we are in a company's link to the idea (high, medium, low).
Ticker / stock code: the short code used to find a company's share on an exchange, e.g. NVDA.
Catalyst / next big event: a dated event (launch, approval, results) that could move the story.
Urgency: our badge for how time-sensitive it is: 🔥 strong signal, ⏳ promising, 👀 too early.
Our judgment · Not financial advice. Exposure notes are qualitative; we don't quote % of revenue unless sourced.
🐂 Bull case
DNA-SaM combines fast encoding, checks that avoid problem DNA sequences, and a two-level index for large files.
Who could win: DNA synthesis and sequencing toolmakers (our judgment)
🐻 What could go wrong
The 270 PB figure is a theoretical capacity, not data actually stored source
📐 How we scored this
Criterion
Score
Weight
Points
Evidence level
1/5 — Lab demo
55%
5.5
Manufacturability
3/5
20%
12.0
Supply chain
2/5
10%
4.0
Corporate backing
2/5
10%
4.0
Independent groups
3/5
5%
3.0
Readiness
28/100
Hype = 10×claim boldness (3/5) + 10×attention (2/5) = 50. Patent/IP risk: Medium (crowding 3/5, litigation 1/5). Sub-scores are our judgment from the linked sources. Full method
👀 What to watch next: Real-world archives beyond lab test files.
⏰ Time Machinedrag: 1 → 3 → 5 years (our scenario, not a forecast)
In 1 year: 1 yr (our judgment): Benchmarked against other codecs
📋 Executive briefing teaser free
Most DNA-storage codecs are slow or create sequences that break lab steps.
Most DNA-storage codecs are slow or create sequences that break lab steps. DNA-SaM targets scale: linear-time encoding and an index for big archives. Capacity is theoretical.
🔒 Full executive briefingIncluded in Pro & InstitutionalUnlock Premium
🎬 30-second video script Premium
DNA-SaM: a DNA storage system tested in the lab and in living cells with 100% recovery. Like a library that labels every shelf and refuses to print pages that would jam the photocopier. Our judgment: wait. Sources on our page.
🔒 Video script with citationsIncluded in Pro & InstitutionalUnlock Premium
Tracked since 2026-10-30Readiness vs prev: = no change · Updated 2026-10-30
History: 10-30 S1/34 → 10-31 S1/34
Stage 1 · Lab proof👀 Too early: keep an eye on itDNA writing chip
11. A porous silica chip writes 11× more DNA per spot, a step to cheaper 'DNA drives'
🧩 Like turning a flat parking lot into a multi-storey garage: same footprint, many more cars.
TWSTTwist Bioscience
🏛 Research team publishing in Microsystems & Nanoengineering · 📅 2026-10
👀 Too early: keep an eye on itOur judgment · Not financial advice
1Lab proof
2Prototype system
3Pilot archives
4Commercial service
💡 What it is
🔬 A porous silica thin film raises on-chip DNA yield to more than 1,821 pmol per cm², over 11 times a flat surface, using chip-making-compatible electrochemistry.
🧩 Like turning a flat parking lot into a multi-storey garage: same footprint, many more cars.
🚀 Why it matters
📈 Readiness 34/100 · Lab proof
⏳ 2-6 yrs to market (our judgment)
🎯 Writing DNA is the costliest step in DNA storage.
💰 Who gains
TWSTTwist Bioscience
🏷 Twist Bioscience TWST (US) (our judgment)
🏷 Semiconductor foundries (our judgment)
⚠️ Risks
❌ Demonstrated with 121-letter strands in a lab-built system
✅ What to do
👀 Too early: keep an eye on it · plan: keep watching
🔎 Watch for: Scaling to dense arrays and longer strands.
🗓 Timeline
1 yrFollow-up with denser arrays
3 yrPrototype DNA-writing chips
5 yrCould cut DNA-write cost if paired with fab partners
Timeline steps are our judgment unless marked as company plan.
What they found: A porous silica thin film raises on-chip DNA yield to more than 1,821 pmol per cm², over 11 times a flat surface, using chip-making-compatible electrochemistry. The team wrote and recovered digital data with error rates comparable to other lab systems.
🧒 Like I'm 10: Making DNA for storage is slow. This chip has tiny sponge-like holes, so each spot makes much more DNA.
🧩 Think of it like: Like turning a flat parking lot into a multi-storey garage: same footprint, many more cars.
Readiness34/100
Years to market: 2-6
Our judgment
🎢 Hype vs Reality
Hype 40
Reality 34
Reality is catching up (our judgment)
⚖️ Patent / IP risk
Electrochemical DNA synthesis has several patent holders. (Our judgment)
🔒 Patent risk noteIncluded in Pro & InstitutionalUnlock Premium
Direct: Makes synthetic DNA; DNA storage is a small side bet (our judgment)
Supplier
Low (watchlist)
Other possible winners: Twist Bioscience TWST (US), Semiconductor foundries (our judgment)
⚠️ Who could lose
Tape/archive storage vendors, only in the very long run (our judgment)
✅ Why now
A porous silica thin film raises on-chip DNA yield to more than 1,821 pmol per cm², over 11 times a flat surface, using chip-making-compatible electrochemistry. The team wrote and recovered digital data with error rates …
Readiness 34/100, stage 1 on our ladder.
U=9: ½×readiness 34 + 0 (no big event expected soon) − 8×1 kill-risk flag(s)
⛔ Why not yet
Demonstrated with 121-letter strands in a lab-built system
Timeline to impact: about 2-6 years (our judgment)
⬆️ Upgrade triggers
Concrete date or release: Scaling to dense arrays and longer strands.
A named paying customer or order
Independent replication / outside test results
Readiness reaching 70+ with a dated catalyst within 90 days (our 🔥 rule)
⬇️ Downgrade signals
Delay or missed milestone (our judgment)
Independent tests fail to confirm the claim (our judgment)
A rival leapfrogs or rules/regulators block it (our judgment)
🧭 Simple plan for this item (👀 Too early: keep an eye on it)
Don't buy because of this item yet.
Add the tickers to a watchlist and check the triggers below each week.
Move to Build only if 2+ upgrade triggers happen.
Tiers: 👀 Too early: keep an eye on it = track triggers only · ⏳ Promising = small staged position · 🔥 Act = catalyst near, sized small. No return promises.
🗓 Timeline
1 yr (our judgment): Follow-up with denser arrays
3 yr (our judgment): Prototype DNA-writing chips
5 yr (our judgment): Could cut DNA-write cost if paired with fab partners
📖 What these words mean
Readiness: our 0–100 score for how close an idea is to real products and sales. Higher = closer.
Conviction: how confident we are in a company's link to the idea (high, medium, low).
Ticker / stock code: the short code used to find a company's share on an exchange, e.g. NVDA.
Catalyst / next big event: a dated event (launch, approval, results) that could move the story.
Urgency: our badge for how time-sensitive it is: 🔥 strong signal, ⏳ promising, 👀 too early.
Our judgment · Not financial advice. Exposure notes are qualitative; we don't quote % of revenue unless sourced.
🐂 Bull case
A porous silica thin film raises on-chip DNA yield to more than 1,821 pmol per cm², over 11 times a flat surface, using chip-making-compatible electrochemistry.
Who could win: Twist Bioscience TWST (US) (our judgment), Semiconductor foundries (our judgment)
🐻 What could go wrong
Demonstrated with 121-letter strands in a lab-built system source
📐 How we scored this
Criterion
Score
Weight
Points
Evidence level
1/5 — Lab demo
55%
5.5
Manufacturability
4/5
20%
16.0
Supply chain
3/5
10%
6.0
Corporate backing
2/5
10%
4.0
Independent groups
2/5
5%
2.0
Readiness
34/100
Hype = 10×claim boldness (2/5) + 10×attention (2/5) = 40. Patent/IP risk: Medium (crowding 3/5, litigation 1/5). Sub-scores are our judgment from the linked sources. Full method
👀 What to watch next: Scaling to dense arrays and longer strands.
⏰ Time Machinedrag: 1 → 3 → 5 years (our scenario, not a forecast)
In 1 year: 1 yr (our judgment): Follow-up with denser arrays
📋 Executive briefing teaser free
Writing DNA is the costliest step in DNA storage.
Writing DNA is the costliest step in DNA storage. Electrochemical chips pack many write sites but each site makes little DNA. A porous surface boosts yield per site while staying compatible with semiconductor processes.
🔒 Full executive briefingIncluded in Pro & InstitutionalUnlock Premium
🎬 30-second video script Premium
A porous silica chip writes 11× more DNA per spot, a step to cheaper 'DNA drives'. Like turning a flat parking lot into a multi-storey garage: same footprint, many more cars. Our judgment: watch. Sources on our page.
🔒 Video script with citationsIncluded in Pro & InstitutionalUnlock Premium
Tracked since 2026-10-30Readiness vs prev: = no change · Updated 2026-10-30
History: 10-30 S2/46 → 10-31 S2/46
Stage 2 · Hardware demo👀 Too early: keep an eye on itError correction
12. Google shows 'magic state cultivation' on its Willow chip, cutting errors about 40×
🧩 Like a kitchen that can finally make a rare spice in-house instead of waiting for costly imports; every complex recipe needs it.
GOOGLAlphabetQTUMDefiance Quantum ETF
🏛 Google Quantum AI (published in Science) · 📅 2026-10-15
👀 Too early: keep an eye on itOur judgment · Not financial advice
1Lab physics
2Hardware demo
3Cloud access / customers
4Commercial advantage
💡 What it is
🔬 Google demonstrated magic state cultivation on real hardware, reducing errors about 40 times versus un-cultivated states and reaching a record 99.99% logical fidelity for these T-states.
🧩 Like a kitchen that can finally make a rare spice in-house instead of waiting for costly imports; every complex recipe needs it.
🚀 Why it matters
📈 Readiness 46/100 · Hardware demo
⏳ 3-6 yrs to market (our judgment)
🎯 Useful quantum algorithms need special 'magic states' that are expensive to make.
💰 Who gains
GOOGLAlphabetQTUMDefiance Quantum ETF
🏷 Alphabet GOOGL (US)
🏷 Defiance Quantum ETF QTUM (our judgment)
⚠️ Risks
❌ Google says it still needs to show this at larger scale
✅ What to do
👀 Too early: keep an eye on it · plan: keep watching
🔎 Watch for: Cultivation at larger scale and inside a full logical computation.
🗓 Timeline
1 yrRepeated on bigger chips
3 yrCombined with logical qubits in algorithms
5 yrPart of an error-corrected machine if scaling works
Timeline steps are our judgment unless marked as company plan.
What they found: Google demonstrated magic state cultivation on real hardware, reducing errors about 40 times versus un-cultivated states and reaching a record 99.99% logical fidelity for these T-states.
🧒 Like I'm 10: Quantum computers need a special ingredient to do hard maths. Google found a cheaper way to make it.
🧩 Think of it like: Like a kitchen that can finally make a rare spice in-house instead of waiting for costly imports; every complex recipe needs it.
Readiness46/100
Years to market: 3-6
Our judgment
🎢 Hype vs Reality
Hype 70
Reality 46
Some hype; watch for proof (our judgment)
⚖️ Patent / IP risk
Large quantum patent portfolios at Google, IBM and others. (Our judgment)
🔒 Patent risk noteIncluded in Pro & InstitutionalUnlock Premium
Basket: ETF holding many quantum and computing stocks (our judgment)
Winner
Medium
Other possible winners: Alphabet GOOGL (US), Defiance Quantum ETF QTUM (our judgment)
⚠️ Who could lose
Today's encryption vendors if quantum-safe upgrades lag (our judgment)
Over-hyped quantum stocks if timelines slip (our judgment)
✅ Why now
Google demonstrated magic state cultivation on real hardware, reducing errors about 40 times versus un-cultivated states and reaching a record 99.99% logical fidelity for these T-states.
Readiness 46/100, stage 2 on our ladder.
U=23: ½×readiness 46 + 0 (no big event expected soon)
⛔ Why not yet
Google says it still needs to show this at larger scale
Quantum revenue at Alphabet is tiny relative to its size
Timeline to impact: about 3-6 years (our judgment)
⬆️ Upgrade triggers
Concrete date or release: Cultivation at larger scale and inside a full logical computation.
A named paying customer or order
Independent replication / outside test results
Readiness reaching 70+ with a dated catalyst within 90 days (our 🔥 rule)
⬇️ Downgrade signals
Delay or missed milestone (our judgment)
Independent tests fail to confirm the claim (our judgment)
A rival leapfrogs or rules/regulators block it (our judgment)
🧭 Simple plan for this item (👀 Too early: keep an eye on it)
Don't buy because of this item yet.
Add the tickers to a watchlist and check the triggers below each week.
Move to Build only if 2+ upgrade triggers happen.
Tiers: 👀 Too early: keep an eye on it = track triggers only · ⏳ Promising = small staged position · 🔥 Act = catalyst near, sized small. No return promises.
🗓 Timeline
1 yr (our judgment): Repeated on bigger chips
3 yr (our judgment): Combined with logical qubits in algorithms
5 yr (our judgment): Part of an error-corrected machine if scaling works
📖 What these words mean
Readiness: our 0–100 score for how close an idea is to real products and sales. Higher = closer.
Conviction: how confident we are in a company's link to the idea (high, medium, low).
Ticker / stock code: the short code used to find a company's share on an exchange, e.g. NVDA.
Catalyst / next big event: a dated event (launch, approval, results) that could move the story.
Urgency: our badge for how time-sensitive it is: 🔥 strong signal, ⏳ promising, 👀 too early.
Our judgment · Not financial advice
🇮🇳 Indian investor angle
No NSE quantum pure play. Access via international funds (e.g. Nasdaq-100 fund-of-funds) or US ETFs like QTUM under LRS. (our judgment)
Our judgment · Not financial advice. Exposure notes are qualitative; we don't quote % of revenue unless sourced.
🐂 Bull case
Google demonstrated magic state cultivation on real hardware, reducing errors about 40 times versus un-cultivated states and reaching a record 99.99% logical fidelity for these T-states.
Who could win: Alphabet GOOGL (US), Defiance Quantum ETF QTUM (our judgment)
🐻 What could go wrong
Google says it still needs to show this at larger scale source
Quantum revenue at Alphabet is tiny relative to its size (judgment)
📐 How we scored this
Criterion
Score
Weight
Points
Evidence level
2/5 — Working prototype chip
55%
13.8
Manufacturability
3/5
20%
12.0
Supply chain
3/5
10%
6.0
Corporate backing
5/5
10%
10.0
Independent groups
4/5
5%
4.0
Readiness
46/100
Hype = 10×claim boldness (3/5) + 10×attention (4/5) = 70. Patent/IP risk: Medium (crowding 3/5, litigation 1/5). Sub-scores are our judgment from the linked sources. Full method
👀 What to watch next: Cultivation at larger scale and inside a full logical computation.
⏰ Time Machinedrag: 1 → 3 → 5 years (our scenario, not a forecast)
In 1 year: 1 yr (our judgment): Repeated on bigger chips
📋 Executive briefing teaser free
Useful quantum algorithms need special 'magic states' that are expensive to make.
Useful quantum algorithms need special 'magic states' that are expensive to make. This is the first hardware demo of a cheaper method. Google says larger-scale demos are still needed.
🔒 Full executive briefingIncluded in Pro & InstitutionalUnlock Premium
🎬 30-second video script Premium
Google shows 'magic state cultivation' on its Willow chip, cutting errors about 40×. Like a kitchen that can finally make a rare spice in-house instead of waiting for costly imports; every complex recipe needs it. Our judgment: watch. Sources on our page.
🔒 Video script with citationsIncluded in Pro & InstitutionalUnlock Premium
Tracked since 2026-10-30Readiness vs prev: = no change · Updated 2026-10-30
History: 10-30 S2/54 → 10-31 S2/54
Stage 2 · Hardware demo👀 Too early: keep an eye on itError correction
13. Quantinuum reports 99.9995% logical fidelity on Helios, five errors per million
🧩 Like a typist who used to make 5 mistakes per 100,000 words now making 5 per million.
QNTQuantinuumQTUMDefiance Quantum ETF
🏛 Quantinuum (NASDAQ: QNT) · 📅 2026-10-19
👀 Too early: keep an eye on itOur judgment · Not financial advice
1Lab physics
2Hardware demo
3Cloud access / customers
4Commercial advantage
💡 What it is
🔬 Using a colour code on its commercial Helios trapped-ion computer, Quantinuum reports 99.9995% logical fidelity, 10× lower error than its own September record.
🧩 Like a typist who used to make 5 mistakes per 100,000 words now making 5 per million.
🚀 Why it matters
📈 Readiness 54/100 · Hardware demo
⏳ 2-4 yrs to market (our judgment)
🎯 Error correction decides when quantum computers become useful.
💰 Who gains
QNTQuantinuumQTUMDefiance Quantum ETF
🏷 Quantinuum QNT (US)
🏷 Defiance Quantum ETF QTUM (our judgment)
⚠️ Risks
❌ Result is company-announced; the press release compares favourably with rivals
✅ What to do
👀 Too early: keep an eye on it · plan: Small, careful bet
🔎 Watch for: Independent replication and Apollo milestones toward 2029.
🗓 Timeline
1 yrMore records on Helios
3 yrApollo prototypes
5 yrFault-tolerant machine if the 2029 plan holds
Timeline steps are our judgment unless marked as company plan.
What they found: Using a colour code on its commercial Helios trapped-ion computer, Quantinuum reports 99.9995% logical fidelity, 10× lower error than its own September record. It says this is in the target range for Apollo, a planned fault-tolerant machine by 2029.
🧒 Like I'm 10: Quantum computers make lots of mistakes. This one now makes only 5 mistakes in a million steps when protected.
🧩 Think of it like: Like a typist who used to make 5 mistakes per 100,000 words now making 5 per million.
Readiness54/100
Years to market: 2-4
Our judgment
🎢 Hype vs Reality
Hype 80
Reality 54
Some hype; watch for proof (our judgment)
⚖️ Patent / IP risk
Trapped-ion patents held by several players. (Our judgment)
🔒 Patent risk noteIncluded in Pro & InstitutionalUnlock Premium
Basket: ETF holding many quantum and computing stocks (our judgment)
Winner
Medium
Other possible winners: Quantinuum QNT (US), Defiance Quantum ETF QTUM (our judgment)
⚠️ Who could lose
Today's encryption vendors if quantum-safe upgrades lag (our judgment)
Over-hyped quantum stocks if timelines slip (our judgment)
✅ Why now
Using a colour code on its commercial Helios trapped-ion computer, Quantinuum reports 99.9995% logical fidelity, 10× lower error than its own September record. It says this is in the target range for Apollo, a planned fa…
Readiness 54/100, stage 2 on our ladder.
U=19: ½×readiness 54 + 0 (no big event expected soon) − 8×1 kill-risk flag(s)
⛔ Why not yet
Result is company-announced; the press release compares favourably with rivals
Apollo is a target for 2029, not a product today
Timeline to impact: about 2-4 years (our judgment)
⬆️ Upgrade triggers
Concrete date or release: Independent replication and Apollo milestones toward 2029.
A named paying customer or order
Independent replication / outside test results
Readiness reaching 70+ with a dated catalyst within 90 days (our 🔥 rule)
⬇️ Downgrade signals
Delay or missed milestone (our judgment)
Independent tests fail to confirm the claim (our judgment)
A rival leapfrogs or rules/regulators block it (our judgment)
🧭 Simple plan for this item (👀 Too early: keep an eye on it)
Don't buy because of this item yet.
Add the tickers to a watchlist and check the triggers below each week.
Move to Build only if 2+ upgrade triggers happen.
Tiers: 👀 Too early: keep an eye on it = track triggers only · ⏳ Promising = small staged position · 🔥 Act = catalyst near, sized small. No return promises.
🗓 Timeline
1 yr (our judgment): More records on Helios
3 yr (our judgment): Apollo prototypes
5 yr (our judgment): Fault-tolerant machine if the 2029 plan holds
📖 What these words mean
Readiness: our 0–100 score for how close an idea is to real products and sales. Higher = closer.
Conviction: how confident we are in a company's link to the idea (high, medium, low).
Ticker / stock code: the short code used to find a company's share on an exchange, e.g. NVDA.
Catalyst / next big event: a dated event (launch, approval, results) that could move the story.
Urgency: our badge for how time-sensitive it is: 🔥 strong signal, ⏳ promising, 👀 too early.
Our judgment · Not financial advice
🇮🇳 Indian investor angle
No NSE quantum pure play. Access via international funds (e.g. Nasdaq-100 fund-of-funds) or US ETFs like QTUM under LRS. (our judgment)
Our judgment · Not financial advice. Exposure notes are qualitative; we don't quote % of revenue unless sourced.
🐂 Bull case
Using a colour code on its commercial Helios trapped-ion computer, Quantinuum reports 99.9995% logical fidelity, 10× lower error than its own September record.
Who could win: Quantinuum QNT (US), Defiance Quantum ETF QTUM (our judgment)
🐻 What could go wrong
Result is company-announced; the press release compares favourably with rivals (judgment)
Apollo is a target for 2029, not a product today source
📐 How we scored this
Criterion
Score
Weight
Points
Evidence level
3/5 — Customer samples / qualification
55%
24.8
Manufacturability
3/5
20%
12.0
Supply chain
3/5
10%
6.0
Corporate backing
4/5
10%
8.0
Independent groups
3/5
5%
3.0
Readiness
54/100
Hype = 10×claim boldness (4/5) + 10×attention (4/5) = 80. Patent/IP risk: Medium (crowding 3/5, litigation 1/5). Sub-scores are our judgment from the linked sources. Full method
👀 What to watch next: Independent replication and Apollo milestones toward 2029.
⏰ Time Machinedrag: 1 → 3 → 5 years (our scenario, not a forecast)
In 1 year: 1 yr (our judgment): More records on Helios
📋 Executive briefing teaser free
Error correction decides when quantum computers become useful.
Error correction decides when quantum computers become useful. Quantinuum sells access to Helios today; the record is company-reported.
🔒 Full executive briefingIncluded in Pro & InstitutionalUnlock Premium
🎬 30-second video script Premium
Quantinuum reports 99.9995% logical fidelity on Helios, five errors per million. Like a typist who used to make 5 mistakes per 100,000 words now making 5 per million. Our judgment: small bet. Sources on our page.
🔒 Video script with citationsIncluded in Pro & InstitutionalUnlock Premium
👀 Too early: keep an eye on itOur judgment · Not financial advice
1Lab physics
2Hardware demo
3Cloud access / customers
4Commercial advantage
💡 What it is
🔬 IQM prepared a GHZ entangled state across all 54 qubits with fidelity 0.516 (with readout error mitigation), above the 0.500 threshold, and 0.515 at 40 qubits without it.
🧩 Like getting a whole orchestra to play in tune at once, not just one section.
🚀 Why it matters
📈 Readiness 67/100 · Cloud access / customers
⏳ 0-2 yrs to market (our judgment)
🎯 Many studies use only 10 to 20 qubits on bigger chips.
💰 Who gains
IQMXIQM Quantum ComputersQTUMDefiance Quantum ETF
🏷 IQM IQMX (US-listed)
🏷 Defiance Quantum ETF QTUM (our judgment)
⚠️ Risks
❌ Fidelity 0.516 is only slightly above the 0.500 entanglement threshold
✅ What to do
👀 Too early: keep an eye on it · plan: keep watching
🔎 Watch for: Full-chip results on useful algorithms, not just benchmarks.
🗓 Timeline
1 yrLarger IQM chips
3 yrCustomer algorithms using full chips
5 yrCompetitive cloud offering if error rates fall
Timeline steps are our judgment unless marked as company plan.
What they found: IQM prepared a GHZ entangled state across all 54 qubits with fidelity 0.516 (with readout error mitigation), above the 0.500 threshold, and 0.515 at 40 qubits without it. Cloud users get the same full-chip performance; previously about 30 qubits were reliably usable.
🧒 Like I'm 10: A quantum chip has 54 tiny parts. IQM got all of them to work together at the same time.
🧩 Think of it like: Like getting a whole orchestra to play in tune at once, not just one section.
Readiness67/100
Years to market: 0-2
Our judgment
🎢 Hype vs Reality
Hype 40
Reality 67
Reality is catching up (our judgment)
⚖️ Patent / IP risk
Superconducting qubit IP is crowded. (Our judgment)
🔒 Patent risk noteIncluded in Pro & InstitutionalUnlock Premium
Basket: ETF holding many quantum and computing stocks (our judgment)
Winner
Medium
Other possible winners: IQM IQMX (US-listed), Defiance Quantum ETF QTUM (our judgment)
⚠️ Who could lose
Today's encryption vendors if quantum-safe upgrades lag (our judgment)
Over-hyped quantum stocks if timelines slip (our judgment)
✅ Why now
IQM prepared a GHZ entangled state across all 54 qubits with fidelity 0.516 (with readout error mitigation), above the 0.500 threshold, and 0.515 at 40 qubits without it. Cloud users get the same full-chip performance; p…
Readiness 67/100, stage 3 on our ladder.
U=34: ½×readiness 67 + 0 (no big event expected soon)
⛔ Why not yet
Fidelity 0.516 is only slightly above the 0.500 entanglement threshold
Timeline to impact: about 0-2 years (our judgment)
⬆️ Upgrade triggers
Concrete date or release: Full-chip results on useful algorithms, not just benchmarks.
A named paying customer or order
Independent replication / outside test results
Readiness reaching 70+ with a dated catalyst within 90 days (our 🔥 rule)
⬇️ Downgrade signals
Delay or missed milestone (our judgment)
Independent tests fail to confirm the claim (our judgment)
A rival leapfrogs or rules/regulators block it (our judgment)
🧭 Simple plan for this item (👀 Too early: keep an eye on it)
Don't buy because of this item yet.
Add the tickers to a watchlist and check the triggers below each week.
Move to Build only if 2+ upgrade triggers happen.
Tiers: 👀 Too early: keep an eye on it = track triggers only · ⏳ Promising = small staged position · 🔥 Act = catalyst near, sized small. No return promises.
🗓 Timeline
1 yr (our judgment): Larger IQM chips
3 yr (our judgment): Customer algorithms using full chips
5 yr (our judgment): Competitive cloud offering if error rates fall
📖 What these words mean
Readiness: our 0–100 score for how close an idea is to real products and sales. Higher = closer.
Conviction: how confident we are in a company's link to the idea (high, medium, low).
Ticker / stock code: the short code used to find a company's share on an exchange, e.g. NVDA.
Catalyst / next big event: a dated event (launch, approval, results) that could move the story.
Urgency: our badge for how time-sensitive it is: 🔥 strong signal, ⏳ promising, 👀 too early.
Our judgment · Not financial advice
🇮🇳 Indian investor angle
No NSE quantum pure play. Access via international funds (e.g. Nasdaq-100 fund-of-funds) or US ETFs like QTUM under LRS. (our judgment)
Our judgment · Not financial advice. Exposure notes are qualitative; we don't quote % of revenue unless sourced.
🐂 Bull case
IQM prepared a GHZ entangled state across all 54 qubits with fidelity 0.516 (with readout error mitigation), above the 0.500 threshold, and 0.515 at 40 qubits without it.
Who could win: IQM IQMX (US-listed), Defiance Quantum ETF QTUM (our judgment)
🐻 What could go wrong
Fidelity 0.516 is only slightly above the 0.500 entanglement threshold source
📐 How we scored this
Criterion
Score
Weight
Points
Evidence level
4/5 — Volume production or orders
55%
41.2
Manufacturability
3/5
20%
12.0
Supply chain
3/5
10%
6.0
Corporate backing
3/5
10%
6.0
Independent groups
2/5
5%
2.0
Readiness
67/100
Hype = 10×claim boldness (2/5) + 10×attention (2/5) = 40. Patent/IP risk: Medium (crowding 3/5, litigation 1/5). Sub-scores are our judgment from the linked sources. Full method
👀 What to watch next: Full-chip results on useful algorithms, not just benchmarks.
⏰ Time Machinedrag: 1 → 3 → 5 years (our scenario, not a forecast)
In 1 year: 1 yr (our judgment): Larger IQM chips
📋 Executive briefing teaser free
Many studies use only 10 to 20 qubits on bigger chips.
Many studies use only 10 to 20 qubits on bigger chips. Using the full chip matters for real workloads. The fidelity is only just above the threshold.
🔒 Full executive briefingIncluded in Pro & InstitutionalUnlock Premium
🎬 30-second video script Premium
IQM entangles all 54 qubits on its cloud Emerald chip at once. Like getting a whole orchestra to play in tune at once, not just one section. Our judgment: watch. Sources on our page.
🔒 Video script with citationsIncluded in Pro & InstitutionalUnlock Premium
Tracked since 2026-10-30Readiness vs prev: = no change · Updated 2026-10-30
History: 10-30 S2/43 → 10-31 S2/43
Stage 2 · Early trial (Ph 1/2)👀 Too early: keep an eye on itGene editing
15. First prime edit inside a human body: Prime Medicine treats a Wilson's disease patient
🧩 Classic CRISPR is scissors; prime editing is find-and-replace in a word processor.
PRMEPrime Medicine
🏛 Prime Medicine (reported by Nature) · 📅 2026-10
👀 Too early: keep an eye on itOur judgment · Not financial advice
1Preclinical
2Early trial (Ph 1/2)
3Late trial (Ph 3)
4Approved
💡 What it is
🔬 Prime Medicine treated the first person in a trial that uses prime editing to rewrite DNA in liver cells, aiming to fix a mutation that stops them clearing excess copper.
🧩 Classic CRISPR is scissors; prime editing is find-and-replace in a word processor.
🚀 Why it matters
📈 Readiness 43/100 · Early trial (Ph 1/2)
⏳ 3-6 yrs to market (our judgment)
🎯 No gene-editing therapy is yet approved for use inside the body.
💰 Who gains
PRMEPrime Medicine
🏷 Prime Medicine PRME (US)
🏷 Gene-editing peers (our judgment)
⚠️ Risks
❌ One patient treated; no efficacy data yet
✅ What to do
👀 Too early: keep an eye on it · plan: Small, careful bet
🔎 Watch for: First patient data next year and any safety signals.
🗓 Timeline
1 yrFirst safety and copper data
3 yrMore patients dosed if safe
5 yrPossible approval path if efficacy holds
Timeline steps are our judgment unless marked as company plan.
What they found: Prime Medicine treated the first person in a trial that uses prime editing to rewrite DNA in liver cells, aiming to fix a mutation that stops them clearing excess copper. First results are expected next year.
🧒 Like I'm 10: Doctors used a super-precise DNA editor inside a patient's liver to fix a broken gene.
🧩 Think of it like: Classic CRISPR is scissors; prime editing is find-and-replace in a word processor.
Readiness43/100
Years to market: 3-6
Our judgment
🎢 Hype vs Reality
Hype 70
Reality 43
Some hype; watch for proof (our judgment)
⚖️ Patent / IP risk
Prime-editing IP is concentrated; CRISPR patent fights have a long history. (Our judgment)
🔒 Patent risk noteIncluded in Pro & InstitutionalUnlock Premium
🏆 Who could win
Prime Medicine PRME (US)Gene-editing peers (our judgment)
💰 Investor view👀 Too early: keep an eye on it
In plain words: Doctors used a super-precise DNA editor inside a patient's liver to fix a broken gene.
Direct: Gene-editing pure play; product is the platform (our judgment)
Winner
High
Other possible winners: Prime Medicine PRME (US), Gene-editing peers (our judgment)
⚠️ Who could lose
Older therapy makers in the same disease if this works (our judgment)
✅ Why now
Prime Medicine treated the first person in a trial that uses prime editing to rewrite DNA in liver cells, aiming to fix a mutation that stops them clearing excess copper. First results are expected next year.
Readiness 43/100, stage 2 on our ladder.
U=22: ½×readiness 43 + 0 (no big event expected soon)
⛔ Why not yet
One patient treated; no efficacy data yet
Gene therapy safety can fail late; see the DMD trial death this month
Timeline to impact: about 3-6 years (our judgment)
⬆️ Upgrade triggers
Concrete date or release: First patient data next year and any safety signals.
A named paying customer or order
Independent replication / outside test results
Readiness reaching 70+ with a dated catalyst within 90 days (our 🔥 rule)
⬇️ Downgrade signals
Delay or missed milestone (our judgment)
Independent tests fail to confirm the claim (our judgment)
A rival leapfrogs or rules/regulators block it (our judgment)
🧭 Simple plan for this item (👀 Too early: keep an eye on it)
Don't buy because of this item yet.
Add the tickers to a watchlist and check the triggers below each week.
Move to Build only if 2+ upgrade triggers happen.
Tiers: 👀 Too early: keep an eye on it = track triggers only · ⏳ Promising = small staged position · 🔥 Act = catalyst near, sized small. No return promises.
🗓 Timeline
1 yr (our judgment): First safety and copper data
3 yr (our judgment): More patients dosed if safe
5 yr (our judgment): Possible approval path if efficacy holds
📖 What these words mean
Readiness: our 0–100 score for how close an idea is to real products and sales. Higher = closer.
Conviction: how confident we are in a company's link to the idea (high, medium, low).
Ticker / stock code: the short code used to find a company's share on an exchange, e.g. NVDA.
Catalyst / next big event: a dated event (launch, approval, results) that could move the story.
Urgency: our badge for how time-sensitive it is: 🔥 strong signal, ⏳ promising, 👀 too early.
Our judgment · Not financial advice
🇮🇳 Indian investor angle
Indian CDMOs (e.g. SYNGENE, DIVISLAB) are indirect; US biotech only via international funds/LRS. (our judgment)
Our judgment · Not financial advice. Exposure notes are qualitative; we don't quote % of revenue unless sourced.
🐂 Bull case
Prime Medicine treated the first person in a trial that uses prime editing to rewrite DNA in liver cells, aiming to fix a mutation that stops them clearing excess copper.
Who could win: Prime Medicine PRME (US), Gene-editing peers (our judgment)
Gene therapy safety can fail late; see the DMD trial death this month source
📐 How we scored this
Criterion
Score
Weight
Points
Evidence level
2/5 — Working prototype chip
55%
13.8
Manufacturability
3/5
20%
12.0
Supply chain
3/5
10%
6.0
Corporate backing
4/5
10%
8.0
Independent groups
3/5
5%
3.0
Readiness
43/100
Hype = 10×claim boldness (3/5) + 10×attention (4/5) = 70. Patent/IP risk: Medium (crowding 4/5, litigation 2/5). Sub-scores are our judgment from the linked sources. Full method
👀 What to watch next: First patient data next year and any safety signals.
⏰ Time Machinedrag: 1 → 3 → 5 years (our scenario, not a forecast)
In 1 year: 1 yr (our judgment): First safety and copper data
📋 Executive briefing teaser free
No gene-editing therapy is yet approved for use inside the body.
No gene-editing therapy is yet approved for use inside the body. Base editing cannot fix the most common Wilson's mutations; prime editing can insert, delete and rewrite. Nature reports the FDA expects to decide early next year on an in-body CRISPR therapy for hereditary angioedema.
🔒 Full executive briefingIncluded in Pro & InstitutionalUnlock Premium
🎬 30-second video script Premium
First prime edit inside a human body: Prime Medicine treats a Wilson's disease patient. Classic CRISPR is scissors; prime editing is find-and-replace in a word processor. Our judgment: small bet. Sources on our page.
🔒 Video script with citationsIncluded in Pro & InstitutionalUnlock Premium
Tracked since 2026-10-30Readiness vs prev: = no change · Updated 2026-10-30
History: 10-30 S2/32 → 10-31 S2/32
Stage 2 · Early trial (Ph 1/2)👀 Too early: keep an eye on itGene editing safety
16. A gene-editing trial for Duchenne muscular dystrophy shows a narrow safety window
🧩 Like a delivery truck that gets the parcel inside, but the truck itself can set off the building's alarm system.
No listed ticker linked
🏛 HuidaGene (Shanghai), published in Cell · 📅 2026-10
👀 Too early: keep an eye on itOur judgment · Not financial advice
1Preclinical
2Early trial (Ph 1/2)
3Late trial (Ph 3)
4Approved
💡 What it is
🔬 A single-virus-delivered editor restored some dystrophin in four boys, but benefit was limited and one boy on the high dose died of a treatment-related immune reaction.
🧩 Like a delivery truck that gets the parcel inside, but the truck itself can set off the building's alarm system.
🚀 Why it matters
📈 Readiness 32/100 · Early trial (Ph 1/2)
⏳ 3-6 yrs to market (our judgment)
🎯 Gene editing delivered by AAV virus works in animals, but human immune reactions can be fatal at high doses.
💰 Who gains
No listed pure-play linked (private or small part of a big company)
🏷 Patients, through safer future trial designs (our judgment)
⚠️ Risks
❌ Limited benefit and one death
✅ What to do
👀 Too early: keep an eye on it · plan: Wait
🔎 Watch for: New dosing and immune-suppression strategies in AAV-CRISPR trials.
🗓 Timeline
1 yrRegulators may tighten AAV dose rules
3 yrTrials shift to lower doses or new delivery
5 yrSafer delivery methods could win
Timeline steps are our judgment unless marked as company plan.
What they found: A single-virus-delivered editor restored some dystrophin in four boys, but benefit was limited and one boy on the high dose died of a treatment-related immune reaction. Monkey tests had shown no dose-limiting toxicity.
🧒 Like I'm 10: Scientists tried fixing a muscle disease gene. It partly worked, but it was very dangerous at a high dose.
🧩 Think of it like: Like a delivery truck that gets the parcel inside, but the truck itself can set off the building's alarm system.
Readiness32/100
Years to market: 3-6
Our judgment
🎢 Hype vs Reality
Hype 60
Reality 32
Some hype; watch for proof (our judgment)
⚖️ Patent / IP risk
Cautionary item, included for risk awareness. (Our judgment)
🔒 Patent risk noteIncluded in Pro & InstitutionalUnlock Premium
🏆 Who could win
Patients, through safer future trial designs (our judgment)
💰 Investor view👀 Too early: keep an eye on it
In plain words: Scientists tried fixing a muscle disease gene. It partly worked, but it was very dangerous at a high dose.
📊 Stocks tied to this
Company
Stock code
How it is linked
Role
Conviction
No listed company directly tied yet. Developer: HuidaGene (Shanghai), published in Cell. Watch for a listed partner or IPO.
Other possible winners: Patients, through safer future trial designs (our judgment)
⚠️ Who could lose
Older therapy makers in the same disease if this works (our judgment)
✅ Why now
A single-virus-delivered editor restored some dystrophin in four boys, but benefit was limited and one boy on the high dose died of a treatment-related immune reaction. Monkey tests had shown no dose-limiting toxicity.
Readiness 32/100, stage 2 on our ladder.
U=16: ½×readiness 32 + 0 (no big event expected soon) · no listed ticker linked → 👀 too early
⛔ Why not yet
Limited benefit and one death
Timeline to impact: about 3-6 years (our judgment)
⬆️ Upgrade triggers
Concrete date or release: New dosing and immune-suppression strategies in AAV-CRISPR trials.
A named paying customer or order
Independent replication / outside test results
Readiness reaching 70+ with a dated catalyst within 90 days (our 🔥 rule)
⬇️ Downgrade signals
Delay or missed milestone (our judgment)
Independent tests fail to confirm the claim (our judgment)
A rival leapfrogs or rules/regulators block it (our judgment)
🧭 Simple plan for this item (👀 Too early: keep an eye on it)
Don't buy because of this item yet.
Add the tickers to a watchlist and check the triggers below each week.
Move to Build only if 2+ upgrade triggers happen.
Tiers: 👀 Too early: keep an eye on it = track triggers only · ⏳ Promising = small staged position · 🔥 Act = catalyst near, sized small. No return promises.
🗓 Timeline
1 yr (our judgment): Regulators may tighten AAV dose rules
3 yr (our judgment): Trials shift to lower doses or new delivery
5 yr (our judgment): Safer delivery methods could win
📖 What these words mean
Readiness: our 0–100 score for how close an idea is to real products and sales. Higher = closer.
Conviction: how confident we are in a company's link to the idea (high, medium, low).
Ticker / stock code: the short code used to find a company's share on an exchange, e.g. NVDA.
Catalyst / next big event: a dated event (launch, approval, results) that could move the story.
Urgency: our badge for how time-sensitive it is: 🔥 strong signal, ⏳ promising, 👀 too early.
Our judgment · Not financial advice
🇮🇳 Indian investor angle
Indian CDMOs (e.g. SYNGENE, DIVISLAB) are indirect; US biotech only via international funds/LRS. (our judgment)
Our judgment · Not financial advice. Exposure notes are qualitative; we don't quote % of revenue unless sourced.
🐂 Bull case
A single-virus-delivered editor restored some dystrophin in four boys, but benefit was limited and one boy on the high dose died of a treatment-related immune reaction.
Who could win: Patients, through safer future trial designs (our judgment)
Hype = 10×claim boldness (2/5) + 10×attention (4/5) = 60. Patent/IP risk: Medium (crowding 3/5, litigation 1/5). Sub-scores are our judgment from the linked sources. Full method
👀 What to watch next: New dosing and immune-suppression strategies in AAV-CRISPR trials.
⏰ Time Machinedrag: 1 → 3 → 5 years (our scenario, not a forecast)
In 1 year: 1 yr (our judgment): Regulators may tighten AAV dose rules
📋 Executive briefing teaser free
Gene editing delivered by AAV virus works in animals, but human immune reactions can be fatal at high doses.
Gene editing delivered by AAV virus works in animals, but human immune reactions can be fatal at high doses. Researchers say safe dosing must be established.
🔒 Full executive briefingIncluded in Pro & InstitutionalUnlock Premium
🎬 30-second video script Premium
A gene-editing trial for Duchenne muscular dystrophy shows a narrow safety window. Like a delivery truck that gets the parcel inside, but the truck itself can set off the building's alarm system. Our judgment: wait. Sources on our page.
🔒 Video script with citationsIncluded in Pro & InstitutionalUnlock Premium
Tracked since 2026-10-30Readiness vs prev: = no change · Updated 2026-10-30
History: 10-30 S1/30 → 10-31 S1/30
Stage 1 · Preclinical👀 Too early: keep an eye on itGene editing
17. Switching back on a baby-stage gene could treat severe alpha-thalassemia
🧩 Like rehiring a retired worker who knows the job, when the current worker can't show up.
No listed ticker linked
🏛 Research team publishing in Nature Genetics · 📅 2026-10-01
👀 Too early: keep an eye on itOur judgment · Not financial advice
1Preclinical
2Early trial (Ph 1/2)
3Late trial (Ph 3)
4Approved
💡 What it is
🔬 The team found two switches that silence the embryonic zeta-globin gene and edited them to turn it back on.
🧩 Like rehiring a retired worker who knows the job, when the current worker can't show up.
🚀 Why it matters
📈 Readiness 30/100 · Preclinical
⏳ 4-8 yrs to market (our judgment)
🎯 Severe alpha-thalassemia needs lifelong transfusions or stem-cell transplants.
💰 Who gains
No listed pure-play linked (private or small part of a big company)
🏷 Gene-editing therapy developers (our judgment)
⚠️ Risks
❌ Mouse embryos survived only until late development (E17.5), not to birth
✅ What to do
👀 Too early: keep an eye on it · plan: Wait
🔎 Watch for: A clinical trial plan.
🗓 Timeline
1 yrMore animal studies
3 yrPossible first trial
5 yrTreatment option if trials succeed
Timeline steps are our judgment unless marked as company plan.
What they found: The team found two switches that silence the embryonic zeta-globin gene and edited them to turn it back on. In a mouse model of the deadliest form, embryos survived to late development, and patient cells made therapeutic levels of alpha-like globin.
🧒 Like I'm 10: Babies use a special blood gene before birth. Scientists switched it back on to help people whose normal gene is broken.
🧩 Think of it like: Like rehiring a retired worker who knows the job, when the current worker can't show up.
Readiness30/100
Years to market: 4-8
Our judgment
🎢 Hype vs Reality
Hype 40
Reality 30
Reality is catching up (our judgment)
⚖️ Patent / IP risk
Globin-switching edits overlap with sickle-cell therapy IP. (Our judgment)
🔒 Patent risk noteIncluded in Pro & InstitutionalUnlock Premium
🏆 Who could win
Gene-editing therapy developers (our judgment)
💰 Investor view👀 Too early: keep an eye on it
In plain words: Babies use a special blood gene before birth. Scientists switched it back on to help people whose normal gene is broken.
📊 Stocks tied to this
Company
Stock code
How it is linked
Role
Conviction
No listed company directly tied yet. Developer: Research team publishing in Nature Genetics. Watch for a listed partner or IPO.
Other possible winners: Gene-editing therapy developers (our judgment)
⚠️ Who could lose
Older therapy makers in the same disease if this works (our judgment)
✅ Why now
The team found two switches that silence the embryonic zeta-globin gene and edited them to turn it back on. In a mouse model of the deadliest form, embryos survived to late development, and patient cells made therapeutic…
Readiness 30/100, stage 1 on our ladder.
U=7: ½×readiness 30 + 0 (no big event expected soon) − 8×1 kill-risk flag(s) · no listed ticker linked → 👀 too early
⛔ Why not yet
Mouse embryos survived only until late development (E17.5), not to birth
Timeline to impact: about 4-8 years (our judgment)
⬆️ Upgrade triggers
Concrete date or release: A clinical trial plan.
A named paying customer or order
Independent replication / outside test results
Readiness reaching 70+ with a dated catalyst within 90 days (our 🔥 rule)
⬇️ Downgrade signals
Delay or missed milestone (our judgment)
Independent tests fail to confirm the claim (our judgment)
A rival leapfrogs or rules/regulators block it (our judgment)
🧭 Simple plan for this item (👀 Too early: keep an eye on it)
Don't buy because of this item yet.
Add the tickers to a watchlist and check the triggers below each week.
Move to Build only if 2+ upgrade triggers happen.
Tiers: 👀 Too early: keep an eye on it = track triggers only · ⏳ Promising = small staged position · 🔥 Act = catalyst near, sized small. No return promises.
🗓 Timeline
1 yr (our judgment): More animal studies
3 yr (our judgment): Possible first trial
5 yr (our judgment): Treatment option if trials succeed
📖 What these words mean
Readiness: our 0–100 score for how close an idea is to real products and sales. Higher = closer.
Conviction: how confident we are in a company's link to the idea (high, medium, low).
Ticker / stock code: the short code used to find a company's share on an exchange, e.g. NVDA.
Catalyst / next big event: a dated event (launch, approval, results) that could move the story.
Urgency: our badge for how time-sensitive it is: 🔥 strong signal, ⏳ promising, 👀 too early.
Our judgment · Not financial advice
🇮🇳 Indian investor angle
Indian CDMOs (e.g. SYNGENE, DIVISLAB) are indirect; US biotech only via international funds/LRS. (our judgment)
Our judgment · Not financial advice. Exposure notes are qualitative; we don't quote % of revenue unless sourced.
🐂 Bull case
The team found two switches that silence the embryonic zeta-globin gene and edited them to turn it back on.
Who could win: Gene-editing therapy developers (our judgment)
🐻 What could go wrong
Mouse embryos survived only until late development (E17.5), not to birth source
📐 How we scored this
Criterion
Score
Weight
Points
Evidence level
1/5 — Lab demo
55%
5.5
Manufacturability
3/5
20%
12.0
Supply chain
3/5
10%
6.0
Corporate backing
2/5
10%
4.0
Independent groups
2/5
5%
2.0
Readiness
30/100
Hype = 10×claim boldness (2/5) + 10×attention (2/5) = 40. Patent/IP risk: Medium (crowding 3/5, litigation 1/5). Sub-scores are our judgment from the linked sources. Full method
👀 What to watch next: A clinical trial plan.
⏰ Time Machinedrag: 1 → 3 → 5 years (our scenario, not a forecast)
In 1 year: 1 yr (our judgment): More animal studies
📋 Executive briefing teaser free
Severe alpha-thalassemia needs lifelong transfusions or stem-cell transplants.
Severe alpha-thalassemia needs lifelong transfusions or stem-cell transplants. Reactivating zeta-globin could substitute for missing alpha-globin. Preclinical only; the resulting hemoglobin needs more study.
🔒 Full executive briefingIncluded in Pro & InstitutionalUnlock Premium
🎬 30-second video script Premium
Switching back on a baby-stage gene could treat severe alpha-thalassemia. Like rehiring a retired worker who knows the job, when the current worker can't show up. Our judgment: wait. Sources on our page.
🔒 Video script with citationsIncluded in Pro & InstitutionalUnlock Premium
Tracked since 2026-10-30Readiness vs prev: = no change · Updated 2026-10-30
History: 10-30 S2/44 → 10-31 S2/44
Stage 2 · Pilot / feasibility👀 Too early: keep an eye on itBedside BCI
18. A bedside brain-wave cap let 1 in 3 'unresponsive' patients control a sound
🧩 Like finding someone locked in a dark room by giving them a light switch, and seeing them flick it.
No listed ticker linked
🏛 Single-centre study published in Brain · 📅 2026-10-22
👀 Too early: keep an eye on itOur judgment · Not financial advice
1Lab study
2Pilot / feasibility
3Pivotal trial
4Approved device
💡 What it is
🔬 13 of 41 clinically unresponsive brain-injury patients (32%) controlled the speed of a tone by attempting to open and close a hand, read by EEG.
🧩 Like finding someone locked in a dark room by giving them a light switch, and seeing them flick it.
🚀 Why it matters
📈 Readiness 44/100 · Pilot / feasibility
⏳ 1-4 yrs to market (our judgment)
🎯 Some patients are conscious but cannot move or speak.
💰 Who gains
No listed pure-play linked (private or small part of a big company)
🏷 EEG and neuro-monitoring device makers (our judgment)
🏷 Hospitals and families
⚠️ Risks
❌ Single centre, 41 patients
✅ What to do
👀 Too early: keep an eye on it · plan: keep watching
🔎 Watch for: Multi-centre replication.
🗓 Timeline
1 yrReplication studies
3 yrICU pilot programs
5 yrPossible standard test if replicated
Timeline steps are our judgment unless marked as company plan.
What they found: 13 of 41 clinically unresponsive brain-injury patients (32%) controlled the speed of a tone by attempting to open and close a hand, read by EEG. 46% of those with control regained independence at 12 months, versus 7% without.
🧒 Like I'm 10: Some very sick patients can't move, but their brains still listen. A cap on the head showed some of them could control a beep with their thoughts.
🧩 Think of it like: Like finding someone locked in a dark room by giving them a light switch, and seeing them flick it.
Readiness44/100
Years to market: 1-4
Our judgment
🎢 Hype vs Reality
Hype 40
Reality 44
Reality is catching up (our judgment)
⚖️ Patent / IP risk
EEG BCI methods are widely published. (Our judgment)
🔒 Patent risk noteIncluded in Pro & InstitutionalUnlock Premium
🏆 Who could win
EEG and neuro-monitoring device makers (our judgment)Hospitals and families
💰 Investor view👀 Too early: keep an eye on it
In plain words: Some very sick patients can't move, but their brains still listen. A cap on the head showed some of them could control a beep with their thoughts.
📊 Stocks tied to this
Company
Stock code
How it is linked
Role
Conviction
No listed company directly tied yet. Developer: Single-centre study published in Brain. Watch for a listed partner or IPO.
Other possible winners: EEG and neuro-monitoring device makers, Hospitals and families (our judgment)
⚠️ Who could lose
Older assistive-device makers (our judgment)
✅ Why now
13 of 41 clinically unresponsive brain-injury patients (32%) controlled the speed of a tone by attempting to open and close a hand, read by EEG. 46% of those with control regained independence at 12 months, versus 7% wit…
Readiness 44/100, stage 2 on our ladder.
U=22: ½×readiness 44 + 0 (no big event expected soon) · no listed ticker linked → 👀 too early
⛔ Why not yet
Single centre, 41 patients
Median signal delay about 50 s, so it is slow
Timeline to impact: about 1-4 years (our judgment)
⬆️ Upgrade triggers
Concrete date or release: Multi-centre replication.
A named paying customer or order
Independent replication / outside test results
Readiness reaching 70+ with a dated catalyst within 90 days (our 🔥 rule)
⬇️ Downgrade signals
Delay or missed milestone (our judgment)
Independent tests fail to confirm the claim (our judgment)
A rival leapfrogs or rules/regulators block it (our judgment)
🧭 Simple plan for this item (👀 Too early: keep an eye on it)
Don't buy because of this item yet.
Add the tickers to a watchlist and check the triggers below each week.
Move to Build only if 2+ upgrade triggers happen.
Tiers: 👀 Too early: keep an eye on it = track triggers only · ⏳ Promising = small staged position · 🔥 Act = catalyst near, sized small. No return promises.
🗓 Timeline
1 yr (our judgment): Replication studies
3 yr (our judgment): ICU pilot programs
5 yr (our judgment): Possible standard test if replicated
📖 What these words mean
Readiness: our 0–100 score for how close an idea is to real products and sales. Higher = closer.
Conviction: how confident we are in a company's link to the idea (high, medium, low).
Ticker / stock code: the short code used to find a company's share on an exchange, e.g. NVDA.
Catalyst / next big event: a dated event (launch, approval, results) that could move the story.
Urgency: our badge for how time-sensitive it is: 🔥 strong signal, ⏳ promising, 👀 too early.
Our judgment · Not financial advice
🇮🇳 Indian investor angle
No Indian listed exposure; US access only via international funds/LRS. (our judgment)
Median signal delay about 50 s, so it is slow (judgment)
📐 How we scored this
Criterion
Score
Weight
Points
Evidence level
2/5 — Working prototype chip
55%
13.8
Manufacturability
4/5
20%
16.0
Supply chain
4/5
10%
8.0
Corporate backing
2/5
10%
4.0
Independent groups
2/5
5%
2.0
Readiness
44/100
Hype = 10×claim boldness (2/5) + 10×attention (2/5) = 40. Patent/IP risk: Low (crowding 2/5, litigation 1/5). Sub-scores are our judgment from the linked sources. Full method
👀 What to watch next: Multi-centre replication.
⏰ Time Machinedrag: 1 → 3 → 5 years (our scenario, not a forecast)
In 1 year: 1 yr (our judgment): Replication studies
📋 Executive briefing teaser free
Some patients are conscious but cannot move or speak.
Some patients are conscious but cannot move or speak. Non-invasive EEG at the bedside could detect them early and predict recovery. Single-centre, small sample.
🔒 Full executive briefingIncluded in Pro & InstitutionalUnlock Premium
🎬 30-second video script Premium
A bedside brain-wave cap let 1 in 3 'unresponsive' patients control a sound. Like finding someone locked in a dark room by giving them a light switch, and seeing them flick it. Our judgment: watch. Sources on our page.
🔒 Video script with citationsIncluded in Pro & InstitutionalUnlock Premium
Tracked since 2026-10-30Readiness vs prev: = no change · Updated 2026-10-30
History: 10-30 S2/39 → 10-31 S2/39
Stage 2 · Pilot / feasibility👀 Too early: keep an eye on itImplanted BCI
19. Neuralink pretrains its brain decoder on 50,000 hours of recordings
🧩 Like a phone keyboard that learned from millions of typists, so it works for you with far less practice.
No listed ticker linked
🏛 Neuralink (private) · 📅 2026-10
👀 Too early: keep an eye on itOur judgment · Not financial advice
1Lab study
2Pilot / feasibility
3Pivotal trial
4Approved device
💡 What it is
🔬 Neuralink reports more than 50,000 hours of human BCI recordings used to pretrain decoders, cutting some users' recalibration from daily to weekly and reaching 11.32 bits per second cursor control.
🧩 Like a phone keyboard that learned from millions of typists, so it works for you with far less practice.
🚀 Why it matters
📈 Readiness 39/100 · Pilot / feasibility
⏳ 3-6 yrs to market (our judgment)
🎯 BCI users have needed frequent recalibration.
💰 Who gains
No listed pure-play linked (private or small part of a big company)
🏷 Neuralink (private)
🏷 Synchron (private)
⚠️ Risks
❌ Company-reported, not peer-reviewed
✅ What to do
👀 Too early: keep an eye on it · plan: keep watching
🔎 Watch for: Peer-reviewed results and FDA progress.
🗓 Timeline
1 yrMore participants
3 yrPivotal trials
5 yrCommercial devices if approved
Timeline steps are our judgment unless marked as company plan.
What they found: Neuralink reports more than 50,000 hours of human BCI recordings used to pretrain decoders, cutting some users' recalibration from daily to weekly and reaching 11.32 bits per second cursor control.
🧒 Like I'm 10: Brain chips need to learn each person. Neuralink taught its computer with lots of brain data so it learns faster.
🧩 Think of it like: Like a phone keyboard that learned from millions of typists, so it works for you with far less practice.
Readiness39/100
Years to market: 3-6
Our judgment
🎢 Hype vs Reality
Hype 90
Reality 39
Mostly hype so far (our judgment)
⚖️ Patent / IP risk
Implant BCI IP is active among several firms. (Our judgment)
🔒 Patent risk noteIncluded in Pro & InstitutionalUnlock Premium
🏆 Who could win
Neuralink (private)Synchron (private)
💰 Investor view👀 Too early: keep an eye on it
In plain words: Brain chips need to learn each person. Neuralink taught its computer with lots of brain data so it learns faster.
📊 Stocks tied to this
Company
Stock code
How it is linked
Role
Conviction
No listed company directly tied yet. Developer: Neuralink (private). Watch for a listed partner or IPO.
Other possible winners: Neuralink (private), Synchron (private) (our judgment)
⚠️ Who could lose
Older assistive-device makers (our judgment)
✅ Why now
Neuralink reports more than 50,000 hours of human BCI recordings used to pretrain decoders, cutting some users' recalibration from daily to weekly and reaching 11.32 bits per second cursor control.
Readiness 39/100, stage 2 on our ladder.
U=12: ½×readiness 39 + 0 (no big event expected soon) − 8×1 kill-risk flag(s) · no listed ticker linked → 👀 too early
⛔ Why not yet
Company-reported, not peer-reviewed
No public stock; exposure only via private markets
Timeline to impact: about 3-6 years (our judgment)
⬆️ Upgrade triggers
Concrete date or release: Peer-reviewed results and FDA progress.
A named paying customer or order
Independent replication / outside test results
Readiness reaching 70+ with a dated catalyst within 90 days (our 🔥 rule)
⬇️ Downgrade signals
Delay or missed milestone (our judgment)
Independent tests fail to confirm the claim (our judgment)
A rival leapfrogs or rules/regulators block it (our judgment)
🧭 Simple plan for this item (👀 Too early: keep an eye on it)
Don't buy because of this item yet.
Add the tickers to a watchlist and check the triggers below each week.
Move to Build only if 2+ upgrade triggers happen.
Tiers: 👀 Too early: keep an eye on it = track triggers only · ⏳ Promising = small staged position · 🔥 Act = catalyst near, sized small. No return promises.
🗓 Timeline
1 yr (our judgment): More participants
3 yr (our judgment): Pivotal trials
5 yr (our judgment): Commercial devices if approved
📖 What these words mean
Readiness: our 0–100 score for how close an idea is to real products and sales. Higher = closer.
Conviction: how confident we are in a company's link to the idea (high, medium, low).
Ticker / stock code: the short code used to find a company's share on an exchange, e.g. NVDA.
Catalyst / next big event: a dated event (launch, approval, results) that could move the story.
Urgency: our badge for how time-sensitive it is: 🔥 strong signal, ⏳ promising, 👀 too early.
Our judgment · Not financial advice
🇮🇳 Indian investor angle
No Indian listed exposure; US access only via international funds/LRS. (our judgment)
Our judgment · Not financial advice. Exposure notes are qualitative; we don't quote % of revenue unless sourced.
🐂 Bull case
Neuralink reports more than 50,000 hours of human BCI recordings used to pretrain decoders, cutting some users' recalibration from daily to weekly and reaching 11.32 bits per second cursor control.
Who could win: Neuralink (private), Synchron (private)
🐻 What could go wrong
Company-reported, not peer-reviewed (judgment)
No public stock; exposure only via private markets (judgment)
📐 How we scored this
Criterion
Score
Weight
Points
Evidence level
2/5 — Working prototype chip
55%
13.8
Manufacturability
3/5
20%
12.0
Supply chain
2/5
10%
4.0
Corporate backing
4/5
10%
8.0
Independent groups
1/5
5%
1.0
Readiness
39/100
Hype = 10×claim boldness (4/5) + 10×attention (5/5) = 90. Patent/IP risk: Medium (crowding 3/5, litigation 1/5). Sub-scores are our judgment from the linked sources. Full method
👀 What to watch next: Peer-reviewed results and FDA progress.
⏰ Time Machinedrag: 1 → 3 → 5 years (our scenario, not a forecast)
In 1 year: 1 yr (our judgment): More participants
📋 Executive briefing teaser free
BCI users have needed frequent recalibration.
BCI users have needed frequent recalibration. Pretraining on pooled data, as AI models do, could make implants easier to live with. Company-reported.
🔒 Full executive briefingIncluded in Pro & InstitutionalUnlock Premium
🎬 30-second video script Premium
Neuralink pretrains its brain decoder on 50,000 hours of recordings. Like a phone keyboard that learned from millions of typists, so it works for you with far less practice. Our judgment: watch. Sources on our page.
🔒 Video script with citationsIncluded in Pro & InstitutionalUnlock Premium
Tracked since 2026-10-30Readiness vs prev: = no change · Updated 2026-10-30
History: 10-30 S2/37 → 10-31 S2/37
Stage 2 · Pilot / feasibility👀 Too early: keep an eye on itSurface BCI
20. Precision Neuroscience pools 70 patients into one map of the human nervous system
🧩 Like stitching many street-view drives into one city map.
No listed ticker linked
🏛 Precision Neuroscience (private) · 📅 2026-10-09
👀 Too early: keep an eye on itOur judgment · Not financial advice
1Lab study
2Pilot / feasibility
3Pivotal trial
4Approved device
💡 What it is
🔬 Precision announced a 70-patient, 180-plus-hour neural atlas recorded with its temporary Layer 7 surface arrays, supporting movement, speech and facial-expression decoding.
🧩 Like stitching many street-view drives into one city map.
🚀 Why it matters
📈 Readiness 37/100 · Pilot / feasibility
⏳ 3-6 yrs to market (our judgment)
🎯 Surface arrays sit on the brain rather than penetrating it.
💰 Who gains
No listed pure-play linked (private or small part of a big company)
🏷 Precision Neuroscience (private)
⚠️ Risks
❌ Data from temporary recordings during procedures
✅ What to do
👀 Too early: keep an eye on it · plan: keep watching
🔎 Watch for: Permanent-implant trial and regulatory milestones.
🗓 Timeline
1 yrMore sites and patients
3 yrLonger-term implant studies
5 yrCommercial product if approved
Timeline steps are our judgment unless marked as company plan.
What they found: Precision announced a 70-patient, 180-plus-hour neural atlas recorded with its temporary Layer 7 surface arrays, supporting movement, speech and facial-expression decoding. It also announced its first international clinical site, in Abu Dhabi.
🧒 Like I'm 10: A company put thin stickers on 70 people's brains during surgery and made a big map of how brains send signals.
🧩 Think of it like: Like stitching many street-view drives into one city map.
Readiness37/100
Years to market: 3-6
Our judgment
🎢 Hype vs Reality
Hype 60
Reality 37
Some hype; watch for proof (our judgment)
⚖️ Patent / IP risk
Thin-film electrode IP held by several companies. (Our judgment)
🔒 Patent risk noteIncluded in Pro & InstitutionalUnlock Premium
🏆 Who could win
Precision Neuroscience (private)
💰 Investor view👀 Too early: keep an eye on it
In plain words: A company put thin stickers on 70 people's brains during surgery and made a big map of how brains send signals.
📊 Stocks tied to this
Company
Stock code
How it is linked
Role
Conviction
No listed company directly tied yet. Developer: Precision Neuroscience (private). Watch for a listed partner or IPO.
Other possible winners: Precision Neuroscience (private) (our judgment)
⚠️ Who could lose
Older assistive-device makers (our judgment)
✅ Why now
Precision announced a 70-patient, 180-plus-hour neural atlas recorded with its temporary Layer 7 surface arrays, supporting movement, speech and facial-expression decoding. It also announced its first international clini…
Readiness 37/100, stage 2 on our ladder.
U=18: ½×readiness 37 + 0 (no big event expected soon) · no listed ticker linked → 👀 too early
⛔ Why not yet
Data from temporary recordings during procedures
Timeline to impact: about 3-6 years (our judgment)
⬆️ Upgrade triggers
Concrete date or release: Permanent-implant trial and regulatory milestones.
A named paying customer or order
Independent replication / outside test results
Readiness reaching 70+ with a dated catalyst within 90 days (our 🔥 rule)
⬇️ Downgrade signals
Delay or missed milestone (our judgment)
Independent tests fail to confirm the claim (our judgment)
A rival leapfrogs or rules/regulators block it (our judgment)
🧭 Simple plan for this item (👀 Too early: keep an eye on it)
Don't buy because of this item yet.
Add the tickers to a watchlist and check the triggers below each week.
Move to Build only if 2+ upgrade triggers happen.
Tiers: 👀 Too early: keep an eye on it = track triggers only · ⏳ Promising = small staged position · 🔥 Act = catalyst near, sized small. No return promises.
🗓 Timeline
1 yr (our judgment): More sites and patients
3 yr (our judgment): Longer-term implant studies
5 yr (our judgment): Commercial product if approved
📖 What these words mean
Readiness: our 0–100 score for how close an idea is to real products and sales. Higher = closer.
Conviction: how confident we are in a company's link to the idea (high, medium, low).
Ticker / stock code: the short code used to find a company's share on an exchange, e.g. NVDA.
Catalyst / next big event: a dated event (launch, approval, results) that could move the story.
Urgency: our badge for how time-sensitive it is: 🔥 strong signal, ⏳ promising, 👀 too early.
Our judgment · Not financial advice
🇮🇳 Indian investor angle
No Indian listed exposure; US access only via international funds/LRS. (our judgment)
Our judgment · Not financial advice. Exposure notes are qualitative; we don't quote % of revenue unless sourced.
🐂 Bull case
Precision announced a 70-patient, 180-plus-hour neural atlas recorded with its temporary Layer 7 surface arrays, supporting movement, speech and facial-expression decoding.
Who could win: Precision Neuroscience (private)
🐻 What could go wrong
Data from temporary recordings during procedures source
📐 How we scored this
Criterion
Score
Weight
Points
Evidence level
2/5 — Working prototype chip
55%
13.8
Manufacturability
3/5
20%
12.0
Supply chain
2/5
10%
4.0
Corporate backing
3/5
10%
6.0
Independent groups
1/5
5%
1.0
Readiness
37/100
Hype = 10×claim boldness (3/5) + 10×attention (3/5) = 60. Patent/IP risk: Medium (crowding 3/5, litigation 1/5). Sub-scores are our judgment from the linked sources. Full method
👀 What to watch next: Permanent-implant trial and regulatory milestones.
⏰ Time Machinedrag: 1 → 3 → 5 years (our scenario, not a forecast)
In 1 year: 1 yr (our judgment): More sites and patients
📋 Executive briefing teaser free
Surface arrays sit on the brain rather than penetrating it.
Surface arrays sit on the brain rather than penetrating it. Pooled data could speed decoder training. Temporary-use recordings, not a permanent implant.
🔒 Full executive briefingIncluded in Pro & InstitutionalUnlock Premium
🎬 30-second video script Premium
Precision Neuroscience pools 70 patients into one map of the human nervous system. Like stitching many street-view drives into one city map. Our judgment: watch. Sources on our page.
🔒 Video script with citationsIncluded in Pro & InstitutionalUnlock Premium
Tracked since 2026-10-30Readiness vs prev: = no change · Updated 2026-10-30
History: 10-30 S3/78 → 10-31 S3/78
Stage 3 · Shipping👀 Too early: keep an eye on itFrontier model
21. Meta's superintelligence lab ships its first frontier model, Muse Wonder
🧩 Like a new head chef who can read a whole cookbook at once and cook while watching, listening and planning the next course.
METAMeta Platforms
🏛 Meta Superintelligence Lab · 📅 2026-10-12
👀 Too early: keep an eye on itOur judgment · Not financial advice
1Research
2Preview
3Shipping
4Widely adopted
💡 What it is
🔬 Meta released Muse Wonder and Muse Wonder Full for agents, coding, long workflows and multimodal reasoning.
🧩 Like a new head chef who can read a whole cookbook at once and cook while watching, listening and planning the next course.
🚀 Why it matters
📈 Readiness 78/100 · Shipping
⏳ 0-2 yrs to market (our judgment)
🎯 Meta frames it as a step toward 'personal superintelligence' under its safety framework.
💰 Who gains
METAMeta Platforms
🏷 Meta Platforms META (US)
🏷 AI chip and data-centre suppliers (our judgment)
⚠️ Risks
❌ Capabilities are company-reported
✅ What to do
👀 Too early: keep an eye on it · plan: keep watching
🔎 Watch for: Independent benchmarks and paid adoption.
🗓 Timeline
1 yrRapid model updates
3 yrAgent products built on it
5 yrCompetitive position vs other labs unclear
Timeline steps are our judgment unless marked as company plan.
What they found: Meta released Muse Wonder and Muse Wonder Full for agents, coding, long workflows and multimodal reasoning. Muse Wonder supports a 1-million-token context and text, image, video and audio inputs, via the Meta Model API and Muse Code; Full is subscription-only.
🧒 Like I'm 10: Meta made a new AI that can read, look, listen and help with long jobs.
🧩 Think of it like: Like a new head chef who can read a whole cookbook at once and cook while watching, listening and planning the next course.
Readiness78/100
Years to market: 0-2
Our judgment
🎢 Hype vs Reality
Hype 90
Reality 78
Some hype; watch for proof (our judgment)
⚖️ Patent / IP risk
AI IP and copyright litigation is active industry-wide. (Our judgment)
🔒 Patent risk noteIncluded in Pro & InstitutionalUnlock Premium
🏆 Who could win
Meta Platforms META (US)AI chip and data-centre suppliers (our judgment)
💰 Investor view👀 Too early: keep an eye on it
In plain words: Meta made a new AI that can read, look, listen and help with long jobs.
Indirect: AI models support ads; not sold as main product (our judgment)
Winner
High
Other possible winners: Meta Platforms META (US), AI chip and data-centre suppliers (our judgment)
⚠️ Who could lose
Software firms whose tasks AI models can do cheaply (our judgment)
✅ Why now
Meta released Muse Wonder and Muse Wonder Full for agents, coding, long workflows and multimodal reasoning. Muse Wonder supports a 1-million-token context and text, image, video and audio inputs, via the Meta Model API a…
Readiness 78/100, stage 3 on our ladder.
U=31: ½×readiness 78 + 0 (no big event expected soon) − 8×1 kill-risk flag(s)
⛔ Why not yet
Capabilities are company-reported
Frontier AI is a crowded race with fast-changing leaders
Timeline to impact: about 0-2 years (our judgment)
⬆️ Upgrade triggers
Concrete date or release: Independent benchmarks and paid adoption.
A named paying customer or order
Independent replication / outside test results
Readiness reaching 70+ with a dated catalyst within 90 days (our 🔥 rule)
⬇️ Downgrade signals
Delay or missed milestone (our judgment)
Independent tests fail to confirm the claim (our judgment)
A rival leapfrogs or rules/regulators block it (our judgment)
🧭 Simple plan for this item (👀 Too early: keep an eye on it)
Don't buy because of this item yet.
Add the tickers to a watchlist and check the triggers below each week.
Move to Build only if 2+ upgrade triggers happen.
Tiers: 👀 Too early: keep an eye on it = track triggers only · ⏳ Promising = small staged position · 🔥 Act = catalyst near, sized small. No return promises.
🗓 Timeline
1 yr (our judgment): Rapid model updates
3 yr (our judgment): Agent products built on it
5 yr (our judgment): Competitive position vs other labs unclear
📖 What these words mean
Readiness: our 0–100 score for how close an idea is to real products and sales. Higher = closer.
Conviction: how confident we are in a company's link to the idea (high, medium, low).
Ticker / stock code: the short code used to find a company's share on an exchange, e.g. NVDA.
Catalyst / next big event: a dated event (launch, approval, results) that could move the story.
Urgency: our badge for how time-sensitive it is: 🔥 strong signal, ⏳ promising, 👀 too early.
Our judgment · Not financial advice
🇮🇳 Indian investor angle
Indian IT (TCS, INFY) both use and are threatened by AI; US AI names via Nasdaq-100 fund-of-funds. (our judgment)
Our judgment · Not financial advice. Exposure notes are qualitative; we don't quote % of revenue unless sourced.
🐂 Bull case
Meta released Muse Wonder and Muse Wonder Full for agents, coding, long workflows and multimodal reasoning.
Who could win: Meta Platforms META (US), AI chip and data-centre suppliers (our judgment)
🐻 What could go wrong
Capabilities are company-reported (judgment)
Frontier AI is a crowded race with fast-changing leaders (judgment)
📐 How we scored this
Criterion
Score
Weight
Points
Evidence level
4/5 — Volume production or orders
55%
41.2
Manufacturability
4/5
20%
16.0
Supply chain
4/5
10%
8.0
Corporate backing
5/5
10%
10.0
Independent groups
3/5
5%
3.0
Readiness
78/100
Hype = 10×claim boldness (4/5) + 10×attention (5/5) = 90. Patent/IP risk: Medium (crowding 4/5, litigation 2/5). Sub-scores are our judgment from the linked sources. Full method
👀 What to watch next: Independent benchmarks and paid adoption.
⏰ Time Machinedrag: 1 → 3 → 5 years (our scenario, not a forecast)
In 1 year: 1 yr (our judgment): Rapid model updates
📋 Executive briefing teaser free
Meta frames it as a step toward 'personal superintelligence' under its safety framework.
Meta frames it as a step toward 'personal superintelligence' under its safety framework. Benchmarks are company-reported.
🔒 Full executive briefingIncluded in Pro & InstitutionalUnlock Premium
🎬 30-second video script Premium
Meta's superintelligence lab ships its first frontier model, Muse Wonder. Like a new head chef who can read a whole cookbook at once and cook while watching, listening and planning the next course. Our judgment: watch. Sources on our page.
🔒 Video script with citationsIncluded in Pro & InstitutionalUnlock Premium
Tracked since 2026-10-30Readiness vs prev: = no change · Updated 2026-10-30
History: 10-30 S2/45 → 10-31 S2/45
Stage 2 · Preview👀 Too early: keep an eye on itWorld model
22. Google DeepMind's Genie 4 generates interactive worlds with sound and dialogue
🧩 Like a video game that builds itself as you walk, instead of being coded level by level.
GOOGLAlphabet
🏛 Google DeepMind · 📅 2026-10
👀 Too early: keep an eye on itOur judgment · Not financial advice
1Research
2Preview
3Shipping
4Widely adopted
💡 What it is
🔬 Genie 4 is a natively multimodal world model for real-time interactive simulation, generating audio, ambient sound and dialogue.
🧩 Like a video game that builds itself as you walk, instead of being coded level by level.
🚀 Why it matters
📈 Readiness 45/100 · Preview
⏳ 3-6 yrs to market (our judgment)
🎯 World models could train robots and AI agents in simulated worlds.
💰 Who gains
GOOGLAlphabet
🏷 Alphabet GOOGL (US)
⚠️ Risks
❌ Research preview for trusted testers only
✅ What to do
👀 Too early: keep an eye on it · plan: keep watching
🔎 Watch for: Public access and use in robotics training.
🗓 Timeline
1 yrWider tester access
3 yrUse in agent and robot training
5 yrPossible game and simulation products
Timeline steps are our judgment unless marked as company plan.
What they found: Genie 4 is a natively multimodal world model for real-time interactive simulation, generating audio, ambient sound and dialogue. It is a research preview for trusted testers.
🧒 Like I'm 10: An AI that makes a pretend world you can walk around in, with sounds and talking.
🧩 Think of it like: Like a video game that builds itself as you walk, instead of being coded level by level.
Readiness45/100
Years to market: 3-6
Our judgment
🎢 Hype vs Reality
Hype 80
Reality 45
Some hype; watch for proof (our judgment)
⚖️ Patent / IP risk
World-model IP is early. (Our judgment)
🔒 Patent risk noteIncluded in Pro & InstitutionalUnlock Premium
🏆 Who could win
Alphabet GOOGL (US)
💰 Investor view👀 Too early: keep an eye on it
In plain words: An AI that makes a pretend world you can walk around in, with sounds and talking.
Indirect: AI models and Google Cloud are one part; ads are most of the business (our judgment)
Winner
Medium
Other possible winners: Alphabet GOOGL (US) (our judgment)
⚠️ Who could lose
Software firms whose tasks AI models can do cheaply (our judgment)
✅ Why now
Genie 4 is a natively multimodal world model for real-time interactive simulation, generating audio, ambient sound and dialogue. It is a research preview for trusted testers.
Readiness 45/100, stage 2 on our ladder.
U=14: ½×readiness 45 + 0 (no big event expected soon) − 8×1 kill-risk flag(s)
⛔ Why not yet
Research preview for trusted testers only
Timeline to impact: about 3-6 years (our judgment)
⬆️ Upgrade triggers
Concrete date or release: Public access and use in robotics training.
A named paying customer or order
Independent replication / outside test results
Readiness reaching 70+ with a dated catalyst within 90 days (our 🔥 rule)
⬇️ Downgrade signals
Delay or missed milestone (our judgment)
Independent tests fail to confirm the claim (our judgment)
A rival leapfrogs or rules/regulators block it (our judgment)
🧭 Simple plan for this item (👀 Too early: keep an eye on it)
Don't buy because of this item yet.
Add the tickers to a watchlist and check the triggers below each week.
Move to Build only if 2+ upgrade triggers happen.
Tiers: 👀 Too early: keep an eye on it = track triggers only · ⏳ Promising = small staged position · 🔥 Act = catalyst near, sized small. No return promises.
🗓 Timeline
1 yr (our judgment): Wider tester access
3 yr (our judgment): Use in agent and robot training
5 yr (our judgment): Possible game and simulation products
📖 What these words mean
Readiness: our 0–100 score for how close an idea is to real products and sales. Higher = closer.
Conviction: how confident we are in a company's link to the idea (high, medium, low).
Ticker / stock code: the short code used to find a company's share on an exchange, e.g. NVDA.
Catalyst / next big event: a dated event (launch, approval, results) that could move the story.
Urgency: our badge for how time-sensitive it is: 🔥 strong signal, ⏳ promising, 👀 too early.
Our judgment · Not financial advice
🇮🇳 Indian investor angle
Indian IT (TCS, INFY) both use and are threatened by AI; US AI names via Nasdaq-100 fund-of-funds. (our judgment)
Hype = 10×claim boldness (4/5) + 10×attention (4/5) = 80. Patent/IP risk: Medium (crowding 3/5, litigation 1/5). Sub-scores are our judgment from the linked sources. Full method
👀 What to watch next: Public access and use in robotics training.
⏰ Time Machinedrag: 1 → 3 → 5 years (our scenario, not a forecast)
In 1 year: 1 yr (our judgment): Wider tester access
📋 Executive briefing teaser free
World models could train robots and AI agents in simulated worlds.
World models could train robots and AI agents in simulated worlds. Research preview only.
🔒 Full executive briefingIncluded in Pro & InstitutionalUnlock Premium
🎬 30-second video script Premium
Google DeepMind's Genie 4 generates interactive worlds with sound and dialogue. Like a video game that builds itself as you walk, instead of being coded level by level. Our judgment: watch. Sources on our page.
🔒 Video script with citationsIncluded in Pro & InstitutionalUnlock Premium
Indirect: AI models support ads; not sold as main product (our judgment)
Winner
High
Other possible winners: Meta Platforms META (US), Companies running AI on their own hardware (our judgment)
⚠️ Who could lose
Software firms whose tasks AI models can do cheaply (our judgment)
✅ Why now
Meta released Muse Spark Open as an open-weight model, describing it as the most capable US open-weight model to date.
Readiness 78/100, stage 3 on our ladder.
U=39: ½×readiness 78 + 0 (no big event expected soon)
⛔ Why not yet
'Most capable' is a company claim
Timeline to impact: about 0-2 years (our judgment)
⬆️ Upgrade triggers
Concrete date or release: Independent comparisons with other open models.
A named paying customer or order
Independent replication / outside test results
Readiness reaching 70+ with a dated catalyst within 90 days (our 🔥 rule)
⬇️ Downgrade signals
Delay or missed milestone (our judgment)
Independent tests fail to confirm the claim (our judgment)
A rival leapfrogs or rules/regulators block it (our judgment)
🧭 Simple plan for this item (👀 Too early: keep an eye on it)
Don't buy because of this item yet.
Add the tickers to a watchlist and check the triggers below each week.
Move to Build only if 2+ upgrade triggers happen.
Tiers: 👀 Too early: keep an eye on it = track triggers only · ⏳ Promising = small staged position · 🔥 Act = catalyst near, sized small. No return promises.
🗓 Timeline
1 yr (our judgment): Fine-tuned versions appear
3 yr (our judgment): Enterprise on-premise adoption
5 yr (our judgment): Open models may close the gap with closed ones
📖 What these words mean
Readiness: our 0–100 score for how close an idea is to real products and sales. Higher = closer.
Conviction: how confident we are in a company's link to the idea (high, medium, low).
Ticker / stock code: the short code used to find a company's share on an exchange, e.g. NVDA.
Catalyst / next big event: a dated event (launch, approval, results) that could move the story.
Urgency: our badge for how time-sensitive it is: 🔥 strong signal, ⏳ promising, 👀 too early.
Our judgment · Not financial advice
🇮🇳 Indian investor angle
Indian IT (TCS, INFY) both use and are threatened by AI; US AI names via Nasdaq-100 fund-of-funds. (our judgment)
Hype = 10×claim boldness (3/5) + 10×attention (4/5) = 70. Patent/IP risk: Medium (crowding 4/5, litigation 2/5). Sub-scores are our judgment from the linked sources. Full method
👀 What to watch next: Independent comparisons with other open models.
⏰ Time Machinedrag: 1 → 3 → 5 years (our scenario, not a forecast)
In 1 year: 1 yr (our judgment): Fine-tuned versions appear
📋 Executive briefing teaser free
Open weights let companies run models on their own hardware.
Open weights let companies run models on their own hardware. The 'most capable' claim is Meta's own.
🔒 Full executive briefingIncluded in Pro & InstitutionalUnlock Premium
🎬 30-second video script Premium
Meta releases Muse Spark Open, which it calls the most capable US open-weight model. Like publishing a recipe in full, so any restaurant can cook it and tweak it. Our judgment: watch. Sources on our page.
🔒 Video script with citationsIncluded in Pro & InstitutionalUnlock Premium
Tracked since 2026-10-30Readiness vs prev: = no change · Updated 2026-10-30
History: 10-30 S1/32 → 10-31 S1/32
Stage 1 · Lab cell👀 Too early: keep an eye on itSolid-state battery
24. A new solid electrolyte keeps 81% capacity after 2,000 fast charges at high voltage
🧩 Like a road that paves over its own potholes as heavy trucks drive on it.
No listed ticker linked
🏛 Fuzhou University and collaborators (Nature Communications) · 📅 2026-10-17
👀 Too early: keep an eye on itOur judgment · Not financial advice
1Lab cell
2Pilot cell
3Pilot line
4Mass production
💡 What it is
🔬 An amorphous zirconium oxyhalide electrolyte reaches 4.11 mS/cm at 25 °C and forms a self-protecting layer at the cathode.
🧩 Like a road that paves over its own potholes as heavy trucks drive on it.
🚀 Why it matters
📈 Readiness 32/100 · Lab cell
⏳ 4-8 yrs to market (our judgment)
🎯 Many fast-conducting solid electrolytes break down above about 4.3 V, blocking high-energy cathodes.
💰 Who gains
No listed pure-play linked (private or small part of a big company)
🏷 Solid-state battery developers, e.g. QuantumScape QS, Solid Power SLDP (our judgment)
⚠️ Risks
❌ Lab coin-type cells with Li-In alloy anode
✅ What to do
👀 Too early: keep an eye on it · plan: Wait
🔎 Watch for: Tests in larger pouch cells with standard anodes.
🗓 Timeline
1 yrFollow-up pouch cells
3 yrLicensing interest
5 yrPossible use in next-gen EV cells
Timeline steps are our judgment unless marked as company plan.
What they found: An amorphous zirconium oxyhalide electrolyte reaches 4.11 mS/cm at 25 °C and forms a self-protecting layer at the cathode. Cells retained up to 81.2% capacity after 2,000 cycles at 10C, at up to 4.8 V versus lithium.
🧒 Like I'm 10: Batteries without liquid could charge faster and be safer. This new material survives 2,000 quick charges.
🧩 Think of it like: Like a road that paves over its own potholes as heavy trucks drive on it.
Readiness32/100
Years to market: 4-8
Our judgment
🎢 Hype vs Reality
Hype 50
Reality 32
Some hype; watch for proof (our judgment)
⚖️ Patent / IP risk
Solid electrolyte IP is very crowded. (Our judgment)
🔒 Patent risk noteIncluded in Pro & InstitutionalUnlock Premium
🏆 Who could win
Solid-state battery developers, e.g. QuantumScape QS, Solid Power SLDP (our judgment)
💰 Investor view👀 Too early: keep an eye on it
In plain words: Batteries without liquid could charge faster and be safer. This new material survives 2,000 quick charges.
📊 Stocks tied to this
Company
Stock code
How it is linked
Role
Conviction
No listed company directly tied yet. Developer: Fuzhou University and collaborators (Nature Communications). Watch for a listed partner or IPO.
Other possible winners: Solid-state battery developers, e.g. QuantumScape QS, Solid Power SLDP (our judgment)
⚠️ Who could lose
Incumbent technologies this could replace (our judgment)
✅ Why now
An amorphous zirconium oxyhalide electrolyte reaches 4.11 mS/cm at 25 °C and forms a self-protecting layer at the cathode. Cells retained up to 81.2% capacity after 2,000 cycles at 10C, at up to 4.8 V versus lithium.
Readiness 32/100, stage 1 on our ladder.
U=8: ½×readiness 32 + 0 (no big event expected soon) − 8×1 kill-risk flag(s) · no listed ticker linked → 👀 too early
⛔ Why not yet
Lab coin-type cells with Li-In alloy anode
Timeline to impact: about 4-8 years (our judgment)
⬆️ Upgrade triggers
Concrete date or release: Tests in larger pouch cells with standard anodes.
A named paying customer or order
Independent replication / outside test results
Readiness reaching 70+ with a dated catalyst within 90 days (our 🔥 rule)
⬇️ Downgrade signals
Delay or missed milestone (our judgment)
Independent tests fail to confirm the claim (our judgment)
A rival leapfrogs or rules/regulators block it (our judgment)
🧭 Simple plan for this item (👀 Too early: keep an eye on it)
Don't buy because of this item yet.
Add the tickers to a watchlist and check the triggers below each week.
Move to Build only if 2+ upgrade triggers happen.
Tiers: 👀 Too early: keep an eye on it = track triggers only · ⏳ Promising = small staged position · 🔥 Act = catalyst near, sized small. No return promises.
🗓 Timeline
1 yr (our judgment): Follow-up pouch cells
3 yr (our judgment): Licensing interest
5 yr (our judgment): Possible use in next-gen EV cells
📖 What these words mean
Readiness: our 0–100 score for how close an idea is to real products and sales. Higher = closer.
Conviction: how confident we are in a company's link to the idea (high, medium, low).
Ticker / stock code: the short code used to find a company's share on an exchange, e.g. NVDA.
Catalyst / next big event: a dated event (launch, approval, results) that could move the story.
Urgency: our badge for how time-sensitive it is: 🔥 strong signal, ⏳ promising, 👀 too early.
Our judgment · Not financial advice
🇮🇳 Indian investor angle
Look at NSE energy/materials leaders in the same field (check before acting). (our judgment)
Hype = 10×claim boldness (3/5) + 10×attention (2/5) = 50. Patent/IP risk: Medium (crowding 4/5, litigation 2/5). Sub-scores are our judgment from the linked sources. Full method
👀 What to watch next: Tests in larger pouch cells with standard anodes.
⏰ Time Machinedrag: 1 → 3 → 5 years (our scenario, not a forecast)
In 1 year: 1 yr (our judgment): Follow-up pouch cells
📋 Executive briefing teaser free
Many fast-conducting solid electrolytes break down above about 4.3 V, blocking high-energy cathodes.
Many fast-conducting solid electrolytes break down above about 4.3 V, blocking high-energy cathodes. This lab material tolerates higher voltage. Lab cells with a lithium-indium anode, not commercial cells.
🔒 Full executive briefingIncluded in Pro & InstitutionalUnlock Premium
🎬 30-second video script Premium
A new solid electrolyte keeps 81% capacity after 2,000 fast charges at high voltage. Like a road that paves over its own potholes as heavy trucks drive on it. Our judgment: wait. Sources on our page.
🔒 Video script with citationsIncluded in Pro & InstitutionalUnlock Premium
Tracked since 2026-10-30Readiness vs prev: = no change · Updated 2026-10-30
History: 10-30 S1/32 → 10-31 S1/32
Stage 1 · Lab cell👀 Too early: keep an eye on itSolar cells
25. Two-sided perovskite-silicon solar cells keep 90% efficiency after 1,000 hot hours
🧩 Like choosing a bridge that flexes in the wind instead of cracking.
No listed ticker linked
🏛 Research team publishing in Nature Energy · 📅 2026-10
👀 Too early: keep an eye on itOur judgment · Not financial advice
1Lab cell
2Pilot cell
3Pilot line
4Mass production
💡 What it is
🔬 The team identified 'lattice compliance', how well the crystal flexes under stress, as a key to heat-and-light stability.
🧩 Like choosing a bridge that flexes in the wind instead of cracking.
🚀 Why it matters
📈 Readiness 32/100 · Lab cell
⏳ 4-8 yrs to market (our judgment)
🎯 Perovskite-silicon tandems promise more power per panel, but perovskites degrade.
💰 Who gains
No listed pure-play linked (private or small part of a big company)
🏷 Solar manufacturers developing tandems (our judgment)
⚠️ Risks
❌ 1,000 hours is far below panel lifetimes
✅ What to do
👀 Too early: keep an eye on it · plan: keep watching
🔎 Watch for: Longer outdoor tests and module-scale results.
🗓 Timeline
1 yrMore stability data
3 yrPilot tandem modules
5 yrPossible commercial tandems
Timeline steps are our judgment unless marked as company plan.
What they found: The team identified 'lattice compliance', how well the crystal flexes under stress, as a key to heat-and-light stability. Bifacial tandems produced 36.2 mW/cm² and kept 90% of initial efficiency after over 1,000 hours at 1 sun and 65 °C.
🧒 Like I'm 10: Special solar cells catch light on both sides. Scientists found how to stop them breaking down in heat.
🧩 Think of it like: Like choosing a bridge that flexes in the wind instead of cracking.
Readiness32/100
Years to market: 4-8
Our judgment
🎢 Hype vs Reality
Hype 40
Reality 32
Reality is catching up (our judgment)
⚖️ Patent / IP risk
Perovskite patents are crowded. (Our judgment)
🔒 Patent risk noteIncluded in Pro & InstitutionalUnlock Premium
🏆 Who could win
Solar manufacturers developing tandems (our judgment)
💰 Investor view👀 Too early: keep an eye on it
In plain words: Special solar cells catch light on both sides. Scientists found how to stop them breaking down in heat.
📊 Stocks tied to this
Company
Stock code
How it is linked
Role
Conviction
No listed company directly tied yet. Developer: Research team publishing in Nature Energy. Watch for a listed partner or IPO.
Other possible winners: Solar manufacturers developing tandems (our judgment)
⚠️ Who could lose
Incumbent technologies this could replace (our judgment)
✅ Why now
The team identified 'lattice compliance', how well the crystal flexes under stress, as a key to heat-and-light stability. Bifacial tandems produced 36.2 mW/cm² and kept 90% of initial efficiency after over 1,000 hours at…
Readiness 32/100, stage 1 on our ladder.
U=8: ½×readiness 32 + 0 (no big event expected soon) − 8×1 kill-risk flag(s) · no listed ticker linked → 👀 too early
⛔ Why not yet
1,000 hours is far below panel lifetimes
Timeline to impact: about 4-8 years (our judgment)
⬆️ Upgrade triggers
Concrete date or release: Longer outdoor tests and module-scale results.
A named paying customer or order
Independent replication / outside test results
Readiness reaching 70+ with a dated catalyst within 90 days (our 🔥 rule)
⬇️ Downgrade signals
Delay or missed milestone (our judgment)
Independent tests fail to confirm the claim (our judgment)
A rival leapfrogs or rules/regulators block it (our judgment)
🧭 Simple plan for this item (👀 Too early: keep an eye on it)
Don't buy because of this item yet.
Add the tickers to a watchlist and check the triggers below each week.
Move to Build only if 2+ upgrade triggers happen.
Tiers: 👀 Too early: keep an eye on it = track triggers only · ⏳ Promising = small staged position · 🔥 Act = catalyst near, sized small. No return promises.
🗓 Timeline
1 yr (our judgment): More stability data
3 yr (our judgment): Pilot tandem modules
5 yr (our judgment): Possible commercial tandems
📖 What these words mean
Readiness: our 0–100 score for how close an idea is to real products and sales. Higher = closer.
Conviction: how confident we are in a company's link to the idea (high, medium, low).
Ticker / stock code: the short code used to find a company's share on an exchange, e.g. NVDA.
Catalyst / next big event: a dated event (launch, approval, results) that could move the story.
Urgency: our badge for how time-sensitive it is: 🔥 strong signal, ⏳ promising, 👀 too early.
Our judgment · Not financial advice
🇮🇳 Indian investor angle
Look at NSE energy/materials leaders in the same field (check before acting). (our judgment)
Our judgment · Not financial advice. Exposure notes are qualitative; we don't quote % of revenue unless sourced.
🐂 Bull case
The team identified 'lattice compliance', how well the crystal flexes under stress, as a key to heat-and-light stability.
Who could win: Solar manufacturers developing tandems (our judgment)
🐻 What could go wrong
1,000 hours is far below panel lifetimes (judgment)
📐 How we scored this
Criterion
Score
Weight
Points
Evidence level
1/5 — Lab demo
55%
5.5
Manufacturability
3/5
20%
12.0
Supply chain
3/5
10%
6.0
Corporate backing
2/5
10%
4.0
Independent groups
4/5
5%
4.0
Readiness
32/100
Hype = 10×claim boldness (2/5) + 10×attention (2/5) = 40. Patent/IP risk: Medium (crowding 4/5, litigation 1/5). Sub-scores are our judgment from the linked sources. Full method
👀 What to watch next: Longer outdoor tests and module-scale results.
⏰ Time Machinedrag: 1 → 3 → 5 years (our scenario, not a forecast)
In 1 year: 1 yr (our judgment): More stability data
📋 Executive briefing teaser free
Perovskite-silicon tandems promise more power per panel, but perovskites degrade.
Perovskite-silicon tandems promise more power per panel, but perovskites degrade. A design rule for stability helps. 1,000 hours is short versus 25-year panel lifetimes.
🔒 Full executive briefingIncluded in Pro & InstitutionalUnlock Premium
🎬 30-second video script Premium
Two-sided perovskite-silicon solar cells keep 90% efficiency after 1,000 hot hours. Like choosing a bridge that flexes in the wind instead of cracking. Our judgment: watch. Sources on our page.
🔒 Video script with citationsIncluded in Pro & InstitutionalUnlock Premium
Tracked since 2026-10-30Readiness vs prev: = no change · Updated 2026-10-30
History: 10-30 S2/41 → 10-31 S2/41
Stage 2 · Pilot cell👀 Too early: keep an eye on itSolid-state battery
26. EU's HELENA project makes halide solid-state battery pouch cells
🧩 Like moving a recipe from a test kitchen to a small bakery line.
No listed ticker linked
🏛 HELENA consortium (EU, coordinated work package by CIC energiGUNE) · 📅 2026-10-08
👀 Too early: keep an eye on itOur judgment · Not financial advice
1Lab cell
2Pilot cell
3Pilot line
4Mass production
💡 What it is
🔬 HELENA built 40 mAh single-layer pouch cells using scalable extrusion for high-loading cathodes (about 4.5–5 mAh/cm²) and halide electrolyte separators about 40 μm thin, with ionic conductivity near 4 mS/cm after densification.
🧩 Like moving a recipe from a test kitchen to a small bakery line.
🚀 Why it matters
📈 Readiness 41/100 · Pilot cell
⏳ 3-6 yrs to market (our judgment)
🎯 Most solid-state battery papers stop at lab cells.
💰 Who gains
No listed pure-play linked (private or small part of a big company)
🏷 European battery makers (our judgment)
⚠️ Risks
❌ 40 mAh cells are tiny versus EV cells
✅ What to do
👀 Too early: keep an eye on it · plan: keep watching
🔎 Watch for: Multi-layer cells and cycle-life data.
🗓 Timeline
1 yrBigger multi-layer cells
3 yrIndustrial partners scale up
5 yrPossible pilot production
Timeline steps are our judgment unless marked as company plan.
What they found: HELENA built 40 mAh single-layer pouch cells using scalable extrusion for high-loading cathodes (about 4.5–5 mAh/cm²) and halide electrolyte separators about 40 μm thin, with ionic conductivity near 4 mS/cm after densification.
🧒 Like I'm 10: European scientists learned how to build small flat batteries with a new safe material.
🧩 Think of it like: Like moving a recipe from a test kitchen to a small bakery line.
Readiness41/100
Years to market: 3-6
Our judgment
🎢 Hype vs Reality
Hype 40
Reality 41
Reality is catching up (our judgment)
⚖️ Patent / IP risk
Crowded solid-state IP. (Our judgment)
🔒 Patent risk noteIncluded in Pro & InstitutionalUnlock Premium
🏆 Who could win
European battery makers (our judgment)
💰 Investor view👀 Too early: keep an eye on it
In plain words: European scientists learned how to build small flat batteries with a new safe material.
📊 Stocks tied to this
Company
Stock code
How it is linked
Role
Conviction
No listed company directly tied yet. Developer: HELENA consortium (EU, coordinated work package by CIC energiGUNE). Watch for a listed partner or IPO.
Other possible winners: European battery makers (our judgment)
⚠️ Who could lose
Incumbent technologies this could replace (our judgment)
✅ Why now
HELENA built 40 mAh single-layer pouch cells using scalable extrusion for high-loading cathodes (about 4.5–5 mAh/cm²) and halide electrolyte separators about 40 μm thin, with ionic conductivity near 4 mS/cm after densifi…
Readiness 41/100, stage 2 on our ladder.
U=20: ½×readiness 41 + 0 (no big event expected soon) · no listed ticker linked → 👀 too early
⛔ Why not yet
40 mAh cells are tiny versus EV cells
Timeline to impact: about 3-6 years (our judgment)
⬆️ Upgrade triggers
Concrete date or release: Multi-layer cells and cycle-life data.
A named paying customer or order
Independent replication / outside test results
Readiness reaching 70+ with a dated catalyst within 90 days (our 🔥 rule)
⬇️ Downgrade signals
Delay or missed milestone (our judgment)
Independent tests fail to confirm the claim (our judgment)
A rival leapfrogs or rules/regulators block it (our judgment)
🧭 Simple plan for this item (👀 Too early: keep an eye on it)
Don't buy because of this item yet.
Add the tickers to a watchlist and check the triggers below each week.
Move to Build only if 2+ upgrade triggers happen.
Tiers: 👀 Too early: keep an eye on it = track triggers only · ⏳ Promising = small staged position · 🔥 Act = catalyst near, sized small. No return promises.
🗓 Timeline
1 yr (our judgment): Bigger multi-layer cells
3 yr (our judgment): Industrial partners scale up
5 yr (our judgment): Possible pilot production
📖 What these words mean
Readiness: our 0–100 score for how close an idea is to real products and sales. Higher = closer.
Conviction: how confident we are in a company's link to the idea (high, medium, low).
Ticker / stock code: the short code used to find a company's share on an exchange, e.g. NVDA.
Catalyst / next big event: a dated event (launch, approval, results) that could move the story.
Urgency: our badge for how time-sensitive it is: 🔥 strong signal, ⏳ promising, 👀 too early.
Our judgment · Not financial advice
🇮🇳 Indian investor angle
Look at NSE energy/materials leaders in the same field (check before acting). (our judgment)
Our judgment · Not financial advice. Exposure notes are qualitative; we don't quote % of revenue unless sourced.
🐂 Bull case
HELENA built 40 mAh single-layer pouch cells using scalable extrusion for high-loading cathodes (about 4.5–5 mAh/cm²) and halide electrolyte separators about 40 μm thin, with ionic conductivity near 4 mS/cm after densification.
Who could win: European battery makers (our judgment)
Hype = 10×claim boldness (2/5) + 10×attention (2/5) = 40. Patent/IP risk: Medium (crowding 4/5, litigation 1/5). Sub-scores are our judgment from the linked sources. Full method
👀 What to watch next: Multi-layer cells and cycle-life data.
⏰ Time Machinedrag: 1 → 3 → 5 years (our scenario, not a forecast)
In 1 year: 1 yr (our judgment): Bigger multi-layer cells
📋 Executive briefing teaser free
Most solid-state battery papers stop at lab cells.
Most solid-state battery papers stop at lab cells. HELENA shows manufacturing steps. 40 mAh cells are still far smaller than EV cells.
🔒 Full executive briefingIncluded in Pro & InstitutionalUnlock Premium
🎬 30-second video script Premium
EU's HELENA project makes halide solid-state battery pouch cells. Like moving a recipe from a test kitchen to a small bakery line. Our judgment: watch. Sources on our page.
🔒 Video script with citationsIncluded in Pro & InstitutionalUnlock Premium
Tracked since 2026-10-30Readiness vs prev: = no change · Updated 2026-10-30
History: 10-30 S3/74 → 10-31 S3/74
Stage 3 · Flight👀 Too early: keep an eye on itReusable rockets
27. SpaceX plans to catch both Starship stages on Flight 15
🧩 Like catching both a plane and its fuel tanker back on the runway, refuelled and ready to fly again.
UFOProcure Space ETF
🏛 SpaceX (private) · 📅 2026-10
👀 Too early: keep an eye on itOur judgment · Not financial advice
1Design
2Testing
3Flight
4Operations
💡 What it is
🔬 SpaceX plans its first attempt to catch both the Super Heavy booster and the Starship upper stage at the tower on Flight 15, reported for a tentative November date.
🧩 Like catching both a plane and its fuel tanker back on the runway, refuelled and ready to fly again.
🚀 Why it matters
📈 Readiness 74/100 · Flight
⏳ 0-2 yrs to market (our judgment)
🎯 Full reuse could slash the cost of reaching orbit.
💰 Who gains
UFOProcure Space ETF
🏷 SpaceX (private)
🏷 Space ETFs such as Procure Space ETF UFO (our judgment)
⚠️ Risks
❌ FAA authorisation for the dual catch was reported as not yet granted
✅ What to do
👀 Too early: keep an eye on it · plan: keep watching
🔎 Watch for: FAA approval and the Flight 15 result.
🗓 Timeline
1 yrCatch attempt result
3 yrFaster launch cadence
5 yrCheaper launches if reuse is routine
Timeline steps are our judgment unless marked as company plan.
What they found: SpaceX plans its first attempt to catch both the Super Heavy booster and the Starship upper stage at the tower on Flight 15, reported for a tentative November date. Ars Technica reports SpaceX aims for weekly launches by early 2027.
🧒 Like I'm 10: SpaceX wants to catch both parts of its giant rocket with a tower so it can fly again.
🧩 Think of it like: Like catching both a plane and its fuel tanker back on the runway, refuelled and ready to fly again.
Readiness74/100
Years to market: 0-2
Our judgment
🎢 Hype vs Reality
Hype 90
Reality 74
Some hype; watch for proof (our judgment)
⚖️ Patent / IP risk
Reusable-rocket IP mostly in-house. (Our judgment)
🔒 Patent risk noteIncluded in Pro & InstitutionalUnlock Premium
🏆 Who could win
SpaceX (private)Space ETFs such as Procure Space ETF UFO (our judgment)
💰 Investor view👀 Too early: keep an eye on it
In plain words: SpaceX wants to catch both parts of its giant rocket with a tower so it can fly again.
Other possible winners: SpaceX (private), Space ETFs such as Procure Space ETF UFO (our judgment)
⚠️ Who could lose
Higher-cost launch providers (our judgment)
✅ Why now
SpaceX plans its first attempt to catch both the Super Heavy booster and the Starship upper stage at the tower on Flight 15, reported for a tentative November date. Ars Technica reports SpaceX aims for weekly launches by…
Readiness 74/100, stage 3 on our ladder.
U=29: ½×readiness 74 + 0 (no big event expected soon) − 8×1 kill-risk flag(s)
⛔ Why not yet
FAA authorisation for the dual catch was reported as not yet granted
Target dates often slip
Timeline to impact: about 0-2 years (our judgment)
⬆️ Upgrade triggers
Concrete date or release: FAA approval and the Flight 15 result.
A named paying customer or order
Independent replication / outside test results
Readiness reaching 70+ with a dated catalyst within 90 days (our 🔥 rule)
⬇️ Downgrade signals
Delay or missed milestone (our judgment)
Independent tests fail to confirm the claim (our judgment)
A rival leapfrogs or rules/regulators block it (our judgment)
🧭 Simple plan for this item (👀 Too early: keep an eye on it)
Don't buy because of this item yet.
Add the tickers to a watchlist and check the triggers below each week.
Move to Build only if 2+ upgrade triggers happen.
Tiers: 👀 Too early: keep an eye on it = track triggers only · ⏳ Promising = small staged position · 🔥 Act = catalyst near, sized small. No return promises.
🗓 Timeline
1 yr (our judgment): Catch attempt result
3 yr (our judgment): Faster launch cadence
5 yr (our judgment): Cheaper launches if reuse is routine
📖 What these words mean
Readiness: our 0–100 score for how close an idea is to real products and sales. Higher = closer.
Conviction: how confident we are in a company's link to the idea (high, medium, low).
Ticker / stock code: the short code used to find a company's share on an exchange, e.g. NVDA.
Catalyst / next big event: a dated event (launch, approval, results) that could move the story.
Urgency: our badge for how time-sensitive it is: 🔥 strong signal, ⏳ promising, 👀 too early.
Our judgment · Not financial advice
🇮🇳 Indian investor angle
NSE: HAL, BEL, MTARTECH (MTAR, ISRO engine parts), DATAPATTNS (Data Patterns) are defence/space suppliers; US via UFO/LRS. (our judgment)
Our judgment · Not financial advice. Exposure notes are qualitative; we don't quote % of revenue unless sourced.
🐂 Bull case
SpaceX plans its first attempt to catch both the Super Heavy booster and the Starship upper stage at the tower on Flight 15, reported for a tentative November date.
Who could win: SpaceX (private), Space ETFs such as Procure Space ETF UFO (our judgment)
🐻 What could go wrong
FAA authorisation for the dual catch was reported as not yet granted (judgment)
Target dates often slip (judgment)
📐 How we scored this
Criterion
Score
Weight
Points
Evidence level
4/5 — Volume production or orders
55%
41.2
Manufacturability
4/5
20%
16.0
Supply chain
3/5
10%
6.0
Corporate backing
5/5
10%
10.0
Independent groups
1/5
5%
1.0
Readiness
74/100
Hype = 10×claim boldness (4/5) + 10×attention (5/5) = 90. Patent/IP risk: Low (crowding 2/5, litigation 1/5). Sub-scores are our judgment from the linked sources. Full method
👀 What to watch next: FAA approval and the Flight 15 result.
⏰ Time Machinedrag: 1 → 3 → 5 years (our scenario, not a forecast)
In 1 year: 1 yr (our judgment): Catch attempt result
📋 Executive briefing teaser free
Full reuse could slash the cost of reaching orbit.
Full reuse could slash the cost of reaching orbit. Static fires are done, but FAA approval for the dual catch was reported as unresolved.
🔒 Full executive briefingIncluded in Pro & InstitutionalUnlock Premium
🎬 30-second video script Premium
SpaceX plans to catch both Starship stages on Flight 15. Like catching both a plane and its fuel tanker back on the runway, refuelled and ready to fly again. Our judgment: watch. Sources on our page.
🔒 Video script with citationsIncluded in Pro & InstitutionalUnlock Premium
Tracked since 2026-10-30Readiness vs prev: = no change · Updated 2026-10-30
History: 10-30 S2/41 → 10-31 S2/41
Stage 2 · Testing👀 Too early: keep an eye on itMedium-lift rocket
28. Rocket Lab pushes Neutron's first launch to 2027 after finding flaws in fuel-tank domes
🧩 Like finding air bubbles in a cake's frosting: you remake it before the party, and the party moves.
RKLBRocket LabUFOProcure Space ETF
🏛 Rocket Lab (Nasdaq: RKLB) · 📅 2026-10-14
👀 Too early: keep an eye on itOur judgment · Not financial advice
1Design
2Testing
3Flight
4Operations
💡 What it is
🔬 Rocket Lab found voids in carbon-fibre propellant domes and moved Neutron's first flight from late 2026 to 2027.
🧩 Like finding air bubbles in a cake's frosting: you remake it before the party, and the party moves.
🚀 Why it matters
📈 Readiness 41/100 · Testing
⏳ 3-6 yrs to market (our judgment)
🎯 Neutron is Rocket Lab's reusable medium-lift rocket, key to competing for larger launch contracts.
💰 Who gains
RKLBRocket LabUFOProcure Space ETF
🏷 Rocket Lab RKLB (US)
⚠️ Risks
❌ Schedule slip; further delays possible
✅ What to do
👀 Too early: keep an eye on it · plan: Wait
🔎 Watch for: Q1 2027 stage tests and a firm launch date.
🗓 Timeline
1 yrStage tests finish
3 yrFirst launch
5 yrRegular flights if debut succeeds
Timeline steps are our judgment unless marked as company plan.
What they found: Rocket Lab found voids in carbon-fibre propellant domes and moved Neutron's first flight from late 2026 to 2027. It expects to finish first-stage testing in Q1 2027 before setting a firm date.
🧒 Like I'm 10: Rocket Lab found tiny holes in a rocket part, so its new rocket will fly later.
🧩 Think of it like: Like finding air bubbles in a cake's frosting: you remake it before the party, and the party moves.
Readiness41/100
Years to market: 3-6
Our judgment
🎢 Hype vs Reality
Hype 60
Reality 41
Some hype; watch for proof (our judgment)
⚖️ Patent / IP risk
Launch IP mostly in-house. (Our judgment)
🔒 Patent risk noteIncluded in Pro & InstitutionalUnlock Premium
🏆 Who could win
Rocket Lab RKLB (US)
💰 Investor view👀 Too early: keep an eye on it
In plain words: Rocket Lab found tiny holes in a rocket part, so its new rocket will fly later.
Other possible winners: Rocket Lab RKLB (US) (our judgment)
⚠️ Who could lose
Higher-cost launch providers (our judgment)
✅ Why now
Rocket Lab found voids in carbon-fibre propellant domes and moved Neutron's first flight from late 2026 to 2027. It expects to finish first-stage testing in Q1 2027 before setting a firm date.
Readiness 41/100, stage 2 on our ladder.
U=20: ½×readiness 41 + 0 (no big event expected soon)
⛔ Why not yet
Schedule slip; further delays possible
Timeline to impact: about 3-6 years (our judgment)
⬆️ Upgrade triggers
Concrete date or release: Q1 2027 stage tests and a firm launch date.
A named paying customer or order
Independent replication / outside test results
Readiness reaching 70+ with a dated catalyst within 90 days (our 🔥 rule)
⬇️ Downgrade signals
Delay or missed milestone (our judgment)
Independent tests fail to confirm the claim (our judgment)
A rival leapfrogs or rules/regulators block it (our judgment)
🧭 Simple plan for this item (👀 Too early: keep an eye on it)
Don't buy because of this item yet.
Add the tickers to a watchlist and check the triggers below each week.
Move to Build only if 2+ upgrade triggers happen.
Tiers: 👀 Too early: keep an eye on it = track triggers only · ⏳ Promising = small staged position · 🔥 Act = catalyst near, sized small. No return promises.
🗓 Timeline
1 yr (our judgment): Stage tests finish
3 yr (our judgment): First launch
5 yr (our judgment): Regular flights if debut succeeds
📖 What these words mean
Readiness: our 0–100 score for how close an idea is to real products and sales. Higher = closer.
Conviction: how confident we are in a company's link to the idea (high, medium, low).
Ticker / stock code: the short code used to find a company's share on an exchange, e.g. NVDA.
Catalyst / next big event: a dated event (launch, approval, results) that could move the story.
Urgency: our badge for how time-sensitive it is: 🔥 strong signal, ⏳ promising, 👀 too early.
Our judgment · Not financial advice
🇮🇳 Indian investor angle
NSE: HAL, BEL, MTARTECH (MTAR, ISRO engine parts), DATAPATTNS (Data Patterns) are defence/space suppliers; US via UFO/LRS. (our judgment)
Hype = 10×claim boldness (2/5) + 10×attention (4/5) = 60. Patent/IP risk: Low (crowding 2/5, litigation 1/5). Sub-scores are our judgment from the linked sources. Full method
👀 What to watch next: Q1 2027 stage tests and a firm launch date.
⏰ Time Machinedrag: 1 → 3 → 5 years (our scenario, not a forecast)
In 1 year: 1 yr (our judgment): Stage tests finish
📋 Executive briefing teaser free
Neutron is Rocket Lab's reusable medium-lift rocket, key to competing for larger launch contracts..
Neutron is Rocket Lab's reusable medium-lift rocket, key to competing for larger launch contracts.
🔒 Full executive briefingIncluded in Pro & InstitutionalUnlock Premium
🎬 30-second video script Premium
Rocket Lab pushes Neutron's first launch to 2027 after finding flaws in fuel-tank domes. Like finding air bubbles in a cake's frosting: you remake it before the party, and the party moves. Our judgment: wait. Sources on our page.
🔒 Video script with citationsIncluded in Pro & InstitutionalUnlock Premium
Tracked since 2026-10-30Readiness vs prev: = no change · Updated 2026-10-30
History: 10-30 S3/70 → 10-31 S3/70
Stage 3 · Flight👀 Too early: keep an eye on itHeavy-lift rocket
29. Blue Origin plans new Florida launch pads to raise New Glenn's flight rate
🧩 Like a bakery rebuilding its oven after a fire while planning two more ovens.
No listed ticker linked
🏛 Blue Origin (private) · 📅 2026-10-16
👀 Too early: keep an eye on itOur judgment · Not financial advice
1Design
2Testing
3Flight
4Operations
💡 What it is
🔬 Blue Origin is rebuilding pad LC-36A after a May static-fire explosion, expects it ready by early December, targets a New Glenn return to flight this year, and plans new Florida pads for a higher flight rate.
🧩 Like a bakery rebuilding its oven after a fire while planning two more ovens.
🚀 Why it matters
📈 Readiness 70/100 · Flight
⏳ 0-2 yrs to market (our judgment)
🎯 More heavy-lift capacity means more competition and capacity for satellite constellations.
💰 Who gains
No listed pure-play linked (private or small part of a big company)
Timeline steps are our judgment unless marked as company plan.
What they found: Blue Origin is rebuilding pad LC-36A after a May static-fire explosion, expects it ready by early December, targets a New Glenn return to flight this year, and plans new Florida pads for a higher flight rate.
🧒 Like I'm 10: Blue Origin is fixing its launch pad after an accident and building more pads to launch more often.
🧩 Think of it like: Like a bakery rebuilding its oven after a fire while planning two more ovens.
Readiness70/100
Years to market: 0-2
Our judgment
🎢 Hype vs Reality
Hype 70
Reality 70
Reality is catching up (our judgment)
⚖️ Patent / IP risk
Launch IP mostly in-house. (Our judgment)
🔒 Patent risk noteIncluded in Pro & InstitutionalUnlock Premium
🏆 Who could win
Blue Origin (private)Satellite operators needing launches (our judgment)
💰 Investor view👀 Too early: keep an eye on it
In plain words: Blue Origin is fixing its launch pad after an accident and building more pads to launch more often.
📊 Stocks tied to this
Company
Stock code
How it is linked
Role
Conviction
No listed company directly tied yet. Developer: Blue Origin (private). Watch for a listed partner or IPO.
Other possible winners: Blue Origin (private), Satellite operators needing launches (our judgment)
⚠️ Who could lose
Higher-cost launch providers (our judgment)
✅ Why now
Blue Origin is rebuilding pad LC-36A after a May static-fire explosion, expects it ready by early December, targets a New Glenn return to flight this year, and plans new Florida pads for a higher flight rate.
Readiness 70/100, stage 3 on our ladder.
U=35: ½×readiness 70 + 0 (no big event expected soon) · no listed ticker linked → 👀 too early
⛔ Why not yet
Return-to-flight timing depends on pad rebuild
Timeline to impact: about 0-2 years (our judgment)
⬆️ Upgrade triggers
Concrete date or release: Return-to-flight date.
A named paying customer or order
Independent replication / outside test results
Readiness reaching 70+ with a dated catalyst within 90 days (our 🔥 rule)
⬇️ Downgrade signals
Delay or missed milestone (our judgment)
Independent tests fail to confirm the claim (our judgment)
A rival leapfrogs or rules/regulators block it (our judgment)
🧭 Simple plan for this item (👀 Too early: keep an eye on it)
Don't buy because of this item yet.
Add the tickers to a watchlist and check the triggers below each week.
Move to Build only if 2+ upgrade triggers happen.
Tiers: 👀 Too early: keep an eye on it = track triggers only · ⏳ Promising = small staged position · 🔥 Act = catalyst near, sized small. No return promises.
🗓 Timeline
1 yr (our judgment): Return to flight
3 yr (our judgment): More pads built
5 yr (our judgment): Higher cadence if reliable
📖 What these words mean
Readiness: our 0–100 score for how close an idea is to real products and sales. Higher = closer.
Conviction: how confident we are in a company's link to the idea (high, medium, low).
Ticker / stock code: the short code used to find a company's share on an exchange, e.g. NVDA.
Catalyst / next big event: a dated event (launch, approval, results) that could move the story.
Urgency: our badge for how time-sensitive it is: 🔥 strong signal, ⏳ promising, 👀 too early.
Our judgment · Not financial advice
🇮🇳 Indian investor angle
NSE: HAL, BEL, MTARTECH (MTAR, ISRO engine parts), DATAPATTNS (Data Patterns) are defence/space suppliers; US via UFO/LRS. (our judgment)
Our judgment · Not financial advice. Exposure notes are qualitative; we don't quote % of revenue unless sourced.
🐂 Bull case
Blue Origin is rebuilding pad LC-36A after a May static-fire explosion, expects it ready by early December, targets a New Glenn return to flight this year, and plans new Florida pads for a higher flight rate.
Who could win: Blue Origin (private), Satellite operators needing launches (our judgment)
🐻 What could go wrong
Return-to-flight timing depends on pad rebuild source
📐 How we scored this
Criterion
Score
Weight
Points
Evidence level
4/5 — Volume production or orders
55%
41.2
Manufacturability
3/5
20%
12.0
Supply chain
3/5
10%
6.0
Corporate backing
5/5
10%
10.0
Independent groups
1/5
5%
1.0
Readiness
70/100
Hype = 10×claim boldness (3/5) + 10×attention (4/5) = 70. Patent/IP risk: Low (crowding 2/5, litigation 1/5). Sub-scores are our judgment from the linked sources. Full method
👀 What to watch next: Return-to-flight date.
⏰ Time Machinedrag: 1 → 3 → 5 years (our scenario, not a forecast)
In 1 year: 1 yr (our judgment): Return to flight
📋 Executive briefing teaser free
More heavy-lift capacity means more competition and capacity for satellite constellations..
More heavy-lift capacity means more competition and capacity for satellite constellations.
🔒 Full executive briefingIncluded in Pro & InstitutionalUnlock Premium
🎬 30-second video script Premium
Blue Origin plans new Florida launch pads to raise New Glenn's flight rate. Like a bakery rebuilding its oven after a fire while planning two more ovens. Our judgment: wait. Sources on our page.
🔒 Video script with citationsIncluded in Pro & InstitutionalUnlock Premium
Tracked since 2026-10-29Readiness vs prev: = no change · Updated 2026-10-29
History: 10-29 S2/46 → 10-30 S2/46 → 10-31 S2/46
Stage 2 · Prototype👀 Too early: keep an eye on itPhotonic interconnect
30. PsiQuantum shows a light-based switch that rewires AI data-centre networks in 3 ms
🧩 Like a railway junction that swaps tracks in a blink, so data trains of light never have to stop and be turned into electricity.
GFSGlobalFoundries
🏛 PsiQuantum (chips made at GlobalFoundries) · 📅 2026-10-28
👀 Too early: keep an eye on itOur judgment · Not financial advice
1Paper
2Prototype
3Factories & orders
4Revenue
💡 What it is
🔬 The quantum-computing company turned its ultra-low-loss silicon-photonics process into an 8×8 optical circuit switch for AI networks.
🧩 Like a railway junction that swaps tracks in a blink, so data trains of light never have to stop and be turned into electricity.
🚀 Why it matters
📈 Readiness 46/100 · Prototype
⏳ 1-4 yrs to market (our judgment)
🎯 Optical circuit switches cut power and latency in AI clusters by skipping optical-to-electrical conversion.
💰 Who gains
GFSGlobalFoundries
🏷 PsiQuantum
🏷 GlobalFoundries
🏷 Hyperscalers building AI clusters
⚠️ Risks
❌ Results are company-reported lab results, not independently verified; only an 8×8 port count so far
✅ What to do
👀 Too early: keep an eye on it · plan: keep watching
🔎 Watch for: Product launch "in coming months", a higher port count than 8×8, and a named data-centre customer.
🗓 Timeline
Step 1Samples tested by a few big cloud firms.
Step 2First switches in real AI clusters if tests go well.
Step 3Could be a standard part of AI networks, or lose to cheaper electrical switches.
Timeline steps are our judgment unless marked as company plan.
What they found: The quantum-computing company turned its ultra-low-loss silicon-photonics process into an 8×8 optical circuit switch for AI networks. The company reports 1.2 dB loss, 40 dB crosstalk and under 3 ms to reconfigure, and is sharing samples with select prospective customers.
🧒 Like I'm 10: Computers in AI buildings talk with flashes of light. This chip is a super-fast traffic cop that points the light at the right computer without slowing it down.
🧩 Think of it like: Like a railway junction that swaps tracks in a blink, so data trains of light never have to stop and be turned into electricity.
Readiness46/100
Years to market: 1-4
Our judgment
🎢 Hype vs Reality
Hype 50
Reality 46
Reality is catching up (our judgment)
⚖️ Patent / IP risk
Optical switching is crowded (Google, Lumentum, Coherent and MEMS makers). No known litigation.
🔒 Patent risk noteIncluded in Pro & InstitutionalUnlock Premium
🏆 Who could win
PsiQuantumGlobalFoundriesHyperscalers building AI clusters
💰 Investor view👀 Too early: keep an eye on it
In plain words: Computers in AI buildings talk with flashes of light. This chip is a super-fast traffic cop that points the light at the right computer without slowing it down.
Direct: Contract fab incl. photonics (our judgment)
Supplier
Medium
Other possible winners: PsiQuantum, GlobalFoundries, Hyperscalers building AI clusters (our judgment)
⚠️ Who could lose
Makers of older copper/electrical interconnect and packaging may lose share (our judgment)
✅ Why now
The quantum-computing company turned its ultra-low-loss silicon-photonics process into an 8×8 optical circuit switch for AI networks. The company reports 1.2 dB loss, 40 dB crosstalk and under 3 ms to reconfigure, and is…
Readiness 46/100, stage 2 on our ladder.
U=23: ½×readiness 46 + 0 (no big event expected soon)
⛔ Why not yet
Results are company-reported lab results, not independently verified; only an 8×8 port count so far
Google already uses MEMS-based optical switches in production, so the market has a strong incumbent
Timeline to impact: about 1-4 years (our judgment)
⬆️ Upgrade triggers
Concrete date or release: Product launch "in coming months", a higher port count than 8×8, and a named data-centre customer.
A named paying customer or order
Independent replication / outside test results
Readiness reaching 70+ with a dated catalyst within 90 days (our 🔥 rule)
⬇️ Downgrade signals
Delay or missed milestone (our judgment)
Independent tests fail to confirm the claim (our judgment)
A rival leapfrogs or rules/regulators block it (our judgment)
🧭 Simple plan for this item (👀 Too early: keep an eye on it)
Don't buy because of this item yet.
Add the tickers to a watchlist and check the triggers below each week.
Move to Build only if 2+ upgrade triggers happen.
Tiers: 👀 Too early: keep an eye on it = track triggers only · ⏳ Promising = small staged position · 🔥 Act = catalyst near, sized small. No return promises.
🗓 Timeline
Samples tested by a few big cloud firms.
First switches in real AI clusters if tests go well.
Could be a standard part of AI networks, or lose to cheaper electrical switches.
📖 What these words mean
Readiness: our 0–100 score for how close an idea is to real products and sales. Higher = closer.
Conviction: how confident we are in a company's link to the idea (high, medium, low).
Ticker / stock code: the short code used to find a company's share on an exchange, e.g. NVDA.
Catalyst / next big event: a dated event (launch, approval, results) that could move the story.
Urgency: our badge for how time-sensitive it is: 🔥 strong signal, ⏳ promising, 👀 too early.
Our judgment · Not financial advice
🇮🇳 Indian investor angle
NSE: KAYNES and CGPOWER (both started chip assembly/test, OSAT, production at Sanand in 2026); US names via Nasdaq-100 or US-tech funds under the LRS route (RBI scheme for investing abroad). (our judgment)
Our judgment · Not financial advice. Exposure notes are qualitative; we don't quote % of revenue unless sourced.
🐂 Bull case
The quantum-computing company turned its ultra-low-loss silicon-photonics process into an 8×8 optical circuit switch for AI networks.
Who could win: PsiQuantum, GlobalFoundries, Hyperscalers building AI clusters
🐻 What could go wrong
Results are company-reported lab results, not independently verified; only an 8×8 port count so far source
Google already uses MEMS-based optical switches in production, so the market has a strong incumbent source
All-optical switching has a long history of hype in telecom (judgment)
📐 How we scored this
Criterion
Score
Weight
Points
Evidence level
2/5 — Working prototype chip
55%
13.8
Manufacturability
4/5
20%
16.0
Supply chain
3/5
10%
6.0
Corporate backing
3/5
10%
6.0
Independent groups
4/5
5%
4.0
Readiness
46/100
Hype = 10×claim boldness (2/5) + 10×attention (3/5) = 50. Patent/IP risk: Medium (crowding 3/5, litigation 1/5). Sub-scores are our judgment from the linked sources. Full method
👀 What to watch next: Product launch "in coming months", a higher port count than 8×8, and a named data-centre customer.
⏰ Time Machinedrag: 1 → 3 → 5 years (our scenario, not a forecast)
In 1 year: Samples tested by a few big cloud firms.
📋 Executive briefing teaser free
Optical circuit switches cut power and latency in AI clusters by skipping optical-to-electrical conversion.
Optical circuit switches cut power and latency in AI clusters by skipping optical-to-electrical conversion. Google already runs MEMS-based switches. PsiQuantum offers a chip-scale silicon-photonics version from a standard foundry. The results are company-reported lab results, not yet independent.
🔒 Full executive briefingIncluded in Pro & InstitutionalUnlock Premium
🎬 30-second video script Premium
Your AI data centre has a traffic problem. Every switch turns light into electricity and back. PsiQuantum just showed a chip that switches the light itself, in 3 milliseconds. Samples are out. Sources: PsiQuantum, IEEE ComSoc.
🔒 Video script with citationsIncluded in Pro & InstitutionalUnlock Premium
Tracked since 2026-10-29Readiness vs prev: = no change · Updated 2026-10-29
History: 10-29 S1/27 → 10-30 S1/27 → 10-31 S1/27
Stage 1 · Paper👀 Too early: keep an eye on itIn-memory compute
31. DuoPD: small compute units inside HBM4 memory could make AI chatbots answer up to 2.2× faster
🧩 Instead of running to the library for every sentence, the librarian writes the answer at the shelf and only hands you the result.
No listed ticker linked
🏛 Seoul National University (Jae-Joon Kim group) · 📅 2026-10-29
👀 Too early: keep an eye on itOur judgment · Not financial advice
1Paper
2Prototype
3Factories & orders
4Revenue
💡 What it is
🔬 The authors add lightweight processing-near-memory units to the logic die at the bottom of HBM4 stacks.
🧩 Instead of running to the library for every sentence, the librarian writes the answer at the shelf and only hands you the result.
🚀 Why it matters
📈 Readiness 27/100 · Paper
⏳ 4-8 yrs to market (our judgment)
🎯 HBM4 moves the base die to a logic process, which opens room for compute.
💰 Who gains
No listed pure-play linked (private or small part of a big company)
🏷 SK hynix
🏷 Samsung
🏷 Micron
⚠️ Risks
❌ Simulation only, no fabricated chip
✅ What to do
👀 Too early: keep an eye on it · plan: keep watching
🔎 Watch for: Whether an HBM maker puts compute in the HBM4/4E base die, and any real silicon measurement.
🗓 Timeline
Step 1More simulation papers; HBM makers test ideas.
Step 2Possible first compute features in custom HBM base dies.
Step 3Common in AI memory, if standards and software follow.
Timeline steps are our judgment unless marked as company plan.
What they found: The authors add lightweight processing-near-memory units to the logic die at the bottom of HBM4 stacks. The GPU handles the prompt and the memory handles word-by-word answering, sharing the same HBM. In simulation this gives up to 2.23× more throughput and up to 37.9% energy saving, for 6.51 mm² and 6.45 W per stack.
🧒 Like I'm 10: The computer's brain keeps running to its notebook. This idea puts a little helper inside the notebook so it can do some of the work itself.
🧩 Think of it like: Instead of running to the library for every sentence, the librarian writes the answer at the shelf and only hands you the result.
Readiness27/100
Years to market: 4-8
Our judgment
🎢 Hype vs Reality
Hype 40
Reality 27
Some hype; watch for proof (our judgment)
⚖️ Patent / IP risk
Processing-in-memory is heavily patented by Samsung, SK hynix and others. No known litigation.
🔒 Patent risk noteIncluded in Pro & InstitutionalUnlock Premium
🏆 Who could win
SK hynixSamsungMicron
💰 Investor view👀 Too early: keep an eye on it
In plain words: The computer's brain keeps running to its notebook. This idea puts a little helper inside the notebook so it can do some of the work itself.
📊 Stocks tied to this
Company
Stock code
How it is linked
Role
Conviction
No listed company directly tied yet. Developer: Seoul National University (Jae-Joon Kim group). Watch for a listed partner or IPO.
Other possible winners: SK hynix, Samsung, Micron (our judgment)
⚠️ Who could lose
Makers of older copper/electrical interconnect and packaging may lose share (our judgment)
✅ Why now
The authors add lightweight processing-near-memory units to the logic die at the bottom of HBM4 stacks. The GPU handles the prompt and the memory handles word-by-word answering, sharing the same HBM. In simulation this g…
Readiness 27/100, stage 1 on our ladder.
U=6: ½×readiness 27 + 0 (no big event expected soon) − 8×1 kill-risk flag(s) · no listed ticker linked → 👀 too early
⛔ Why not yet
Simulation only, no fabricated chip
Needs HBM vendors and GPU makers to agree on a new interface; earlier in-memory compute products saw limited adoption
Timeline to impact: about 4-8 years (our judgment)
⬆️ Upgrade triggers
Concrete date or release: Whether an HBM maker puts compute in the HBM4/4E base die, and any real silicon measurement.
A named paying customer or order
Independent replication / outside test results
Readiness reaching 70+ with a dated catalyst within 90 days (our 🔥 rule)
⬇️ Downgrade signals
Delay or missed milestone (our judgment)
Independent tests fail to confirm the claim (our judgment)
A rival leapfrogs or rules/regulators block it (our judgment)
🧭 Simple plan for this item (👀 Too early: keep an eye on it)
Don't buy because of this item yet.
Add the tickers to a watchlist and check the triggers below each week.
Move to Build only if 2+ upgrade triggers happen.
Tiers: 👀 Too early: keep an eye on it = track triggers only · ⏳ Promising = small staged position · 🔥 Act = catalyst near, sized small. No return promises.
🗓 Timeline
More simulation papers; HBM makers test ideas.
Possible first compute features in custom HBM base dies.
Common in AI memory, if standards and software follow.
📖 What these words mean
Readiness: our 0–100 score for how close an idea is to real products and sales. Higher = closer.
Conviction: how confident we are in a company's link to the idea (high, medium, low).
Ticker / stock code: the short code used to find a company's share on an exchange, e.g. NVDA.
Catalyst / next big event: a dated event (launch, approval, results) that could move the story.
Urgency: our badge for how time-sensitive it is: 🔥 strong signal, ⏳ promising, 👀 too early.
Our judgment · Not financial advice
🇮🇳 Indian investor angle
NSE: KAYNES and CGPOWER (both started chip assembly/test, OSAT, production at Sanand in 2026); US names via Nasdaq-100 or US-tech funds under the LRS route (RBI scheme for investing abroad). (our judgment)
Needs HBM vendors and GPU makers to agree on a new interface; earlier in-memory compute products saw limited adoption (judgment)
📐 How we scored this
Criterion
Score
Weight
Points
Evidence level
0/5 — Paper / simulation only
55%
0.0
Manufacturability
4/5
20%
16.0
Supply chain
3/5
10%
6.0
Corporate backing
1/5
10%
2.0
Independent groups
3/5
5%
3.0
Readiness
27/100
Hype = 10×claim boldness (3/5) + 10×attention (1/5) = 40. Patent/IP risk: Medium (crowding 4/5, litigation 1/5). Sub-scores are our judgment from the linked sources. Full method
👀 What to watch next: Whether an HBM maker puts compute in the HBM4/4E base die, and any real silicon measurement.
⏰ Time Machinedrag: 1 → 3 → 5 years (our scenario, not a forecast)
In 1 year: More simulation papers; HBM makers test ideas.
📋 Executive briefing teaser free
HBM4 moves the base die to a logic process, which opens room for compute.
HBM4 moves the base die to a logic process, which opens room for compute. DuoPD splits LLM prefill (GPU) from decode (near-memory). Gains are simulation-only and need memory-vendor buy-in.
🔒 Full executive briefingIncluded in Pro & InstitutionalUnlock Premium
🎬 30-second video script Premium
AI answers are slow because data shuttles back and forth from memory. A Seoul team put tiny processors inside the memory stack. Simulated result: up to 2.2× faster answers. Real chips needed. Source: arXiv.
🔒 Video script with citationsIncluded in Pro & InstitutionalUnlock Premium
Tracked since 2026-10-29Readiness vs prev: = no change · Updated 2026-10-29
History: 10-29 S1/16 → 10-30 S1/16 → 10-31 S1/16
Stage 1 · Paper👀 Too early: keep an eye on itMemory materials
32. Brown University: a magnetic-electric material that keeps working at 1.6 nm, a step toward ultra-low-power memory
🧩 Like a paint that used to stop working if you brushed it on too thin; now even a near-invisible coat still works.
No listed ticker linked
🏛 Brown University and collaborators (Nature Materials) · 📅 2026-10-28
👀 Too early: keep an eye on itOur judgment · Not financial advice
1Paper
2Prototype
3Factories & orders
4Revenue
💡 What it is
🔬 Thin films of bismuth ferrite (BiFeO3) usually lose their properties near the surface, called a "dead layer".
🧩 Like a paint that used to stop working if you brushed it on too thin; now even a near-invisible coat still works.
🚀 Why it matters
📈 Readiness 16/100 · Paper
⏳ 6-10 yrs to market (our judgment)
🎯 Multiferroics could let voltage, not current, flip magnetic bits, cutting memory energy.
💰 Who gains
No listed pure-play linked (private or small part of a big company)
🏷 Memory and spintronics research labs
⚠️ Risks
❌ Films are grown on a rare-earth DyScO3 crystal, not on standard silicon wafers
✅ What to do
👀 Too early: keep an eye on it · plan: keep watching
🔎 Watch for: Growth on silicon instead of the rare DyScO3 crystal, and a working memory cell.
🗓 Timeline
Step 1More labs reproduce it.
Step 2Test memory cells in labs.
Step 3Still research unless it grows on silicon.
Timeline steps are our judgment unless marked as company plan.
What they found: Thin films of bismuth ferrite (BiFeO3) usually lose their properties near the surface, called a "dead layer". The team removed it, keeping electric and magnetic order down to four atomic unit cells (about 1.6 nm), and found signs of altermagnetism.
🧒 Like I'm 10: Scientists found a way to make a special material work even when it is thinner than a strand of DNA. One day it could make memory chips use much less power.
🧩 Think of it like: Like a paint that used to stop working if you brushed it on too thin; now even a near-invisible coat still works.
Readiness16/100
Years to market: 6-10
Our judgment
🎢 Hype vs Reality
Hype 40
Reality 16
Some hype; watch for proof (our judgment)
⚖️ Patent / IP risk
Early science; little patent crowding.
🔒 Patent risk noteIncluded in Pro & InstitutionalUnlock Premium
🏆 Who could win
Memory and spintronics research labs
💰 Investor view👀 Too early: keep an eye on it
In plain words: Scientists found a way to make a special material work even when it is thinner than a strand of DNA. One day it could make memory chips use much less power.
📊 Stocks tied to this
Company
Stock code
How it is linked
Role
Conviction
No listed company directly tied yet. Developer: Brown University and collaborators (Nature Materials). Watch for a listed partner or IPO.
Other possible winners: Memory and spintronics research labs (our judgment)
⚠️ Who could lose
Makers of older copper/electrical interconnect and packaging may lose share (our judgment)
✅ Why now
Thin films of bismuth ferrite (BiFeO3) usually lose their properties near the surface, called a "dead layer". The team removed it, keeping electric and magnetic order down to four atomic unit cells (about 1.6 nm), and fo…
Readiness 16/100, stage 1 on our ladder.
U=0: ½×readiness 16 + 0 (no big event expected soon) − 8×1 kill-risk flag(s) · no listed ticker linked → 👀 too early
⛔ Why not yet
Films are grown on a rare-earth DyScO3 crystal, not on standard silicon wafers
Altermagnetic order is shown by indirect signatures, which other groups still need to confirm
Timeline to impact: about 6-10 years (our judgment)
⬆️ Upgrade triggers
Concrete date or release: Growth on silicon instead of the rare DyScO3 crystal, and a working memory cell.
A named paying customer or order
Independent replication / outside test results
Readiness reaching 70+ with a dated catalyst within 90 days (our 🔥 rule)
⬇️ Downgrade signals
Delay or missed milestone (our judgment)
Independent tests fail to confirm the claim (our judgment)
A rival leapfrogs or rules/regulators block it (our judgment)
🧭 Simple plan for this item (👀 Too early: keep an eye on it)
Don't buy because of this item yet.
Add the tickers to a watchlist and check the triggers below each week.
Move to Build only if 2+ upgrade triggers happen.
Tiers: 👀 Too early: keep an eye on it = track triggers only · ⏳ Promising = small staged position · 🔥 Act = catalyst near, sized small. No return promises.
🗓 Timeline
More labs reproduce it.
Test memory cells in labs.
Still research unless it grows on silicon.
📖 What these words mean
Readiness: our 0–100 score for how close an idea is to real products and sales. Higher = closer.
Conviction: how confident we are in a company's link to the idea (high, medium, low).
Ticker / stock code: the short code used to find a company's share on an exchange, e.g. NVDA.
Catalyst / next big event: a dated event (launch, approval, results) that could move the story.
Urgency: our badge for how time-sensitive it is: 🔥 strong signal, ⏳ promising, 👀 too early.
Our judgment · Not financial advice
🇮🇳 Indian investor angle
NSE: KAYNES and CGPOWER (both started chip assembly/test, OSAT, production at Sanand in 2026); US names via Nasdaq-100 or US-tech funds under the LRS route (RBI scheme for investing abroad). (our judgment)
Our judgment · Not financial advice. Exposure notes are qualitative; we don't quote % of revenue unless sourced.
🐂 Bull case
Thin films of bismuth ferrite (BiFeO3) usually lose their properties near the surface, called a "dead layer".
Who could win: Memory and spintronics research labs
🐻 What could go wrong
Films are grown on a rare-earth DyScO3 crystal, not on standard silicon wafers source
Altermagnetic order is shown by indirect signatures, which other groups still need to confirm source
📐 How we scored this
Criterion
Score
Weight
Points
Evidence level
1/5 — Lab demo
55%
5.5
Manufacturability
1/5
20%
4.0
Supply chain
1/5
10%
2.0
Corporate backing
1/5
10%
2.0
Independent groups
3/5
5%
3.0
Readiness
16/100
Hype = 10×claim boldness (2/5) + 10×attention (2/5) = 40. Patent/IP risk: Low (crowding 2/5, litigation 1/5). Sub-scores are our judgment from the linked sources. Full method
👀 What to watch next: Growth on silicon instead of the rare DyScO3 crystal, and a working memory cell.
⏰ Time Machinedrag: 1 → 3 → 5 years (our scenario, not a forecast)
In 1 year: More labs reproduce it.
📋 Executive briefing teaser free
Multiferroics could let voltage, not current, flip magnetic bits, cutting memory energy.
Multiferroics could let voltage, not current, flip magnetic bits, cutting memory energy. This paper shows the effect survives at the scale real devices need. It is fundamental physics; manufacturing is far off.
🔒 Full executive briefingIncluded in Pro & InstitutionalUnlock Premium
🎬 30-second video script Premium
Chips waste energy pushing current to flip bits. A material that flips magnetism with voltage could fix that, but it died when made thin. Brown just made it work at 1.6 nanometres. Source: Nature Materials.
🔒 Video script with citationsIncluded in Pro & InstitutionalUnlock Premium
Tracked since 2026-10-29Readiness vs prev: = no change · Updated 2026-10-29
History: 10-29 S2/67 → 10-30 S2/67 → 10-31 S2/67
Stage 2 · Prototype👀 Too early: keep an eye on itProgrammable AI chips
33. Altera launches Agilex 2X FPGAs with 1.8× better performance per watt for AI infrastructure
🧩 A chip you can re-wire after you buy it, like Lego you can rebuild for each new AI job.
No listed ticker linked
🏛 Altera (majority owned by Silver Lake; Intel minority stake) · 📅 2026-10-28
👀 Too early: keep an eye on itOur judgment · Not financial advice
1Paper
2Prototype
3Factories & orders
4Revenue
💡 What it is
🔬 Altera introduced its Agilex 2X family, led by Agilex 27, claiming 1.8× performance per watt over the previous generation for AI infrastructure, networking and edge.
🧩 A chip you can re-wire after you buy it, like Lego you can rebuild for each new AI job.
🚀 Why it matters
📈 Readiness 67/100 · Prototype
⏳ 2-4 yrs to market (our judgment)
🎯 FPGAs fill gaps where AI networking and pre-processing change too fast for custom chips.
💰 Who gains
No listed pure-play linked (private or small part of a big company)
🏷 Altera
🏷 Network and telecom equipment makers
⚠️ Risks
❌ Performance-per-watt figure is vendor-claimed, not independently tested
✅ What to do
👀 Too early: keep an eye on it · plan: keep watching
🔎 Watch for: Customer design wins and shipment dates for Agilex 27.
🗓 Timeline
Step 1Early customer designs.
Step 2In network gear and AI servers.
Step 3Replaced by the next generation.
Timeline steps are our judgment unless marked as company plan.
What they found: Altera introduced its Agilex 2X family, led by Agilex 27, claiming 1.8× performance per watt over the previous generation for AI infrastructure, networking and edge.
🧒 Like I'm 10: Most chips do one job forever. This one can be re-programmed for new jobs, and the new version uses less electricity.
🧩 Think of it like: A chip you can re-wire after you buy it, like Lego you can rebuild for each new AI job.
Readiness67/100
Years to market: 2-4
Our judgment
🎢 Hype vs Reality
Hype 40
Reality 67
Reality is catching up (our judgment)
⚖️ Patent / IP risk
FPGA patents are concentrated in AMD (Xilinx) and Altera. Some historic litigation.
🔒 Patent risk noteIncluded in Pro & InstitutionalUnlock Premium
🏆 Who could win
AlteraNetwork and telecom equipment makers
💰 Investor view👀 Too early: keep an eye on it
In plain words: Most chips do one job forever. This one can be re-programmed for new jobs, and the new version uses less electricity.
📊 Stocks tied to this
Company
Stock code
How it is linked
Role
Conviction
No listed company directly tied yet. Developer: Altera (majority owned by Silver Lake; Intel minority stake). Watch for a listed partner or IPO.
Other possible winners: Altera, Network and telecom equipment makers (our judgment)
⚠️ Who could lose
Makers of older copper/electrical interconnect and packaging may lose share (our judgment)
✅ Why now
Altera introduced its Agilex 2X family, led by Agilex 27, claiming 1.8× performance per watt over the previous generation for AI infrastructure, networking and edge.
Readiness 67/100, stage 2 on our ladder.
U=34: ½×readiness 67 + 0 (no big event expected soon) · no listed ticker linked → 👀 too early
⛔ Why not yet
Performance-per-watt figure is vendor-claimed, not independently tested
For pure AI maths, FPGAs usually lose to GPUs and custom chips on cost per task
Timeline to impact: about 2-4 years (our judgment)
⬆️ Upgrade triggers
Concrete date or release: Customer design wins and shipment dates for Agilex 27.
A named paying customer or order
Independent replication / outside test results
Readiness reaching 70+ with a dated catalyst within 90 days (our 🔥 rule)
⬇️ Downgrade signals
Delay or missed milestone (our judgment)
Independent tests fail to confirm the claim (our judgment)
A rival leapfrogs or rules/regulators block it (our judgment)
🧭 Simple plan for this item (👀 Too early: keep an eye on it)
Don't buy because of this item yet.
Add the tickers to a watchlist and check the triggers below each week.
Move to Build only if 2+ upgrade triggers happen.
Tiers: 👀 Too early: keep an eye on it = track triggers only · ⏳ Promising = small staged position · 🔥 Act = catalyst near, sized small. No return promises.
🗓 Timeline
Early customer designs.
In network gear and AI servers.
Replaced by the next generation.
📖 What these words mean
Readiness: our 0–100 score for how close an idea is to real products and sales. Higher = closer.
Conviction: how confident we are in a company's link to the idea (high, medium, low).
Ticker / stock code: the short code used to find a company's share on an exchange, e.g. NVDA.
Catalyst / next big event: a dated event (launch, approval, results) that could move the story.
Urgency: our badge for how time-sensitive it is: 🔥 strong signal, ⏳ promising, 👀 too early.
Our judgment · Not financial advice
🇮🇳 Indian investor angle
NSE: KAYNES and CGPOWER (both started chip assembly/test, OSAT, production at Sanand in 2026); US names via Nasdaq-100 or US-tech funds under the LRS route (RBI scheme for investing abroad). (our judgment)
Our judgment · Not financial advice. Exposure notes are qualitative; we don't quote % of revenue unless sourced.
🐂 Bull case
Altera introduced its Agilex 2X family, led by Agilex 27, claiming 1.8× performance per watt over the previous generation for AI infrastructure, networking and edge.
Who could win: Altera, Network and telecom equipment makers
🐻 What could go wrong
Performance-per-watt figure is vendor-claimed, not independently tested source
For pure AI maths, FPGAs usually lose to GPUs and custom chips on cost per task (judgment)
📐 How we scored this
Criterion
Score
Weight
Points
Evidence level
3/5 — Customer samples / qualification
55%
24.8
Manufacturability
5/5
20%
20.0
Supply chain
5/5
10%
10.0
Corporate backing
4/5
10%
8.0
Independent groups
4/5
5%
4.0
Readiness
67/100
Hype = 10×claim boldness (2/5) + 10×attention (2/5) = 40. Patent/IP risk: Medium (crowding 3/5, litigation 2/5). Sub-scores are our judgment from the linked sources. Full method
👀 What to watch next: Customer design wins and shipment dates for Agilex 27.
⏰ Time Machinedrag: 1 → 3 → 5 years (our scenario, not a forecast)
In 1 year: Early customer designs.
📋 Executive briefing teaser free
FPGAs fill gaps where AI networking and pre-processing change too fast for custom chips.
FPGAs fill gaps where AI networking and pre-processing change too fast for custom chips. The figure is vendor-claimed. Altera is private, so there is no direct listed stock.
🔒 Full executive briefingIncluded in Pro & InstitutionalUnlock Premium
🎬 30-second video script Premium
Some chips can be re-wired after they ship. Altera's new Agilex 2X claims 1.8× more work per watt for AI networks. Source: Altera.
🔒 Video script with citationsIncluded in Pro & InstitutionalUnlock Premium
Tracked since 2026-10-29Readiness vs prev: = no change · Updated 2026-10-29
History: 10-29 S2/66 → 10-30 S2/66 → 10-31 S2/66
Stage 2 · Prototype👀 Too early: keep an eye on itAI chip IP
34. Ceva unveils next-gen NeuPro AI engines (2× throughput per mm²) and enters AI infrastructure
🧩 Ceva sells blueprints, not buildings. Chip makers license the AI-engine design and build it into their own chips.
CEVACeva
🏛 Ceva (NASDAQ: CEVA) · 📅 2026-10-28
👀 Too early: keep an eye on itOur judgment · Not financial advice
1Paper
2Prototype
3Factories & orders
4Revenue
💡 What it is
🔬 Ceva announced a new NeuPro neural-processor IP family claiming 2× throughput per mm² and 50% better efficiency, with FP4/FP8 support, and said it is expanding from edge devices into AI infrastructure.
🧩 Ceva sells blueprints, not buildings. Chip makers license the AI-engine design and build it into their own chips.
🚀 Why it matters
📈 Readiness 66/100 · Prototype
⏳ 2-4 yrs to market (our judgment)
🎯 Licensable NPUs let many companies add AI without designing an engine from scratch.
💰 Who gains
CEVACeva
🏷 Ceva
🏷 Chip makers licensing NPU IP
⚠️ Risks
❌ General availability not until Q2 2027; figures are vendor-claimed
✅ What to do
👀 Too early: keep an eye on it · plan: keep watching
🔎 Watch for: Named licensees for the infrastructure version and the Q2 2027 general-availability date.
🗓 Timeline
Step 1Early-access licensees.
Step 2First chips using it ship.
Step 3Royalties if widely adopted.
Timeline steps are our judgment unless marked as company plan.
What they found: Ceva announced a new NeuPro neural-processor IP family claiming 2× throughput per mm² and 50% better efficiency, with FP4/FP8 support, and said it is expanding from edge devices into AI infrastructure. Early access is open now; general availability is planned for Q2 2027.
🧒 Like I'm 10: Ceva draws the plans for the "thinking" part of a chip, and other companies use the plans. The new plans are twice as good for the same space.
🧩 Think of it like: Ceva sells blueprints, not buildings. Chip makers license the AI-engine design and build it into their own chips.
Readiness66/100
Years to market: 2-4
Our judgment
🎢 Hype vs Reality
Hype 50
Reality 66
Reality is catching up (our judgment)
⚖️ Patent / IP risk
NPU IP is crowded (Arm, Cadence, Synopsys, many startups).
🔒 Patent risk noteIncluded in Pro & InstitutionalUnlock Premium
🏆 Who could win
CevaChip makers licensing NPU IP
💰 Investor view👀 Too early: keep an eye on it
In plain words: Ceva draws the plans for the "thinking" part of a chip, and other companies use the plans. The new plans are twice as good for the same space.
Direct: Licenses chip designs (IP) incl. AI engines (our judgment)
Supplier
Medium
Other possible winners: Ceva, Chip makers licensing NPU IP (our judgment)
⚠️ Who could lose
Makers of older copper/electrical interconnect and packaging may lose share (our judgment)
✅ Why now
Ceva announced a new NeuPro neural-processor IP family claiming 2× throughput per mm² and 50% better efficiency, with FP4/FP8 support, and said it is expanding from edge devices into AI infrastructure. Early access is op…
Readiness 66/100, stage 2 on our ladder.
U=33: ½×readiness 66 + 0 (no big event expected soon)
⛔ Why not yet
General availability not until Q2 2027; figures are vendor-claimed
Crowded market against Arm, Cadence, Synopsys and in-house designs
Timeline to impact: about 2-4 years (our judgment)
⬆️ Upgrade triggers
Concrete date or release: Named licensees for the infrastructure version and the Q2 2027 general-availability date.
A named paying customer or order
Independent replication / outside test results
Readiness reaching 70+ with a dated catalyst within 90 days (our 🔥 rule)
⬇️ Downgrade signals
Delay or missed milestone (our judgment)
Independent tests fail to confirm the claim (our judgment)
A rival leapfrogs or rules/regulators block it (our judgment)
🧭 Simple plan for this item (👀 Too early: keep an eye on it)
Don't buy because of this item yet.
Add the tickers to a watchlist and check the triggers below each week.
Move to Build only if 2+ upgrade triggers happen.
Tiers: 👀 Too early: keep an eye on it = track triggers only · ⏳ Promising = small staged position · 🔥 Act = catalyst near, sized small. No return promises.
🗓 Timeline
Early-access licensees.
First chips using it ship.
Royalties if widely adopted.
📖 What these words mean
Readiness: our 0–100 score for how close an idea is to real products and sales. Higher = closer.
Conviction: how confident we are in a company's link to the idea (high, medium, low).
Ticker / stock code: the short code used to find a company's share on an exchange, e.g. NVDA.
Catalyst / next big event: a dated event (launch, approval, results) that could move the story.
Urgency: our badge for how time-sensitive it is: 🔥 strong signal, ⏳ promising, 👀 too early.
Our judgment · Not financial advice
🇮🇳 Indian investor angle
NSE: KAYNES and CGPOWER (both started chip assembly/test, OSAT, production at Sanand in 2026); US names via Nasdaq-100 or US-tech funds under the LRS route (RBI scheme for investing abroad). (our judgment)
Our judgment · Not financial advice. Exposure notes are qualitative; we don't quote % of revenue unless sourced.
🐂 Bull case
Ceva announced a new NeuPro neural-processor IP family claiming 2× throughput per mm² and 50% better efficiency, with FP4/FP8 support, and said it is expanding from edge devices into AI infrastructure.
Who could win: Ceva, Chip makers licensing NPU IP
🐻 What could go wrong
General availability not until Q2 2027; figures are vendor-claimed source
Crowded market against Arm, Cadence, Synopsys and in-house designs (judgment)
📐 How we scored this
Criterion
Score
Weight
Points
Evidence level
3/5 — Customer samples / qualification
55%
24.8
Manufacturability
5/5
20%
20.0
Supply chain
5/5
10%
10.0
Corporate backing
3/5
10%
6.0
Independent groups
5/5
5%
5.0
Readiness
66/100
Hype = 10×claim boldness (3/5) + 10×attention (2/5) = 50. Patent/IP risk: Medium (crowding 4/5, litigation 2/5). Sub-scores are our judgment from the linked sources. Full method
👀 What to watch next: Named licensees for the infrastructure version and the Q2 2027 general-availability date.
⏰ Time Machinedrag: 1 → 3 → 5 years (our scenario, not a forecast)
In 1 year: Early-access licensees.
📋 Executive briefing teaser free
Licensable NPUs let many companies add AI without designing an engine from scratch.
Licensable NPUs let many companies add AI without designing an engine from scratch. Gains are vendor-claimed and revenue arrives through royalties years later.
🔒 Full executive briefingIncluded in Pro & InstitutionalUnlock Premium
🎬 30-second video script Premium
Not every company can design an AI chip. Ceva sells the design. Its new NeuPro claims double the work per area. Ships to licensees in 2027. Source: Ceva.
🔒 Video script with citationsIncluded in Pro & InstitutionalUnlock Premium
Stage 2 · Prototype👀 Too early: keep an eye on itOptical compute
35. Computing with light instead of electricity (optical AI chip)
🧩 Like sorting mail by shining a torch through a stencil instead of reading every envelope.
TSEMTower Semiconductor
🏛 Neurophos (US startup) + MIT CSAIL Julia Lab · 📅 Patent US11843182B2 granted 2023-12-12 (filed 2021-09-13); MIT collab 2026
👀 Too early: keep an eye on itOur judgment · Not financial advice
1Paper
2Prototype
3Factories & orders
4Revenue
💡 What it is
🔬 A startup is building chips that do AI math with light passing through tiny 'metamaterial' patterns, and is working with MIT on the software to run them.
🧩 Like sorting mail by shining a torch through a stencil instead of reading every envelope.
🚀 Why it matters
📈 Readiness 31/100 · Prototype
⏳ 3-6 yrs to market (our judgment)
🎯 Optical AI compute is still pre-revenue but backed by granted IP and an MIT software partnership.
💰 Who gains
TSEMTower Semiconductor
🏷 Neurophos (private, US)
🏷 GlobalFoundries GFS (US, photonics foundry)
🏷 Tower Semiconductor TSEM (Israel)
⚠️ Risks
❌ Nature Photonics review (2026): in the cloud, losses and light-to-electric conversions 'dominate power' and have so far prevented commercial photonic tensor cores.
✅ What to do
👀 Too early: keep an eye on it · plan: keep watching
🔎 Watch for: First chip samples to customers and any foundry partnership announcement.
🗓 Timeline
Step 1Lab demos and first test chips
Step 2Pilot units in a few data centres, if tests go well
Step 3Could be a niche accelerator for specific AI jobs
Timeline steps are our judgment unless marked as company plan.
What they found: A startup is building chips that do AI math with light passing through tiny 'metamaterial' patterns, and is working with MIT on the software to run them.
🧒 Like I'm 10: Some computers might one day think with flashlight beams instead of electricity, so they stay cool and fast.
🧩 Think of it like: Like sorting mail by shining a torch through a stencil instead of reading every envelope.
Readiness31/100
Years to market: 3-6
Our judgment
🎢 Hype vs Reality
Hype 80
Reality 31
Mostly hype so far (our judgment)
⚖️ Patent / IP risk
Neurophos holds granted US and international patents on its optical design. Other optical-compute firms (e.g. Lightmatter) hold their own patents, so overlap disputes are possible. (Our judgment)
🔒 Patent risk noteIncluded in Pro & InstitutionalUnlock Premium
Direct: Contract fab including silicon photonics (our judgment)
Supplier
Medium
Other possible winners: Neurophos (private, US), GlobalFoundries GFS (US, photonics foundry), Tower Semiconductor TSEM (Israel) (our judgment)
⚠️ Who could lose
Makers of older copper/electrical interconnect and packaging may lose share (our judgment)
✅ Why now
A startup is building chips that do AI math with light passing through tiny 'metamaterial' patterns, and is working with MIT on the software to run them.
Readiness 31/100, stage 2 on our ladder.
U=8: ½×readiness 31 + 0 (no big event expected soon) − 8×1 kill-risk flag(s)
⛔ Why not yet
Nature Photonics review (2026): in the cloud, losses and light-to-electric conversions 'dominate power' and have so far prevented commercial photonic tensor cores.
SPIE paper: data converters can be over 80% of the conversion power budget in photonic AI accelerators.
Timeline to impact: about 3-6 years (our judgment)
⬆️ Upgrade triggers
Concrete date or release: First chip samples to customers and any foundry partnership announcement.
A named paying customer or order
Independent replication / outside test results
Readiness reaching 70+ with a dated catalyst within 90 days (our 🔥 rule)
⬇️ Downgrade signals
Delay or missed milestone (our judgment)
Independent tests fail to confirm the claim (our judgment)
A rival leapfrogs or rules/regulators block it (our judgment)
🧭 Simple plan for this item (👀 Too early: keep an eye on it)
Don't buy because of this item yet.
Add the tickers to a watchlist and check the triggers below each week.
Move to Build only if 2+ upgrade triggers happen.
Tiers: 👀 Too early: keep an eye on it = track triggers only · ⏳ Promising = small staged position · 🔥 Act = catalyst near, sized small. No return promises.
🗓 Timeline
Lab demos and first test chips
Pilot units in a few data centres, if tests go well
Could be a niche accelerator for specific AI jobs
📖 What these words mean
Readiness: our 0–100 score for how close an idea is to real products and sales. Higher = closer.
Conviction: how confident we are in a company's link to the idea (high, medium, low).
Ticker / stock code: the short code used to find a company's share on an exchange, e.g. NVDA.
Catalyst / next big event: a dated event (launch, approval, results) that could move the story.
Urgency: our badge for how time-sensitive it is: 🔥 strong signal, ⏳ promising, 👀 too early.
Our judgment · Not financial advice
🇮🇳 Indian investor angle
NSE: KAYNES and CGPOWER (both started chip assembly/test, OSAT, production at Sanand in 2026); US names via Nasdaq-100 or US-tech funds under the LRS route (RBI scheme for investing abroad). (our judgment)
Our judgment · Not financial advice. Exposure notes are qualitative; we don't quote % of revenue unless sourced.
🐂 Bull case
A startup is building chips that do AI math with light passing through tiny 'metamaterial' patterns, and is working with MIT on the software to run them.
Who could win: Neurophos (private, US), GlobalFoundries GFS (US, photonics foundry), Tower Semiconductor TSEM (Israel)
🐻 What could go wrong
Nature Photonics review (2026): in the cloud, losses and light-to-electric conversions 'dominate power' and have so far prevented commercial photonic tensor cores. source
SPIE paper: data converters can be over 80% of the conversion power budget in photonic AI accelerators. source
📐 How we scored this
Criterion
Score
Weight
Points
Evidence level
2/5 — Working prototype chip
55%
13.8
Manufacturability
2/5
20%
8.0
Supply chain
1/5
10%
2.0
Corporate backing
2/5
10%
4.0
Independent groups
3/5
5%
3.0
Readiness
31/100
Hype = 10×claim boldness (4/5) + 10×attention (4/5) = 80. Patent/IP risk: Medium (crowding 4/5, litigation 2/5). Sub-scores are our judgment from the linked sources. Full method
👀 What to watch next: First chip samples to customers and any foundry partnership announcement.
⏰ Time Machinedrag: 1 → 3 → 5 years (our scenario, not a forecast)
In 1 year: Lab demos and first test chips
📋 Executive briefing teaser free
Optical AI compute is still pre-revenue but backed by granted IP and an MIT software partnership.
Optical AI compute is still pre-revenue but backed by granted IP and an MIT software partnership. Watch for tape-out news; foundries with photonics lines are the picks-and-shovels play.
🔒 Full executive briefingIncluded in Pro & InstitutionalUnlock Premium
🎬 30-second video script Premium
What if your AI chip ran on light? A US startup called Neurophos is doing AI math by shining light through microscopic patterns. Less heat, more speed. It's early: no product yet. But they hold patents and just teamed up with MIT. If it works, photonics foundries win first. Source links on our page.
🔒 Video script with citationsIncluded in Pro & InstitutionalUnlock Premium
👀 Too early: keep an eye on itOur judgment · Not financial advice
1Paper
2Prototype
3Factories & orders
4Revenue
💡 What it is
🔬 Volantis revealed a plan to build optical connections into the base layer (interposer) that sits under an AI chip and its memory, so data moves by light.
🧩 Replacing a crowded two-lane road between factory and warehouse with a bullet train.
🚀 Why it matters
📈 Readiness 32/100 · Paper
⏳ 4-8 yrs to market (our judgment)
🎯 Early-stage photonic interposer aimed at the 'memory wall'.
💰 Who gains
COHRCoherent
🏷 Volantis (private)
🏷 Coherent COHR (US)
🏷 Lumentum LITE (US)
⚠️ Risks
❌ Nvidia networking SVP: 'If you can use copper, use copper' — optics only where distance forces it.
✅ What to do
👀 Too early: keep an eye on it · plan: keep watching
🔎 Watch for: Prototype demo data and named customer pilots.
🗓 Timeline
Step 1Prototype shown to partners
Step 2Early customer trials
Step 3Possibly inside some AI servers
Timeline steps are our judgment unless marked as company plan.
What they found: Volantis revealed a plan to build optical connections into the base layer (interposer) that sits under an AI chip and its memory, so data moves by light.
🧒 Like I'm 10: Chips wait for memory like kids waiting in a lunch line. This idea builds a super-fast light slide to bring the food.
🧩 Think of it like: Replacing a crowded two-lane road between factory and warehouse with a bullet train.
Readiness32/100
Years to market: 4-8
Our judgment
🎢 Hype vs Reality
Hype 80
Reality 32
Mostly hype so far (our judgment)
⚖️ Patent / IP risk
Volantis has filed patents (see assignee profile). Big players like Nvidia, Broadcom and Ayar Labs hold large optical I/O portfolios, so licensing may be needed. (Our judgment)
🔒 Patent risk noteIncluded in Pro & InstitutionalUnlock Premium
🏆 Who could win
Volantis (private)Coherent COHR (US)Lumentum LITE (US)STMicro STM (EU)
💰 Investor view👀 Too early: keep an eye on it
In plain words: Chips wait for memory like kids waiting in a lunch line. This idea builds a super-fast light slide to bring the food.
Direct: Optical/laser parts are a core business (our judgment)
Supplier
Medium
Other possible winners: Volantis (private), Coherent COHR (US), Lumentum LITE (US), STMicro STM (EU) (our judgment)
⚠️ Who could lose
Makers of older copper/electrical interconnect and packaging may lose share (our judgment)
✅ Why now
Volantis revealed a plan to build optical connections into the base layer (interposer) that sits under an AI chip and its memory, so data moves by light.
Readiness 32/100, stage 1 on our ladder.
U=0: ½×readiness 32 + 0 (no big event expected soon) − 8×2 kill-risk flag(s)
⛔ Why not yet
Nvidia networking SVP: 'If you can use copper, use copper' — optics only where distance forces it.
SemiAnalysis: Nvidia is going to 'extreme lengths' to stay on copper for scale-up through 2027-2028; limited first-wave CPO adoption expected.
Timeline to impact: about 4-8 years (our judgment)
⬆️ Upgrade triggers
Concrete date or release: Prototype demo data and named customer pilots.
A named paying customer or order
Independent replication / outside test results
Readiness reaching 70+ with a dated catalyst within 90 days (our 🔥 rule)
⬇️ Downgrade signals
Delay or missed milestone (our judgment)
Independent tests fail to confirm the claim (our judgment)
A rival leapfrogs or rules/regulators block it (our judgment)
🧭 Simple plan for this item (👀 Too early: keep an eye on it)
Don't buy because of this item yet.
Add the tickers to a watchlist and check the triggers below each week.
Move to Build only if 2+ upgrade triggers happen.
Tiers: 👀 Too early: keep an eye on it = track triggers only · ⏳ Promising = small staged position · 🔥 Act = catalyst near, sized small. No return promises.
🗓 Timeline
Prototype shown to partners
Early customer trials
Possibly inside some AI servers
📖 What these words mean
Readiness: our 0–100 score for how close an idea is to real products and sales. Higher = closer.
Conviction: how confident we are in a company's link to the idea (high, medium, low).
Ticker / stock code: the short code used to find a company's share on an exchange, e.g. NVDA.
Catalyst / next big event: a dated event (launch, approval, results) that could move the story.
Urgency: our badge for how time-sensitive it is: 🔥 strong signal, ⏳ promising, 👀 too early.
Our judgment · Not financial advice
🇮🇳 Indian investor angle
NSE: KAYNES and CGPOWER (both started chip assembly/test, OSAT, production at Sanand in 2026); US names via Nasdaq-100 or US-tech funds under the LRS route (RBI scheme for investing abroad). (our judgment)
Our judgment · Not financial advice. Exposure notes are qualitative; we don't quote % of revenue unless sourced.
🐂 Bull case
Volantis revealed a plan to build optical connections into the base layer (interposer) that sits under an AI chip and its memory, so data moves by light.
Who could win: Volantis (private), Coherent COHR (US), Lumentum LITE (US)
🐻 What could go wrong
Nvidia networking SVP: 'If you can use copper, use copper' — optics only where distance forces it. source
SemiAnalysis: Nvidia is going to 'extreme lengths' to stay on copper for scale-up through 2027-2028; limited first-wave CPO adoption expected. source
Plan revealed, no shipping product disclosed yet (our reading of the source). (judgment)
📐 How we scored this
Criterion
Score
Weight
Points
Evidence level
1/5 — Lab demo
55%
5.5
Manufacturability
3/5
20%
12.0
Supply chain
3/5
10%
6.0
Corporate backing
2/5
10%
4.0
Independent groups
4/5
5%
4.0
Readiness
32/100
Hype = 10×claim boldness (4/5) + 10×attention (4/5) = 80. Patent/IP risk: Medium (crowding 4/5, litigation 2/5). Sub-scores are our judgment from the linked sources. Full method
👀 What to watch next: Prototype demo data and named customer pilots.
⏰ Time Machinedrag: 1 → 3 → 5 years (our scenario, not a forecast)
In 1 year: Prototype shown to partners
📋 Executive briefing teaser free
Early-stage photonic interposer aimed at the 'memory wall'.
Early-stage photonic interposer aimed at the 'memory wall'. High upside, high execution risk; laser and photonics suppliers benefit regardless of which startup wins.
🔒 Full executive briefingIncluded in Pro & InstitutionalUnlock Premium
🎬 30-second video script Premium
AI chips are starving, waiting for data from memory. Volantis wants to fix that with light: an optical highway built right under the chip. It's just a plan for now. But if it works, laser makers like Coherent and Lumentum get a new market. Links on our page.
🔒 Video script with citationsIncluded in Pro & InstitutionalUnlock Premium
Stage 1 · Paper👀 Too early: keep an eye on itIn-memory / analog compute
37. Storing many values in one memory spot (superposed analog memory)
🧩 Like one shelf that holds several books layered as transparent sheets, still readable.
MUMicron
🏛 IBM Research · 📅 2026-10 (arXiv 2610.26118); patent app US 2026/0291719
👀 Too early: keep an eye on itOur judgment · Not financial advice
1Paper
2Prototype
3Factories & orders
4Revenue
💡 What it is
🔬 Researchers showed a way to pack several pieces of information into the same analog memory cell and still read them back, cutting memory needed for AI search.
🧩 Like one shelf that holds several books layered as transparent sheets, still readable.
🚀 Why it matters
📈 Readiness 19/100 · Paper
⏳ 6-10 yrs to market (our judgment)
🎯 IBM is pairing research with patent filings, signalling commercial intent.
💰 Who gains
MUMicron
🏷 IBM (US)
🏷 Micron MU (US)
🏷 Weebit Nano WBT (Australia, small)
⚠️ Risks
❌ System-level review: specialised analog/physical accelerators can show 'little or no advantage' once conversion, control and memory access are counted.
✅ What to do
👀 Too early: keep an eye on it · plan: keep watching
🔎 Watch for: Chip-level demo on IBM's analog AI hardware.
🗓 Timeline
Step 1More papers and patents
Step 2Tested on IBM's research chips
Step 3Maybe in specialised memory products
Timeline steps are our judgment unless marked as company plan.
What they found: Researchers showed a way to pack several pieces of information into the same analog memory cell and still read them back, cutting memory needed for AI search.
🧒 Like I'm 10: Imagine one drawer that magically holds three toys at once, and you can still pick each one out.
🧩 Think of it like: Like one shelf that holds several books layered as transparent sheets, still readable.
Readiness19/100
Years to market: 6-10
Our judgment
🎢 Hype vs Reality
Hype 40
Reality 19
Some hype; watch for proof (our judgment)
⚖️ Patent / IP risk
IBM has both the paper and a matching patent application plus older granted patents: strong IP wall. Anyone copying the method may need a licence. (Our judgment)
🔒 Patent risk noteIncluded in Pro & InstitutionalUnlock Premium
🏆 Who could win
IBM (US)Micron MU (US)Weebit Nano WBT (Australia, small)
💰 Investor view👀 Too early: keep an eye on it
In plain words: Imagine one drawer that magically holds three toys at once, and you can still pick each one out.
Direct: Memory chips are its core business (our judgment)
Winner
Medium
Other possible winners: IBM (US), Micron MU (US), Weebit Nano WBT (Australia, small) (our judgment)
⚠️ Who could lose
Makers of older copper/electrical interconnect and packaging may lose share (our judgment)
✅ Why now
Researchers showed a way to pack several pieces of information into the same analog memory cell and still read them back, cutting memory needed for AI search.
Readiness 19/100, stage 1 on our ladder.
U=2: ½×readiness 19 + 0 (no big event expected soon) − 8×1 kill-risk flag(s)
⛔ Why not yet
System-level review: specialised analog/physical accelerators can show 'little or no advantage' once conversion, control and memory access are counted.
Timeline to impact: about 6-10 years (our judgment)
⬆️ Upgrade triggers
Concrete date or release: Chip-level demo on IBM's analog AI hardware.
A named paying customer or order
Independent replication / outside test results
Readiness reaching 70+ with a dated catalyst within 90 days (our 🔥 rule)
⬇️ Downgrade signals
Delay or missed milestone (our judgment)
Independent tests fail to confirm the claim (our judgment)
A rival leapfrogs or rules/regulators block it (our judgment)
🧭 Simple plan for this item (👀 Too early: keep an eye on it)
Don't buy because of this item yet.
Add the tickers to a watchlist and check the triggers below each week.
Move to Build only if 2+ upgrade triggers happen.
Tiers: 👀 Too early: keep an eye on it = track triggers only · ⏳ Promising = small staged position · 🔥 Act = catalyst near, sized small. No return promises.
🗓 Timeline
More papers and patents
Tested on IBM's research chips
Maybe in specialised memory products
📖 What these words mean
Readiness: our 0–100 score for how close an idea is to real products and sales. Higher = closer.
Conviction: how confident we are in a company's link to the idea (high, medium, low).
Ticker / stock code: the short code used to find a company's share on an exchange, e.g. NVDA.
Catalyst / next big event: a dated event (launch, approval, results) that could move the story.
Urgency: our badge for how time-sensitive it is: 🔥 strong signal, ⏳ promising, 👀 too early.
Our judgment · Not financial advice
🇮🇳 Indian investor angle
NSE: KAYNES and CGPOWER (both started chip assembly/test, OSAT, production at Sanand in 2026); US names via Nasdaq-100 or US-tech funds under the LRS route (RBI scheme for investing abroad). (our judgment)
Our judgment · Not financial advice. Exposure notes are qualitative; we don't quote % of revenue unless sourced.
🐂 Bull case
Researchers showed a way to pack several pieces of information into the same analog memory cell and still read them back, cutting memory needed for AI search.
Who could win: IBM (US), Micron MU (US), Weebit Nano WBT (Australia, small)
🐻 What could go wrong
System-level review: specialised analog/physical accelerators can show 'little or no advantage' once conversion, control and memory access are counted. source
📐 How we scored this
Criterion
Score
Weight
Points
Evidence level
0/5 — Paper / simulation only
55%
0.0
Manufacturability
2/5
20%
8.0
Supply chain
2/5
10%
4.0
Corporate backing
3/5
10%
6.0
Independent groups
1/5
5%
1.0
Readiness
19/100
Hype = 10×claim boldness (2/5) + 10×attention (2/5) = 40. Patent/IP risk: Medium (crowding 3/5, litigation 1/5). Sub-scores are our judgment from the linked sources. Full method
👀 What to watch next: Chip-level demo on IBM's analog AI hardware.
⏰ Time Machinedrag: 1 → 3 → 5 years (our scenario, not a forecast)
In 1 year: More papers and patents
📋 Executive briefing teaser free
IBM is pairing research with patent filings, signalling commercial intent.
IBM is pairing research with patent filings, signalling commercial intent. Long-dated; relevant to memory makers and analog-AI specialists.
🔒 Full executive briefingIncluded in Pro & InstitutionalUnlock Premium
🎬 30-second video script Premium
Imagine one memory cell holding several numbers at once. IBM just published that trick, and filed a patent on it the same season. That's a signal they plan to use it. It's years away, but memory makers should pay attention. Sources on our page.
🔒 Video script with citationsIncluded in Pro & InstitutionalUnlock Premium
👀 Too early: keep an eye on itOur judgment · Not financial advice
1Paper
2Prototype
3Factories & orders
4Revenue
💡 What it is
🔬 Micron showed that splitting each AI 'weight' across several memory cells averages out the errors that make analog chips unreliable.
🧩 Asking three friends to estimate a distance and averaging: fewer big mistakes.
🚀 Why it matters
📈 Readiness 35/100 · Paper
⏳ 4-8 yrs to market (our judgment)
🎯 A memory giant publishing fixes for analog AI errors suggests in-memory compute is moving toward products.
💰 Who gains
MUMicronKAYNES.NSKaynes Technology
🏷 Micron MU (US, India plant in Gujarat)
🏷 Kaynes KAYNES.NS (India, OSAT partner ecosystem)
⚠️ Risks
❌ System-level review: specialised analog/physical accelerators can show 'little or no advantage' once conversion, control and memory access are counted.
✅ What to do
👀 Too early: keep an eye on it · plan: keep watching
🔎 Watch for: Whether Micron shows it on real silicon or in a product roadmap.
🗓 Timeline
Step 1Follow-up papers
Step 2Shown on real Micron test silicon
Step 3Could ship inside analog-AI memory products
Timeline steps are our judgment unless marked as company plan.
What they found: Micron showed that splitting each AI 'weight' across several memory cells averages out the errors that make analog chips unreliable.
🧒 Like I'm 10: If one friend guesses wrong, ask three and take the middle answer. Micron does that inside a chip.
🧩 Think of it like: Asking three friends to estimate a distance and averaging: fewer big mistakes.
Readiness35/100
Years to market: 4-8
Our judgment
🎢 Hype vs Reality
Hype 30
Reality 35
Reality is catching up (our judgment)
⚖️ Patent / IP risk
Splitting/redundancy ideas are widely published; patent risk looks moderate. Micron may file follow-ups. (Our judgment)
🔒 Patent risk noteIncluded in Pro & InstitutionalUnlock Premium
🏆 Who could win
Micron MU (US, India plant in Gujarat)Kaynes KAYNES.NS (India, OSAT partner ecosystem)
💰 Investor view👀 Too early: keep an eye on it
In plain words: If one friend guesses wrong, ask three and take the middle answer. Micron does that inside a chip.
Indirect: Electronics maker entering chip packaging in India (our judgment)
Supplier
Low (watchlist)
Other possible winners: Micron MU (US, India plant in Gujarat), Kaynes KAYNES.NS (India, OSAT partner ecosystem) (our judgment)
⚠️ Who could lose
Makers of older copper/electrical interconnect and packaging may lose share (our judgment)
✅ Why now
Micron showed that splitting each AI 'weight' across several memory cells averages out the errors that make analog chips unreliable.
Readiness 35/100, stage 1 on our ladder.
U=10: ½×readiness 35 + 0 (no big event expected soon) − 8×1 kill-risk flag(s)
⛔ Why not yet
System-level review: specialised analog/physical accelerators can show 'little or no advantage' once conversion, control and memory access are counted.
Timeline to impact: about 4-8 years (our judgment)
⬆️ Upgrade triggers
Concrete date or release: Whether Micron shows it on real silicon or in a product roadmap.
A named paying customer or order
Independent replication / outside test results
Readiness reaching 70+ with a dated catalyst within 90 days (our 🔥 rule)
⬇️ Downgrade signals
Delay or missed milestone (our judgment)
Independent tests fail to confirm the claim (our judgment)
A rival leapfrogs or rules/regulators block it (our judgment)
🧭 Simple plan for this item (👀 Too early: keep an eye on it)
Don't buy because of this item yet.
Add the tickers to a watchlist and check the triggers below each week.
Move to Build only if 2+ upgrade triggers happen.
Tiers: 👀 Too early: keep an eye on it = track triggers only · ⏳ Promising = small staged position · 🔥 Act = catalyst near, sized small. No return promises.
🗓 Timeline
Follow-up papers
Shown on real Micron test silicon
Could ship inside analog-AI memory products
📖 What these words mean
Readiness: our 0–100 score for how close an idea is to real products and sales. Higher = closer.
Conviction: how confident we are in a company's link to the idea (high, medium, low).
Ticker / stock code: the short code used to find a company's share on an exchange, e.g. NVDA.
Catalyst / next big event: a dated event (launch, approval, results) that could move the story.
Urgency: our badge for how time-sensitive it is: 🔥 strong signal, ⏳ promising, 👀 too early.
Our judgment · Not financial advice
🇮🇳 Indian investor angle
NSE: KAYNES and CGPOWER (both started chip assembly/test, OSAT, production at Sanand in 2026); US names via Nasdaq-100 or US-tech funds under the LRS route (RBI scheme for investing abroad). (our judgment)
Our judgment · Not financial advice. Exposure notes are qualitative; we don't quote % of revenue unless sourced.
🐂 Bull case
Micron showed that splitting each AI 'weight' across several memory cells averages out the errors that make analog chips unreliable.
Who could win: Micron MU (US, India plant in Gujarat), Kaynes KAYNES.NS (India, OSAT partner ecosystem)
🐻 What could go wrong
System-level review: specialised analog/physical accelerators can show 'little or no advantage' once conversion, control and memory access are counted. source
📐 How we scored this
Criterion
Score
Weight
Points
Evidence level
0/5 — Paper / simulation only
55%
0.0
Manufacturability
4/5
20%
16.0
Supply chain
4/5
10%
8.0
Corporate backing
4/5
10%
8.0
Independent groups
3/5
5%
3.0
Readiness
35/100
Hype = 10×claim boldness (1/5) + 10×attention (2/5) = 30. Patent/IP risk: Low (crowding 2/5, litigation 1/5). Sub-scores are our judgment from the linked sources. Full method
👀 What to watch next: Whether Micron shows it on real silicon or in a product roadmap.
⏰ Time Machinedrag: 1 → 3 → 5 years (our scenario, not a forecast)
In 1 year: Follow-up papers
📋 Executive briefing teaser free
A memory giant publishing fixes for analog AI errors suggests in-memory compute is moving toward products.
A memory giant publishing fixes for analog AI errors suggests in-memory compute is moving toward products. Micron is the direct beneficiary.
🔒 Full executive briefingIncluded in Pro & InstitutionalUnlock Premium
🎬 30-second video script Premium
Analog AI chips are super efficient but sloppy. Micron found a simple fix: spread each number across several cells, like averaging friends' guesses. When a memory giant solves accuracy, products tend to follow. Link on our page.
🔒 Video script with citationsIncluded in Pro & InstitutionalUnlock Premium
Indirect: AI chips are core; photonics is a future input (our judgment)
Winner
Medium
Other possible winners: Marvell MRVL (US), Broadcom AVGO (US), Coherent COHR (US), Tower TSEM (Israel) (our judgment)
⚠️ Who could lose
Makers of older copper/electrical interconnect and packaging may lose share (our judgment)
✅ Why now
A tiny silicon 'slow-light' modulator flips light on and off fast enough to carry 200 Gb/s on a single colour of laser.
Readiness 36/100, stage 1 on our ladder.
U=10: ½×readiness 36 + 0 (no big event expected soon) − 8×1 kill-risk flag(s)
⛔ Why not yet
Nvidia networking SVP: 'If you can use copper, use copper' — optics only where distance forces it.
SemiAnalysis: Nvidia is going to 'extreme lengths' to stay on copper for scale-up through 2027-2028; limited first-wave CPO adoption expected.
Timeline to impact: about 2-6 years (our judgment)
⬆️ Upgrade triggers
Concrete date or release: Adoption in 1.6T/3.2T optical transceiver roadmaps.
A named paying customer or order
Independent replication / outside test results
Readiness reaching 70+ with a dated catalyst within 90 days (our 🔥 rule)
⬇️ Downgrade signals
Delay or missed milestone (our judgment)
Independent tests fail to confirm the claim (our judgment)
A rival leapfrogs or rules/regulators block it (our judgment)
🧭 Simple plan for this item (👀 Too early: keep an eye on it)
Don't buy because of this item yet.
Add the tickers to a watchlist and check the triggers below each week.
Move to Build only if 2+ upgrade triggers happen.
Tiers: 👀 Too early: keep an eye on it = track triggers only · ⏳ Promising = small staged position · 🔥 Act = catalyst near, sized small. No return promises.
🗓 Timeline
More lab records
Included in next-gen 3.2T optics plans
Common in data-centre cables
📖 What these words mean
Readiness: our 0–100 score for how close an idea is to real products and sales. Higher = closer.
Conviction: how confident we are in a company's link to the idea (high, medium, low).
Ticker / stock code: the short code used to find a company's share on an exchange, e.g. NVDA.
Catalyst / next big event: a dated event (launch, approval, results) that could move the story.
Urgency: our badge for how time-sensitive it is: 🔥 strong signal, ⏳ promising, 👀 too early.
Our judgment · Not financial advice
🇮🇳 Indian investor angle
NSE: KAYNES and CGPOWER (both started chip assembly/test, OSAT, production at Sanand in 2026); US names via Nasdaq-100 or US-tech funds under the LRS route (RBI scheme for investing abroad). (our judgment)
Our judgment · Not financial advice. Exposure notes are qualitative; we don't quote % of revenue unless sourced.
🐂 Bull case
A tiny silicon 'slow-light' modulator flips light on and off fast enough to carry 200 Gb/s on a single colour of laser.
Who could win: Marvell MRVL (US), Broadcom AVGO (US), Coherent COHR (US)
🐻 What could go wrong
Nvidia networking SVP: 'If you can use copper, use copper' — optics only where distance forces it. source
SemiAnalysis: Nvidia is going to 'extreme lengths' to stay on copper for scale-up through 2027-2028; limited first-wave CPO adoption expected. source
📐 How we scored this
Criterion
Score
Weight
Points
Evidence level
1/5 — Lab demo
55%
5.5
Manufacturability
4/5
20%
16.0
Supply chain
4/5
10%
8.0
Corporate backing
1/5
10%
2.0
Independent groups
4/5
5%
4.0
Readiness
36/100
Hype = 10×claim boldness (3/5) + 10×attention (1/5) = 40. Patent/IP risk: Medium (crowding 3/5, litigation 1/5). Sub-scores are our judgment from the linked sources. Full method
👀 What to watch next: Adoption in 1.6T/3.2T optical transceiver roadmaps.
⏰ Time Machinedrag: 1 → 3 → 5 years (our scenario, not a forecast)
In 1 year: More lab records
📋 Executive briefing teaser free
Next-gen per-lane speed is a key spec for data-centre optics.
Next-gen per-lane speed is a key spec for data-centre optics. Lab result today, but it maps directly onto transceiver vendors' roadmaps.
🔒 Full executive briefingIncluded in Pro & InstitutionalUnlock Premium
🎬 30-second video script Premium
Data centres talk with light. A new chip-sized switch flips light 200 billion times a second on one colour. Faster switches mean cheaper, cooler AI clusters. Optics makers like Marvell and Coherent are the ones to watch. Link on our page.
🔒 Video script with citationsIncluded in Pro & InstitutionalUnlock Premium
👀 Too early: keep an eye on itOur judgment · Not financial advice
1Paper
2Prototype
3Factories & orders
4Revenue
💡 What it is
🔬 imec tested whether transistors made of atom-thin materials and stacked in pairs beat silicon at the ~2026+ 'A2' node.
🧩 A thinner wall doesn't help if the doors and hallways are the bottleneck.
🚀 Why it matters
📈 Readiness 16/100 · Paper
⏳ 6-10 yrs to market (our judgment)
🎯 A sober reality-check paper: 2D CFETs are a 2030s story.
💰 Who gains
AIXAAixtron
🏷 ASML (EU)
🏷 Applied Materials AMAT (US)
🏷 Lam Research LRCX (US)
⚠️ Risks
❌ No fab today grows 2D-material layers at wafer scale with chip-grade yield (our judgment; no single source).
✅ What to do
👀 Too early: keep an eye on it · plan: keep watching
🔎 Watch for: imec/foundry papers at IEDM (December) on contact resistance fixes.
🗓 Timeline
Step 1More lab tests on contacts
Step 2Research pilot lines
Step 3Still mostly research; mass use likely in the 2030s
Timeline steps are our judgment unless marked as company plan.
What they found: imec tested whether transistors made of atom-thin materials and stacked in pairs beat silicon at the ~2026+ 'A2' node. Honest answer: not yet. Contacts and wiring losses eat the gains.
🧒 Like I'm 10: Making transistors from sheets just one atom thick and stacking them like pancakes.
🧩 Think of it like: A thinner wall doesn't help if the doors and hallways are the bottleneck.
Readiness16/100
Years to market: 6-10
Our judgment
🎢 Hype vs Reality
Hype 50
Reality 16
Some hype; watch for proof (our judgment)
⚖️ Patent / IP risk
CFET structures are heavily patented by TSMC, Intel, Samsung and IBM. Any newcomer faces dense IP. (Our judgment)
🔒 Patent risk noteIncluded in Pro & InstitutionalUnlock Premium
🏆 Who could win
ASML (EU)Applied Materials AMAT (US)Lam Research LRCX (US)Aixtron AIXA (EU, 2D-material tools)
💰 Investor view👀 Too early: keep an eye on it
In plain words: Making transistors from sheets just one atom thick and stacking them like pancakes.
Direct: Sells deposition tools used for new chip materials (our judgment)
Supplier
Low (watchlist)
Other possible winners: ASML (EU), Applied Materials AMAT (US), Lam Research LRCX (US), Aixtron AIXA (EU, 2D-material tools) (our judgment)
⚠️ Who could lose
Makers of older copper/electrical interconnect and packaging may lose share (our judgment)
✅ Why now
imec tested whether transistors made of atom-thin materials and stacked in pairs beat silicon at the ~2026+ 'A2' node. Honest answer: not yet. Contacts and wiring losses eat the gains.
Readiness 16/100, stage 1 on our ladder.
U=0: ½×readiness 16 + 0 (no big event expected soon) − 8×1 kill-risk flag(s)
⛔ Why not yet
No fab today grows 2D-material layers at wafer scale with chip-grade yield (our judgment; no single source).
Timeline to impact: about 6-10 years (our judgment)
⬆️ Upgrade triggers
Concrete date or release: imec/foundry papers at IEDM (December) on contact resistance fixes.
A named paying customer or order
Independent replication / outside test results
Readiness reaching 70+ with a dated catalyst within 90 days (our 🔥 rule)
⬇️ Downgrade signals
Delay or missed milestone (our judgment)
Independent tests fail to confirm the claim (our judgment)
A rival leapfrogs or rules/regulators block it (our judgment)
🧭 Simple plan for this item (👀 Too early: keep an eye on it)
Don't buy because of this item yet.
Add the tickers to a watchlist and check the triggers below each week.
Move to Build only if 2+ upgrade triggers happen.
Tiers: 👀 Too early: keep an eye on it = track triggers only · ⏳ Promising = small staged position · 🔥 Act = catalyst near, sized small. No return promises.
🗓 Timeline
More lab tests on contacts
Research pilot lines
Still mostly research; mass use likely in the 2030s
📖 What these words mean
Readiness: our 0–100 score for how close an idea is to real products and sales. Higher = closer.
Conviction: how confident we are in a company's link to the idea (high, medium, low).
Ticker / stock code: the short code used to find a company's share on an exchange, e.g. NVDA.
Catalyst / next big event: a dated event (launch, approval, results) that could move the story.
Urgency: our badge for how time-sensitive it is: 🔥 strong signal, ⏳ promising, 👀 too early.
Our judgment · Not financial advice
🇮🇳 Indian investor angle
NSE: KAYNES and CGPOWER (both started chip assembly/test, OSAT, production at Sanand in 2026); US names via Nasdaq-100 or US-tech funds under the LRS route (RBI scheme for investing abroad). (our judgment)
Our judgment · Not financial advice. Exposure notes are qualitative; we don't quote % of revenue unless sourced.
🐂 Bull case
imec tested whether transistors made of atom-thin materials and stacked in pairs beat silicon at the ~2026+ 'A2' node.
Who could win: ASML (EU), Applied Materials AMAT (US), Lam Research LRCX (US)
🐻 What could go wrong
No fab today grows 2D-material layers at wafer scale with chip-grade yield (our judgment; no single source). (judgment)
📐 How we scored this
Criterion
Score
Weight
Points
Evidence level
1/5 — Lab demo
55%
5.5
Manufacturability
0/5
20%
0.0
Supply chain
1/5
10%
2.0
Corporate backing
3/5
10%
6.0
Independent groups
3/5
5%
3.0
Readiness
16/100
Hype = 10×claim boldness (3/5) + 10×attention (2/5) = 50. Patent/IP risk: Medium (crowding 3/5, litigation 1/5). Sub-scores are our judgment from the linked sources. Full method
👀 What to watch next: imec/foundry papers at IEDM (December) on contact resistance fixes.
⏰ Time Machinedrag: 1 → 3 → 5 years (our scenario, not a forecast)
In 1 year: More lab tests on contacts
📋 Executive briefing teaser free
A sober reality-check paper: 2D CFETs are a 2030s story.
A sober reality-check paper: 2D CFETs are a 2030s story. The tool makers win either way because every new transistor needs new deposition and etch.
🔒 Full executive briefingIncluded in Pro & InstitutionalUnlock Premium
🎬 30-second video script Premium
Chips are running out of room, so engineers want to stack transistors made of material just one atom thick. Europe's top chip lab, imec, tested it, and says: not yet. That honesty is useful. The safe winners? The toolmakers. Link on our page.
🔒 Video script with citationsIncluded in Pro & InstitutionalUnlock Premium
❌ SK hynix says hybrid bonding won't be ready for HBM4E memory stacks.
✅ What to do
👀 Too early: keep an eye on it · plan: keep watching
🔎 Watch for: Which memory generation (HBM5?) adopts it; Besi order intake.
🗓 Timeline
Step 1More orders for bonding machines
Step 2Used in some memory and logic stacks
Step 3Standard for top AI chips
Timeline steps are our judgment unless marked as company plan.
What they found: Tool makers are teaming up to sell machines that fuse chips directly, copper pad to copper pad. But SK hynix says it won't be ready for the next memory generation (HBM4E).
🧒 Like I'm 10: Instead of using tiny solder balls, chips are pressed together so their copper parts fuse, like welding.
🧩 Think of it like: Welding Lego bricks instead of snapping them: tighter, but harder to do right.
Readiness80/100
Years to market: 0-2
Our judgment
🎢 Hype vs Reality
Hype 50
Reality 80
Reality is catching up (our judgment)
⚖️ Patent / IP risk
Besi/Applied, Adeia (licensor, ADEA) and TSMC hold key hybrid-bonding patents. Adeia actively licenses: a royalty stream, and a lawsuit risk for others. (Our judgment)
🔒 Patent risk noteIncluded in Pro & InstitutionalUnlock Premium
🏆 Who could win
Besi BESI.AS (EU)Applied Materials AMAT (US)Adeia ADEA (US, small, IP licensor)Hanmi Semiconductor 042700.KS (Korea)
💰 Investor view👀 Too early: keep an eye on it
In plain words: Instead of using tiny solder balls, chips are pressed together so their copper parts fuse, like welding.
Other possible winners: Besi BESI.AS (EU), Applied Materials AMAT (US), Adeia ADEA (US, small, IP licensor), Hanmi Semiconductor 042700.KS (Korea) (our judgment)
⚠️ Who could lose
Makers of older copper/electrical interconnect and packaging may lose share (our judgment)
✅ Why now
Tool makers are teaming up to sell machines that fuse chips directly, copper pad to copper pad. But SK hynix says it won't be ready for the next memory generation (HBM4E).
Readiness 80/100, stage 3 on our ladder.
U=32: ½×readiness 80 + 0 (no big event expected soon) − 8×1 kill-risk flag(s)
⛔ Why not yet
SK hynix says hybrid bonding won't be ready for HBM4E memory stacks.
Timeline to impact: about 0-2 years (our judgment)
⬆️ Upgrade triggers
Concrete date or release: Which memory generation (HBM5?) adopts it; Besi order intake.
A named paying customer or order
Independent replication / outside test results
Readiness reaching 70+ with a dated catalyst within 90 days (our 🔥 rule)
⬇️ Downgrade signals
Delay or missed milestone (our judgment)
Independent tests fail to confirm the claim (our judgment)
A rival leapfrogs or rules/regulators block it (our judgment)
🧭 Simple plan for this item (👀 Too early: keep an eye on it)
Don't buy because of this item yet.
Add the tickers to a watchlist and check the triggers below each week.
Move to Build only if 2+ upgrade triggers happen.
Tiers: 👀 Too early: keep an eye on it = track triggers only · ⏳ Promising = small staged position · 🔥 Act = catalyst near, sized small. No return promises.
🗓 Timeline
More orders for bonding machines
Used in some memory and logic stacks
Standard for top AI chips
📖 What these words mean
Readiness: our 0–100 score for how close an idea is to real products and sales. Higher = closer.
Conviction: how confident we are in a company's link to the idea (high, medium, low).
Ticker / stock code: the short code used to find a company's share on an exchange, e.g. NVDA.
Catalyst / next big event: a dated event (launch, approval, results) that could move the story.
Urgency: our badge for how time-sensitive it is: 🔥 strong signal, ⏳ promising, 👀 too early.
Our judgment · Not financial advice
🇮🇳 Indian investor angle
NSE: KAYNES and CGPOWER (both started chip assembly/test, OSAT, production at Sanand in 2026); US names via Nasdaq-100 or US-tech funds under the LRS route (RBI scheme for investing abroad). (our judgment)
Our judgment · Not financial advice. Exposure notes are qualitative; we don't quote % of revenue unless sourced.
🐂 Bull case
Tool makers are teaming up to sell machines that fuse chips directly, copper pad to copper pad.
Who could win: Besi BESI.AS (EU), Applied Materials AMAT (US), Adeia ADEA (US, small, IP licensor)
🐻 What could go wrong
SK hynix says hybrid bonding won't be ready for HBM4E memory stacks. source
📐 How we scored this
Criterion
Score
Weight
Points
Evidence level
4/5 — Volume production or orders
55%
41.2
Manufacturability
4/5
20%
16.0
Supply chain
4/5
10%
8.0
Corporate backing
5/5
10%
10.0
Independent groups
5/5
5%
5.0
Readiness
80/100
Hype = 10×claim boldness (2/5) + 10×attention (3/5) = 50. Patent/IP risk: High (crowding 4/5, litigation 4/5). Sub-scores are our judgment from the linked sources. Full method
👀 What to watch next: Which memory generation (HBM5?) adopts it; Besi order intake.
⏰ Time Machinedrag: 1 → 3 → 5 years (our scenario, not a forecast)
In 1 year: More orders for bonding machines
📋 Executive briefing teaser free
Hybrid bonding is at the orders stage.
Hybrid bonding is at the orders stage. Timing slipped for HBM4E, which favours legacy bonder makers short-term and Besi/AMAT longer-term. Adeia is an under-the-radar IP play.
🔒 Full executive briefingIncluded in Pro & InstitutionalUnlock Premium
🎬 30-second video script Premium
Next-gen AI chips are glued together atom-close using copper. Toolmakers Applied Materials and Besi are teaming up to sell the machines. But memory giant SK hynix says it's not ready yet. Delay now, big wave later. Links on our page.
🔒 Video script with citationsIncluded in Pro & InstitutionalUnlock Premium
👀 Too early: keep an eye on itOur judgment · Not financial advice
1Paper
2Prototype
3Factories & orders
4Revenue
💡 What it is
🔬 Several firms are testing glass as the base board under giant AI chips because it stays flat and lets wires sit closer together.
🧩 Building a skyscraper on granite instead of plywood.
🚀 Why it matters
📈 Readiness 52/100 · Prototype
⏳ 2-4 yrs to market (our judgment)
🎯 Glass substrates are moving from lab to pilot lines.
💰 Who gains
4062.TIbidenUnlisted (parent: Tata group cos)Tata Electronics fabGLWCorningTSMTSMC
🏷 Ibiden 4062.T (Japan)
🏷 Samsung Electro-Mechanics 009150.KS (Korea)
🏷 SKC 011790.KS (Korea)
⚠️ Risks
❌ Tom's Hardware: glass-core substrates are 'still not in a single commercial product' and every timeline has slipped.
✅ What to do
👀 Too early: keep an eye on it · plan: keep watching
🔎 Watch for: Pilot-line yields and first AI product using a glass core. New (Oct 29): toolmaker Lam Research says glass carriers are used today but permanent glass cores are still early, so no stage change.
🗓 Timeline
Step 1Pilot lines and samples
Step 2First AI products on glass, if yields are good
Step 3Common in big AI chips
Timeline steps are our judgment unless marked as company plan.
What they found: Several firms are testing glass as the base board under giant AI chips because it stays flat and lets wires sit closer together.
🧒 Like I'm 10: The board under a chip may switch from plastic to glass, because glass stays flat and doesn't warp.
🧩 Think of it like: Building a skyscraper on granite instead of plywood.
Readiness52/100
Years to market: 2-4
Our judgment
🎢 Hype vs Reality
Hype 70
Reality 52
Some hype; watch for proof (our judgment)
⚖️ Patent / IP risk
Intel, Corning, SKC/Absolics and Samsung hold key glass-core patents. Newcomers may need licences. (Our judgment)
🔒 Patent risk noteIncluded in Pro & InstitutionalUnlock Premium
Indirect: World's largest contract fab; packaging is one part (our judgment)
Supplier
Medium
Other possible winners: Ibiden 4062.T (Japan), Samsung Electro-Mechanics 009150.KS (Korea), SKC 011790.KS (Korea), Corning GLW (US), 3D Glass Solutions (India plant, Odisha) (our judgment)
⚠️ Who could lose
Makers of older copper/electrical interconnect and packaging may lose share (our judgment)
✅ Why now
Several firms are testing glass as the base board under giant AI chips because it stays flat and lets wires sit closer together.
Readiness 52/100, stage 2 on our ladder.
U=26: ½×readiness 52 + 0 (no big event expected soon)
⛔ Why not yet
Tom's Hardware: glass-core substrates are 'still not in a single commercial product' and every timeline has slipped.
TrendForce/The Elec: Samsung Electro-Mechanics order schedule pushed back at least 3 times; mass production possibly 2028+ (company disputes a failed qualification).
Timeline to impact: about 2-4 years (our judgment)
⬆️ Upgrade triggers
Concrete date or release: Pilot-line yields and first AI product using a glass core. New (Oct 29): toolmaker Lam Research says glass carriers are used today but permanent glass cores are still early, so no stage change.
A named paying customer or order
Independent replication / outside test results
Readiness reaching 70+ with a dated catalyst within 90 days (our 🔥 rule)
⬇️ Downgrade signals
Delay or missed milestone (our judgment)
Independent tests fail to confirm the claim (our judgment)
A rival leapfrogs or rules/regulators block it (our judgment)
🧭 Simple plan for this item (👀 Too early: keep an eye on it)
Don't buy because of this item yet.
Add the tickers to a watchlist and check the triggers below each week.
Move to Build only if 2+ upgrade triggers happen.
Tiers: 👀 Too early: keep an eye on it = track triggers only · ⏳ Promising = small staged position · 🔥 Act = catalyst near, sized small. No return promises.
🗓 Timeline
Pilot lines and samples
First AI products on glass, if yields are good
Common in big AI chips
📖 What these words mean
Readiness: our 0–100 score for how close an idea is to real products and sales. Higher = closer.
Conviction: how confident we are in a company's link to the idea (high, medium, low).
Ticker / stock code: the short code used to find a company's share on an exchange, e.g. NVDA.
Catalyst / next big event: a dated event (launch, approval, results) that could move the story.
Urgency: our badge for how time-sensitive it is: 🔥 strong signal, ⏳ promising, 👀 too early.
Our judgment · Not financial advice
🇮🇳 Indian investor angle
NSE: KAYNES and CGPOWER (both started chip assembly/test, OSAT, production at Sanand in 2026); US names via Nasdaq-100 or US-tech funds under the LRS route (RBI scheme for investing abroad). (our judgment)
Our judgment · Not financial advice. Exposure notes are qualitative; we don't quote % of revenue unless sourced.
🐂 Bull case
Several firms are testing glass as the base board under giant AI chips because it stays flat and lets wires sit closer together.
Who could win: Ibiden 4062.T (Japan), Samsung Electro-Mechanics 009150.KS (Korea), SKC 011790.KS (Korea)
🐻 What could go wrong
Tom's Hardware: glass-core substrates are 'still not in a single commercial product' and every timeline has slipped. source
TrendForce/The Elec: Samsung Electro-Mechanics order schedule pushed back at least 3 times; mass production possibly 2028+ (company disputes a failed qualification). source
Lam Research (Oct 29): permanent glass interposers and glass-core substrates are still at earlier stages; manufacturability and standards must be solved first source
📐 How we scored this
Criterion
Score
Weight
Points
Evidence level
3/5 — Customer samples / qualification
55%
24.8
Manufacturability
2/5
20%
8.0
Supply chain
2/5
10%
4.0
Corporate backing
5/5
10%
10.0
Independent groups
5/5
5%
5.0
Readiness
52/100
Hype = 10×claim boldness (3/5) + 10×attention (4/5) = 70. Patent/IP risk: Medium (crowding 3/5, litigation 2/5). Sub-scores are our judgment from the linked sources. Full method
👀 What to watch next: Pilot-line yields and first AI product using a glass core. New (Oct 29): toolmaker Lam Research says glass carriers are used today but permanent glass cores are still early, so no stage change.
⏰ Time Machinedrag: 1 → 3 → 5 years (our scenario, not a forecast)
In 1 year: Pilot lines and samples
📋 Executive briefing teaser free
Glass substrates are moving from lab to pilot lines.
Glass substrates are moving from lab to pilot lines. Substrate makers and glass specialists are positioned; India gets a foothold via 3DGS's Odisha project.
🔒 Full executive briefingIncluded in Pro & InstitutionalUnlock Premium
🎬 30-second video script Premium
The board under an AI chip may soon be made of glass. It stays flat and fits more wires. TSMC is testing it with Japan's Ibiden; Samsung and BOE are racing too. Even India has a glass-packaging plant coming. Links on our page.
🔒 Video script with citationsIncluded in Pro & InstitutionalUnlock Premium
Stage 1 · Paper👀 Too early: keep an eye on itNeuromorphic
43. Brain-like chip that can learn on the device (neuromorphic)
🧩 A student who learns while working instead of going back to school.
BRN.AXBrainChipAMDAMD
🏛 Academic team in China (see author list) · 📅 2026-03-25 (Nature Communications)
👀 Too early: keep an eye on itOur judgment · Not financial advice
1Paper
2Prototype
3Factories & orders
4Revenue
💡 What it is
🔬 A brain-style chip design that can train itself directly, demonstrated on FPGA, beating Nvidia's Jetson Orin 1.9-3.3x and using far less memory traffic than an A100 in training.
🧩 A student who learns while working instead of going back to school.
🚀 Why it matters
📈 Readiness 28/100 · Paper
⏳ 4-8 yrs to market (our judgment)
🎯 On-device learning for edge AI is a real gap.
💰 Who gains
BRN.AXBrainChipAMDAMD
🏷 BrainChip BRN.AX (Australia, small)
🏷 Lattice LSCC (US, FPGAs)
🏷 AMD (Xilinx FPGAs)
⚠️ Risks
❌ BrainChip, a listed neuromorphic pioneer, reported only US$1.22M revenue and a US$12.0M loss for H1 2026 — commercial demand for brain-like chips is still tiny.
✅ What to do
👀 Too early: keep an eye on it · plan: keep watching
🔎 Watch for: Tape-out on real silicon and edge-device partners.
Timeline steps are our judgment unless marked as company plan.
What they found: A brain-style chip design that can train itself directly, demonstrated on FPGA, beating Nvidia's Jetson Orin 1.9-3.3x and using far less memory traffic than an A100 in training.
🧒 Like I'm 10: A chip that works like a tiny brain and can learn new things by itself, without the cloud.
🧩 Think of it like: A student who learns while working instead of going back to school.
Readiness28/100
Years to market: 4-8
Our judgment
🎢 Hype vs Reality
Hype 60
Reality 28
Some hype; watch for proof (our judgment)
⚖️ Patent / IP risk
Neuromorphic patents are held by Intel (Loihi), IBM and BrainChip; academic designs can face overlap. (Our judgment)
🔒 Patent risk noteIncluded in Pro & InstitutionalUnlock Premium
Indirect: Chipmaker; neuromorphic is not a product line (our judgment)
At risk/neutral
Low (watchlist)
Other possible winners: BrainChip BRN.AX (Australia, small), Lattice LSCC (US, FPGAs), AMD (Xilinx FPGAs) (our judgment)
⚠️ Who could lose
Makers of older copper/electrical interconnect and packaging may lose share (our judgment)
✅ Why now
A brain-style chip design that can train itself directly, demonstrated on FPGA, beating Nvidia's Jetson Orin 1.9-3.3x and using far less memory traffic than an A100 in training.
BrainChip, a listed neuromorphic pioneer, reported only US$1.22M revenue and a US$12.0M loss for H1 2026 — commercial demand for brain-like chips is still tiny.
System-level review: specialised analog/physical accelerators can show 'little or no advantage' once conversion, control and memory access are counted.
Timeline to impact: about 4-8 years (our judgment)
⬆️ Upgrade triggers
Concrete date or release: Tape-out on real silicon and edge-device partners.
A named paying customer or order
Independent replication / outside test results
Readiness reaching 70+ with a dated catalyst within 90 days (our 🔥 rule)
⬇️ Downgrade signals
Delay or missed milestone (our judgment)
Independent tests fail to confirm the claim (our judgment)
A rival leapfrogs or rules/regulators block it (our judgment)
🧭 Simple plan for this item (👀 Too early: keep an eye on it)
Don't buy because of this item yet.
Add the tickers to a watchlist and check the triggers below each week.
Move to Build only if 2+ upgrade triggers happen.
Tiers: 👀 Too early: keep an eye on it = track triggers only · ⏳ Promising = small staged position · 🔥 Act = catalyst near, sized small. No return promises.
🗓 Timeline
More FPGA demos
First real chips (tape-out)
Possible use in robots and cameras
📖 What these words mean
Readiness: our 0–100 score for how close an idea is to real products and sales. Higher = closer.
Conviction: how confident we are in a company's link to the idea (high, medium, low).
Ticker / stock code: the short code used to find a company's share on an exchange, e.g. NVDA.
Catalyst / next big event: a dated event (launch, approval, results) that could move the story.
Urgency: our badge for how time-sensitive it is: 🔥 strong signal, ⏳ promising, 👀 too early.
Our judgment · Not financial advice
🇮🇳 Indian investor angle
NSE: KAYNES and CGPOWER (both started chip assembly/test, OSAT, production at Sanand in 2026); US names via Nasdaq-100 or US-tech funds under the LRS route (RBI scheme for investing abroad). (our judgment)
Our judgment · Not financial advice. Exposure notes are qualitative; we don't quote % of revenue unless sourced.
🐂 Bull case
A brain-style chip design that can train itself directly, demonstrated on FPGA, beating Nvidia's Jetson Orin 1.9-3.3x and using far less memory traffic than an A100 in training.
Who could win: BrainChip BRN.AX (Australia, small), Lattice LSCC (US, FPGAs), AMD (Xilinx FPGAs)
🐻 What could go wrong
BrainChip, a listed neuromorphic pioneer, reported only US$1.22M revenue and a US$12.0M loss for H1 2026 — commercial demand for brain-like chips is still tiny. source
System-level review: specialised analog/physical accelerators can show 'little or no advantage' once conversion, control and memory access are counted. source
📐 How we scored this
Criterion
Score
Weight
Points
Evidence level
1/5 — Lab demo
55%
5.5
Manufacturability
3/5
20%
12.0
Supply chain
2/5
10%
4.0
Corporate backing
1/5
10%
2.0
Independent groups
4/5
5%
4.0
Readiness
28/100
Hype = 10×claim boldness (3/5) + 10×attention (3/5) = 60. Patent/IP risk: Low (crowding 2/5, litigation 1/5). Sub-scores are our judgment from the linked sources. Full method
👀 What to watch next: Tape-out on real silicon and edge-device partners.
⏰ Time Machinedrag: 1 → 3 → 5 years (our scenario, not a forecast)
In 1 year: More FPGA demos
📋 Executive briefing teaser free
On-device learning for edge AI is a real gap.
On-device learning for edge AI is a real gap. FPGA demo today; small-cap neuromorphic and FPGA vendors are the exposure.
🔒 Full executive briefingIncluded in Pro & InstitutionalUnlock Premium
🎬 30-second video script Premium
Most AI learns in giant data centres. This brain-like chip learns on the spot, and it beat Nvidia's Jetson by up to 3 times in tests. It's an FPGA demo, not a product. Watch small players like BrainChip. Link on our page.
🔒 Video script with citationsIncluded in Pro & InstitutionalUnlock Premium
Stage 1 · Paper👀 Too early: keep an eye on itNeuromorphic / 2D materials
44. One transistor that can be logic, memory or neuron
🧩 A Swiss-army-knife worker who becomes a gatekeeper, clerk or manager as needed.
No listed ticker linked
🏛 National University of Singapore-led team · 📅 2026-09-14 (Nature Electronics)
👀 Too early: keep an eye on itOur judgment · Not financial advice
1Paper
2Prototype
3Factories & orders
4Revenue
💡 What it is
🔬 A shape-shifting atom-thin transistor that can be reassigned to act as logic, a synapse or a neuron, filtering out useless data before the 'brain' part wastes energy on it.
🧩 A Swiss-army-knife worker who becomes a gatekeeper, clerk or manager as needed.
🚀 Why it matters
📈 Readiness 16/100 · Paper
⏳ 6-10 yrs to market (our judgment)
🎯 Pure research; tracks a promising direction (reconfigurable, back-end-compatible devices).
💰 Who gains
No listed pure-play linked (private or small part of a big company)
🏷 Ferroelectric Memory Co (private, Germany)
🏷 GlobalFoundries GFS (US)
⚠️ Risks
❌ BrainChip, a listed neuromorphic pioneer, reported only US$1.22M revenue and a US$12.0M loss for H1 2026 — commercial demand for brain-like chips is still tiny.
✅ What to do
👀 Too early: keep an eye on it · plan: keep watching
🔎 Watch for: Wafer-scale fabrication results.
🗓 Timeline
Step 1Bigger arrays in labs
Step 2Wafer-scale tests
Step 3Still research
Timeline steps are our judgment unless marked as company plan.
What they found: A shape-shifting atom-thin transistor that can be reassigned to act as logic, a synapse or a neuron, filtering out useless data before the 'brain' part wastes energy on it.
🧒 Like I'm 10: One tiny switch that can change jobs: sometimes a calculator, sometimes a brain cell.
🧩 Think of it like: A Swiss-army-knife worker who becomes a gatekeeper, clerk or manager as needed.
🔒 Patent risk noteIncluded in Pro & InstitutionalUnlock Premium
🏆 Who could win
Ferroelectric Memory Co (private, Germany)GlobalFoundries GFS (US)
💰 Investor view👀 Too early: keep an eye on it
In plain words: One tiny switch that can change jobs: sometimes a calculator, sometimes a brain cell.
📊 Stocks tied to this
Company
Stock code
How it is linked
Role
Conviction
No listed company directly tied yet. Developer: National University of Singapore-led team. Watch for a listed partner or IPO.
Other possible winners: Ferroelectric Memory Co (private, Germany), GlobalFoundries GFS (US) (our judgment)
⚠️ Who could lose
Makers of older copper/electrical interconnect and packaging may lose share (our judgment)
✅ Why now
A shape-shifting atom-thin transistor that can be reassigned to act as logic, a synapse or a neuron, filtering out useless data before the 'brain' part wastes energy on it.
Readiness 16/100, stage 1 on our ladder.
U=0: ½×readiness 16 + 0 (no big event expected soon) − 8×1 kill-risk flag(s) · no listed ticker linked → 👀 too early
⛔ Why not yet
BrainChip, a listed neuromorphic pioneer, reported only US$1.22M revenue and a US$12.0M loss for H1 2026 — commercial demand for brain-like chips is still tiny.
Timeline to impact: about 6-10 years (our judgment)
⬆️ Upgrade triggers
Concrete date or release: Wafer-scale fabrication results.
A named paying customer or order
Independent replication / outside test results
Readiness reaching 70+ with a dated catalyst within 90 days (our 🔥 rule)
⬇️ Downgrade signals
Delay or missed milestone (our judgment)
Independent tests fail to confirm the claim (our judgment)
A rival leapfrogs or rules/regulators block it (our judgment)
🧭 Simple plan for this item (👀 Too early: keep an eye on it)
Don't buy because of this item yet.
Add the tickers to a watchlist and check the triggers below each week.
Move to Build only if 2+ upgrade triggers happen.
Tiers: 👀 Too early: keep an eye on it = track triggers only · ⏳ Promising = small staged position · 🔥 Act = catalyst near, sized small. No return promises.
🗓 Timeline
Bigger arrays in labs
Wafer-scale tests
Still research
📖 What these words mean
Readiness: our 0–100 score for how close an idea is to real products and sales. Higher = closer.
Conviction: how confident we are in a company's link to the idea (high, medium, low).
Ticker / stock code: the short code used to find a company's share on an exchange, e.g. NVDA.
Catalyst / next big event: a dated event (launch, approval, results) that could move the story.
Urgency: our badge for how time-sensitive it is: 🔥 strong signal, ⏳ promising, 👀 too early.
Our judgment · Not financial advice
🇮🇳 Indian investor angle
NSE: KAYNES and CGPOWER (both started chip assembly/test, OSAT, production at Sanand in 2026); US names via Nasdaq-100 or US-tech funds under the LRS route (RBI scheme for investing abroad). (our judgment)
Our judgment · Not financial advice. Exposure notes are qualitative; we don't quote % of revenue unless sourced.
🐂 Bull case
A shape-shifting atom-thin transistor that can be reassigned to act as logic, a synapse or a neuron, filtering out useless data before the 'brain' part wastes energy on it.
Who could win: Ferroelectric Memory Co (private, Germany), GlobalFoundries GFS (US)
🐻 What could go wrong
BrainChip, a listed neuromorphic pioneer, reported only US$1.22M revenue and a US$12.0M loss for H1 2026 — commercial demand for brain-like chips is still tiny. source
📐 How we scored this
Criterion
Score
Weight
Points
Evidence level
1/5 — Lab demo
55%
5.5
Manufacturability
1/5
20%
4.0
Supply chain
1/5
10%
2.0
Corporate backing
1/5
10%
2.0
Independent groups
2/5
5%
2.0
Readiness
16/100
Hype = 10×claim boldness (2/5) + 10×attention (1/5) = 30. Patent/IP risk: Low (crowding 2/5, litigation 1/5). Sub-scores are our judgment from the linked sources. Full method
👀 What to watch next: Wafer-scale fabrication results.
⏰ Time Machinedrag: 1 → 3 → 5 years (our scenario, not a forecast)
In 1 year: Bigger arrays in labs
📋 Executive briefing teaser free
Pure research; tracks a promising direction (reconfigurable, back-end-compatible devices).
Pure research; tracks a promising direction (reconfigurable, back-end-compatible devices). No investable pure play yet.
🔒 Full executive briefingIncluded in Pro & InstitutionalUnlock Premium
🎬 30-second video script Premium
What if one tiny transistor could switch jobs: logic one moment, brain cell the next? Singapore researchers built exactly that from a material one atom thick. Decade-away science, but it's how the future starts. Link on our page.
🔒 Video script with citationsIncluded in Pro & InstitutionalUnlock Premium
Stage 1 · Paper👀 Too early: keep an eye on itPhotonic neuromorphic
45. Light-powered brain chip: 1,176x faster on vision
🧩 Swapping a postal service for a laser pointer between two windows.
No listed ticker linked
🏛 Fudan University-led team (China) · 📅 2026-04-17 (Nature Communications)
👀 Too early: keep an eye on itOur judgment · Not financial advice
1Paper
2Prototype
3Factories & orders
4Revenue
💡 What it is
🔬 Chip-compatible optical devices that act as both synapse and neuron cut delay 1,176x and energy 239x versus standard designs on vision tasks (in their tests).
🧩 Swapping a postal service for a laser pointer between two windows.
🚀 Why it matters
📈 Readiness 16/100 · Paper
⏳ 6-10 yrs to market (our judgment)
🎯 Eye-catching lab gains; geopolitics may keep this inside China.
💰 Who gains
No listed pure-play linked (private or small part of a big company)
🏷 Chinese photonics foundries (not easily investable)
🏷 Tower TSEM (Israel)
⚠️ Risks
❌ Nature Photonics review (2026): in the cloud, losses and light-to-electric conversions 'dominate power' and have so far prevented commercial photonic tensor cores.
✅ What to do
👀 Too early: keep an eye on it · plan: keep watching
🔎 Watch for: Independent replication and larger arrays.
🗓 Timeline
Step 1Other labs try to repeat it
Step 2Bigger prototype chips
Step 3Possible edge-vision products, mostly in China
Timeline steps are our judgment unless marked as company plan.
What they found: Chip-compatible optical devices that act as both synapse and neuron cut delay 1,176x and energy 239x versus standard designs on vision tasks (in their tests).
🧒 Like I'm 10: A brain chip that uses light. In tests it was over a thousand times faster at recognising pictures.
🧩 Think of it like: Swapping a postal service for a laser pointer between two windows.
Readiness16/100
Years to market: 6-10
Our judgment
🎢 Hype vs Reality
Hype 70
Reality 16
Mostly hype so far (our judgment)
⚖️ Patent / IP risk
Chinese groups patent heavily; export-control limits could restrict Western use. (Our judgment)
🔒 Patent risk noteIncluded in Pro & InstitutionalUnlock Premium
🏆 Who could win
Chinese photonics foundries (not easily investable)Tower TSEM (Israel)
💰 Investor view👀 Too early: keep an eye on it
In plain words: A brain chip that uses light. In tests it was over a thousand times faster at recognising pictures.
📊 Stocks tied to this
Company
Stock code
How it is linked
Role
Conviction
No listed company directly tied yet. Developer: Fudan University-led team (China). Watch for a listed partner or IPO.
Other possible winners: Chinese photonics foundries (not easily investable), Tower TSEM (Israel) (our judgment)
⚠️ Who could lose
Makers of older copper/electrical interconnect and packaging may lose share (our judgment)
✅ Why now
Chip-compatible optical devices that act as both synapse and neuron cut delay 1,176x and energy 239x versus standard designs on vision tasks (in their tests).
Readiness 16/100, stage 1 on our ladder.
U=-8: ½×readiness 16 + 0 (no big event expected soon) − 8×2 kill-risk flag(s) · no listed ticker linked → 👀 too early
⛔ Why not yet
Nature Photonics review (2026): in the cloud, losses and light-to-electric conversions 'dominate power' and have so far prevented commercial photonic tensor cores.
BrainChip, a listed neuromorphic pioneer, reported only US$1.22M revenue and a US$12.0M loss for H1 2026 — commercial demand for brain-like chips is still tiny.
Timeline to impact: about 6-10 years (our judgment)
⬆️ Upgrade triggers
Concrete date or release: Independent replication and larger arrays.
A named paying customer or order
Independent replication / outside test results
Readiness reaching 70+ with a dated catalyst within 90 days (our 🔥 rule)
⬇️ Downgrade signals
Delay or missed milestone (our judgment)
Independent tests fail to confirm the claim (our judgment)
A rival leapfrogs or rules/regulators block it (our judgment)
🧭 Simple plan for this item (👀 Too early: keep an eye on it)
Don't buy because of this item yet.
Add the tickers to a watchlist and check the triggers below each week.
Move to Build only if 2+ upgrade triggers happen.
Tiers: 👀 Too early: keep an eye on it = track triggers only · ⏳ Promising = small staged position · 🔥 Act = catalyst near, sized small. No return promises.
🗓 Timeline
Other labs try to repeat it
Bigger prototype chips
Possible edge-vision products, mostly in China
📖 What these words mean
Readiness: our 0–100 score for how close an idea is to real products and sales. Higher = closer.
Conviction: how confident we are in a company's link to the idea (high, medium, low).
Ticker / stock code: the short code used to find a company's share on an exchange, e.g. NVDA.
Catalyst / next big event: a dated event (launch, approval, results) that could move the story.
Urgency: our badge for how time-sensitive it is: 🔥 strong signal, ⏳ promising, 👀 too early.
Our judgment · Not financial advice
🇮🇳 Indian investor angle
NSE: KAYNES and CGPOWER (both started chip assembly/test, OSAT, production at Sanand in 2026); US names via Nasdaq-100 or US-tech funds under the LRS route (RBI scheme for investing abroad). (our judgment)
Our judgment · Not financial advice. Exposure notes are qualitative; we don't quote % of revenue unless sourced.
🐂 Bull case
Chip-compatible optical devices that act as both synapse and neuron cut delay 1,176x and energy 239x versus standard designs on vision tasks (in their tests).
Who could win: Chinese photonics foundries (not easily investable), Tower TSEM (Israel)
🐻 What could go wrong
Nature Photonics review (2026): in the cloud, losses and light-to-electric conversions 'dominate power' and have so far prevented commercial photonic tensor cores. source
BrainChip, a listed neuromorphic pioneer, reported only US$1.22M revenue and a US$12.0M loss for H1 2026 — commercial demand for brain-like chips is still tiny. source
📐 How we scored this
Criterion
Score
Weight
Points
Evidence level
1/5 — Lab demo
55%
5.5
Manufacturability
1/5
20%
4.0
Supply chain
1/5
10%
2.0
Corporate backing
1/5
10%
2.0
Independent groups
3/5
5%
3.0
Readiness
16/100
Hype = 10×claim boldness (5/5) + 10×attention (2/5) = 70. Patent/IP risk: Medium (crowding 3/5, litigation 1/5). Sub-scores are our judgment from the linked sources. Full method
👀 What to watch next: Independent replication and larger arrays.
⏰ Time Machinedrag: 1 → 3 → 5 years (our scenario, not a forecast)
In 1 year: Other labs try to repeat it
📋 Executive briefing teaser free
Eye-catching lab gains; geopolitics may keep this inside China.
Eye-catching lab gains; geopolitics may keep this inside China. Monitor for replication.
🔒 Full executive briefingIncluded in Pro & InstitutionalUnlock Premium
🎬 30-second video script Premium
A Chinese lab says its light-based brain chip is over a thousand times faster on vision tasks. Big claim, lab test. If it holds up, photonics becomes the brain of edge AI. Link on our page.
🔒 Video script with citationsIncluded in Pro & InstitutionalUnlock Premium
⏳ Promising: start smallOur judgment · Not financial advice
1Paper
2Prototype
3Factories & orders
4Revenue
💡 What it is
🔬 ST says its PIC100 silicon-photonics process entered high-volume production on 300 mm lines for hyperscalers (800G and 1.6T optical links), with plans to more than quadruple capacity by 2027.
🧩 The lab recipe is now on the supermarket shelf.
🚀 Why it matters
📈 Readiness 84/100 · Factories & orders
⏳ 0-2 yrs to market (our judgment)
🎯 The proof point that photonics research becomes revenue: ST is at volume.
💰 Who gains
COHRCoherentSTMSTMicroelectronicsNVDANvidia
🏷 STMicro STM (EU)
🏷 Coherent COHR (US)
🏷 Lumentum LITE (US)
⚠️ Risks
❌ Nvidia networking SVP: 'If you can use copper, use copper' — optics only where distance forces it.
✅ What to do
⏳ Promising: start small · plan: keep watching
🔎 Watch for: Named giant cloud company (hyperscaler) customers and revenue disclosure.
🗓 Timeline
Step 1Capacity grows; more customers
Step 2Over 4x capacity planned by 2027 (company plan)
Step 3Next version (TSV) for co-packaged optics
Timeline steps are our judgment unless marked as company plan.
What they found: ST says its PIC100 silicon-photonics process entered high-volume production on 300 mm lines for hyperscalers (800G and 1.6T optical links), with plans to more than quadruple capacity by 2027.
🧒 Like I'm 10: Chips that talk using light are already being made in big factories right now.
🧩 Think of it like: The lab recipe is now on the supermarket shelf.
Readiness84/100
Years to market: 0-2
Our judgment
🎢 Hype vs Reality
Hype 30
Reality 84
Reality is catching up (our judgment)
⚖️ Patent / IP risk
ST licenses/owns its process; competitors (Intel, TSMC COUPE, GlobalFoundries) have their own. Low infringement risk for buyers. (Our judgment)
🔒 Patent risk noteIncluded in Pro & InstitutionalUnlock Premium
🏆 Who could win
STMicro STM (EU)Coherent COHR (US)Lumentum LITE (US)
💰 Investor view⏳ Promising: start small
In plain words: Chips that talk using light are already being made in big factories right now.
Indirect: AI chips are core; photonics is a future input (our judgment)
Winner
Medium
Other possible winners: STMicro STM (EU), Coherent COHR (US), Lumentum LITE (US) (our judgment)
⚠️ Who could lose
Makers of older copper/electrical interconnect and packaging may lose share (our judgment)
✅ Why now
ST says its PIC100 silicon-photonics process entered high-volume production on 300 mm lines for hyperscalers (800G and 1.6T optical links), with plans to more than quadruple capacity by 2027.
Readiness 84/100, stage 3 on our ladder.
U=42: ½×readiness 84 + 0 (no big event expected soon)
⛔ Why not yet
Nvidia networking SVP: 'If you can use copper, use copper' — optics only where distance forces it.
SemiAnalysis: Nvidia is going to 'extreme lengths' to stay on copper for scale-up through 2027-2028; limited first-wave CPO adoption expected.
Timeline to impact: about 0-2 years (our judgment)
⬆️ Upgrade triggers
Concrete date or release: Named giant cloud company (hyperscaler) customers and revenue disclosure.
A named paying customer or order
Independent replication / outside test results
Readiness reaching 70+ with a dated catalyst within 90 days (our 🔥 rule)
⬇️ Downgrade signals
Delay or missed milestone (our judgment)
Independent tests fail to confirm the claim (our judgment)
A rival leapfrogs or rules/regulators block it (our judgment)
🧭 Simple plan for this item (⏳ Promising: start small)
Only a small, staged position (e.g. split buys over several months).
Size so a big drop wouldn't hurt you.
Stop adding if a downgrade signal appears.
Tiers: 👀 Too early: keep an eye on it = track triggers only · ⏳ Promising = small staged position · 🔥 Act = catalyst near, sized small. No return promises.
🗓 Timeline
Capacity grows; more customers
Over 4x capacity planned by 2027 (company plan)
Next version (TSV) for co-packaged optics
📖 What these words mean
Readiness: our 0–100 score for how close an idea is to real products and sales. Higher = closer.
Conviction: how confident we are in a company's link to the idea (high, medium, low).
Ticker / stock code: the short code used to find a company's share on an exchange, e.g. NVDA.
Catalyst / next big event: a dated event (launch, approval, results) that could move the story.
Urgency: our badge for how time-sensitive it is: 🔥 strong signal, ⏳ promising, 👀 too early.
Our judgment · Not financial advice
🇮🇳 Indian investor angle
NSE: KAYNES and CGPOWER (both started chip assembly/test, OSAT, production at Sanand in 2026); US names via Nasdaq-100 or US-tech funds under the LRS route (RBI scheme for investing abroad). (our judgment)
Our judgment · Not financial advice. Exposure notes are qualitative; we don't quote % of revenue unless sourced.
🐂 Bull case
ST says its PIC100 silicon-photonics process entered high-volume production on 300 mm lines for hyperscalers (800G and 1.6T optical links), with plans to more than quadruple capacity by 2027.
Who could win: STMicro STM (EU), Coherent COHR (US), Lumentum LITE (US)
🐻 What could go wrong
Nvidia networking SVP: 'If you can use copper, use copper' — optics only where distance forces it. source
SemiAnalysis: Nvidia is going to 'extreme lengths' to stay on copper for scale-up through 2027-2028; limited first-wave CPO adoption expected. source
📐 How we scored this
Criterion
Score
Weight
Points
Evidence level
4/5 — Volume production or orders
55%
41.2
Manufacturability
5/5
20%
20.0
Supply chain
4/5
10%
8.0
Corporate backing
5/5
10%
10.0
Independent groups
5/5
5%
5.0
Readiness
84/100
Hype = 10×claim boldness (1/5) + 10×attention (2/5) = 30. Patent/IP risk: Medium (crowding 3/5, litigation 2/5). Sub-scores are our judgment from the linked sources. Full method
👀 What to watch next: Named giant cloud company (hyperscaler) customers and revenue disclosure.
⏰ Time Machinedrag: 1 → 3 → 5 years (our scenario, not a forecast)
In 1 year: Capacity grows; more customers
📋 Executive briefing teaser free
The proof point that photonics research becomes revenue: ST is at volume.
The proof point that photonics research becomes revenue: ST is at volume. This is the near-term leg of the optics story.
🔒 Full executive briefingIncluded in Pro & InstitutionalUnlock Premium
🎬 30-second video script Premium
Remember those light-based chip papers? Here's one that made it: ST now mass-produces silicon photonics for data centres. Paper to profit, in action. Link on our page.
🔒 Video script with citationsIncluded in Pro & InstitutionalUnlock Premium
Tracked since 2026-10-30Readiness vs prev: = no change · Updated 2026-10-30
History: 10-30 S3/74 → 10-31 S3/74
Stage 3 · Live launch👀 Too early: keep an eye on itTokenized funds
47. Janus Henderson puts a Nasdaq-100 fund on a blockchain (JQQQ)
🧩 Like moving a mutual fund from paper certificates to a digital ticket that can change hands any hour of the day.
JHGJanus HendersonNDAQNasdaq
🏛 Janus Henderson with Centrifuge; index licensed by Nasdaq · 📅 2026-10-27
👀 Too early: keep an eye on itOur judgment · Not financial advice
1Research / sandbox
2Pilot
3Live launch
4Scaled & regulated
💡 What it is
🔬 Janus Henderson and Centrifuge launched JQQQ, an issuer-sponsored on-chain fund on the Stellar blockchain that tracks the Nasdaq-100.
🧩 Like moving a mutual fund from paper certificates to a digital ticket that can change hands any hour of the day.
🚀 Why it matters
📈 Readiness 74/100 · Live launch
⏳ 0-2 yrs to market (our judgment)
🎯 Tokenization had mostly covered cash-like money-market funds.
💰 Who gains
JHGJanus HendersonNDAQNasdaq
🏷 Asset managers with on-chain platforms (our judgment)
🏷 Index providers licensing to tokenized products (our judgment)
⚠️ Risks
❌ Assets are tiny versus the ETF market; demand not yet proven (our judgment)
✅ What to do
👀 Too early: keep an eye on it · plan: keep watching
🔎 Watch for: Daily trading volume and assets in JQQQ; whether US regulators allow wider retail access.
🗓 Timeline
1 yrMore index funds go on-chain
3 yrTokenized funds used as collateral in trading
5 yrPart of mainstream fund distribution if rules allow
Timeline steps are our judgment unless marked as company plan.
What they found: Janus Henderson and Centrifuge launched JQQQ, an issuer-sponsored on-chain fund on the Stellar blockchain that tracks the Nasdaq-100. Unlike third-party 'stock tokens', the asset manager itself issues and manages it and Nasdaq licenses the index. CoinDesk says this takes Janus Henderson's on-chain platform above $1 billion in assets.
🧒 Like I'm 10: A big fund company made a version of its fund that lives on the internet's shared ledger, so it can move faster.
🧩 Think of it like: Like moving a mutual fund from paper certificates to a digital ticket that can change hands any hour of the day.
Indirect: Exchange operator; tokenization could help or compete (our judgment)
Neutral
Low (watchlist)
Other possible winners: Asset managers with on-chain platforms, Index providers licensing to tokenized products (our judgment)
⚠️ Who could lose
Incumbent banks/payment firms slow to adopt (our judgment)
✅ Why now
Janus Henderson and Centrifuge launched JQQQ, an issuer-sponsored on-chain fund on the Stellar blockchain that tracks the Nasdaq-100. Unlike third-party 'stock tokens', the asset manager itself issues and manages it and …
Readiness 74/100, stage 3 on our ladder.
U=37: ½×readiness 74 + 0 (no big event expected soon)
⛔ Why not yet
Assets are tiny versus the ETF market; demand not yet proven (our judgment)
Rules for retail access to tokenized funds differ by country (our judgment)
Timeline to impact: about 0-2 years (our judgment)
⬆️ Upgrade triggers
Concrete date or release: Daily trading volume and assets in JQQQ; whether US regulators allow wider retail access.
A named paying customer or order
Independent replication / outside test results
Readiness reaching 70+ with a dated catalyst within 90 days (our 🔥 rule)
⬇️ Downgrade signals
Delay or missed milestone (our judgment)
Independent tests fail to confirm the claim (our judgment)
A rival leapfrogs or rules/regulators block it (our judgment)
🧭 Simple plan for this item (👀 Too early: keep an eye on it)
Don't buy because of this item yet.
Add the tickers to a watchlist and check the triggers below each week.
Move to Build only if 2+ upgrade triggers happen.
Tiers: 👀 Too early: keep an eye on it = track triggers only · ⏳ Promising = small staged position · 🔥 Act = catalyst near, sized small. No return promises.
🗓 Timeline
1 yr (our judgment): More index funds go on-chain
3 yr (our judgment): Tokenized funds used as collateral in trading
5 yr (our judgment): Part of mainstream fund distribution if rules allow
📖 What these words mean
Readiness: our 0–100 score for how close an idea is to real products and sales. Higher = closer.
Conviction: how confident we are in a company's link to the idea (high, medium, low).
Ticker / stock code: the short code used to find a company's share on an exchange, e.g. NVDA.
Catalyst / next big event: a dated event (launch, approval, results) that could move the story.
Urgency: our badge for how time-sensitive it is: 🔥 strong signal, ⏳ promising, 👀 too early.
Our judgment · Not financial advice
🇮🇳 Indian investor angle
NSE: PAYTM, BAJFINANCE, POLICYBZR, CAMS, HDFCBANK are the closest local plays. (our judgment)
Our judgment · Not financial advice. Exposure notes are qualitative; we don't quote % of revenue unless sourced.
🐂 Bull case
Janus Henderson and Centrifuge launched JQQQ, an issuer-sponsored on-chain fund on the Stellar blockchain that tracks the Nasdaq-100.
Who could win: Asset managers with on-chain platforms (our judgment), Index providers licensing to tokenized products (our judgment)
🐻 What could go wrong
Assets are tiny versus the ETF market; demand not yet proven (our judgment) (judgment)
Rules for retail access to tokenized funds differ by country (our judgment) (judgment)
📐 How we scored this
Criterion
Score
Weight
Points
Evidence level
4/5 — Volume production or orders
55%
41.2
Manufacturability
4/5
20%
16.0
Supply chain
3/5
10%
6.0
Corporate backing
4/5
10%
8.0
Independent groups
3/5
5%
3.0
Readiness
74/100
Hype = 10×claim boldness (2/5) + 10×attention (3/5) = 50. Patent/IP risk: Low (crowding 1/5, litigation 1/5). Sub-scores are our judgment from the linked sources. Full method
👀 What to watch next: Daily trading volume and assets in JQQQ; whether US regulators allow wider retail access.
⏰ Time Machinedrag: 1 → 3 → 5 years (our scenario, not a forecast)
In 1 year: 1 yr (our judgment): More index funds go on-chain
📋 Executive briefing teaser free
Tokenization had mostly covered cash-like money-market funds.
Tokenization had mostly covered cash-like money-market funds. JQQQ brings a mainstream stock index on-chain with the real issuer behind it. Same month: Aviva (Oct 26) and Generali (Oct 21) tokenized money-market share classes. Still small versus traditional ETFs.
🔒 Full executive briefingIncluded in Pro & InstitutionalUnlock Premium
🎬 30-second video script Premium
Janus Henderson puts a Nasdaq-100 fund on a blockchain (JQQQ). Like moving a mutual fund from paper certificates to a digital ticket that can change hands any hour of the day. Our judgment: watch. Sources on our page.
🔒 Video script with citationsIncluded in Pro & InstitutionalUnlock Premium
👀 Too early: keep an eye on itOur judgment · Not financial advice
1Research / sandbox
2Pilot
3Live launch
4Scaled & regulated
💡 What it is
🔬 In its Fall Product Release Plaid launched LendScore 2, which it says is 42% stronger at predicting ability to repay than traditional credit data alone, and LendScore Arc, its first transformer-based credit score that learns from the order and timing of transactions.
🧩 Like judging a driver by watching how they actually drive every day, not just by their old ticket record.
🏷 Cash-flow lenders and fintech lenders (our judgment)
🏷 Banks lending to thin-file borrowers (our judgment)
⚠️ Risks
❌ Improvement numbers are Plaid's own internal tests
✅ What to do
👀 Too early: keep an eye on it · plan: keep watching
🔎 Watch for: Independent validation by lenders and regulators' view of transformer credit models.
🗓 Timeline
1 yrMore lenders test transaction-based scores
3 yrCommon in fintech lending
5 yrCould feed mainstream bank underwriting
Timeline steps are our judgment unless marked as company plan.
What they found: In its Fall Product Release Plaid launched LendScore 2, which it says is 42% stronger at predicting ability to repay than traditional credit data alone, and LendScore Arc, its first transformer-based credit score that learns from the order and timing of transactions. It also added an AI foundation model for fraud with up to 40% relative improvement in internal tests.
🧒 Like I'm 10: A company made a smart computer that looks at how you spend and save, to guess if you can pay back a loan.
🧩 Think of it like: Like judging a driver by watching how they actually drive every day, not just by their old ticket record.
Readiness75/100
Years to market: 0-2
Our judgment
🎢 Hype vs Reality
Hype 50
Reality 75
Reality is catching up (our judgment)
⚖️ Patent / IP risk
Plaid is private; listed exposure is indirect. (our judgment)
🔒 Patent risk noteIncluded in Pro & InstitutionalUnlock Premium
🏆 Who could win
Cash-flow lenders and fintech lenders (our judgment)Banks lending to thin-file borrowers (our judgment)
💰 Investor view👀 Too early: keep an eye on it
In plain words: A company made a smart computer that looks at how you spend and save, to guess if you can pay back a loan.
Indirect: Indian lender; read-across only, not tied to Plaid (our judgment)
Read-across
Low (watchlist)
Other possible winners: Cash-flow lenders and fintech lenders, Banks lending to thin-file borrowers (our judgment)
⚠️ Who could lose
Incumbent banks/payment firms slow to adopt (our judgment)
✅ Why now
In its Fall Product Release Plaid launched LendScore 2, which it says is 42% stronger at predicting ability to repay than traditional credit data alone, and LendScore Arc, its first transformer-based credit score that le…
Readiness 75/100, stage 3 on our ladder.
U=38: ½×readiness 75 + 0 (no big event expected soon)
⛔ Why not yet
Improvement numbers are Plaid's own internal tests
Fair-lending and explainability rules can slow AI credit models (our judgment)
Timeline to impact: about 0-2 years (our judgment)
⬆️ Upgrade triggers
Concrete date or release: Independent validation by lenders and regulators' view of transformer credit models.
A named paying customer or order
Independent replication / outside test results
Readiness reaching 70+ with a dated catalyst within 90 days (our 🔥 rule)
⬇️ Downgrade signals
Delay or missed milestone (our judgment)
Independent tests fail to confirm the claim (our judgment)
A rival leapfrogs or rules/regulators block it (our judgment)
🧭 Simple plan for this item (👀 Too early: keep an eye on it)
Don't buy because of this item yet.
Add the tickers to a watchlist and check the triggers below each week.
Move to Build only if 2+ upgrade triggers happen.
Tiers: 👀 Too early: keep an eye on it = track triggers only · ⏳ Promising = small staged position · 🔥 Act = catalyst near, sized small. No return promises.
🗓 Timeline
1 yr (our judgment): More lenders test transaction-based scores
3 yr (our judgment): Common in fintech lending
5 yr (our judgment): Could feed mainstream bank underwriting
📖 What these words mean
Readiness: our 0–100 score for how close an idea is to real products and sales. Higher = closer.
Conviction: how confident we are in a company's link to the idea (high, medium, low).
Ticker / stock code: the short code used to find a company's share on an exchange, e.g. NVDA.
Catalyst / next big event: a dated event (launch, approval, results) that could move the story.
Urgency: our badge for how time-sensitive it is: 🔥 strong signal, ⏳ promising, 👀 too early.
Our judgment · Not financial advice
🇮🇳 Indian investor angle
NSE: PAYTM, BAJFINANCE, POLICYBZR, CAMS, HDFCBANK are the closest local plays. (our judgment)
Our judgment · Not financial advice. Exposure notes are qualitative; we don't quote % of revenue unless sourced.
🐂 Bull case
In its Fall Product Release Plaid launched LendScore 2, which it says is 42% stronger at predicting ability to repay than traditional credit data alone, and LendScore Arc, its first transformer-based credit score that learns from the order and timing of transactions.
Who could win: Cash-flow lenders and fintech lenders (our judgment), Banks lending to thin-file borrowers (our judgment)
🐻 What could go wrong
Improvement numbers are Plaid's own internal tests source
Fair-lending and explainability rules can slow AI credit models (our judgment) (judgment)
📐 How we scored this
Criterion
Score
Weight
Points
Evidence level
4/5 — Volume production or orders
55%
41.2
Manufacturability
4/5
20%
16.0
Supply chain
4/5
10%
8.0
Corporate backing
3/5
10%
6.0
Independent groups
4/5
5%
4.0
Readiness
75/100
Hype = 10×claim boldness (3/5) + 10×attention (2/5) = 50. Patent/IP risk: Low (crowding 2/5, litigation 1/5). Sub-scores are our judgment from the linked sources. Full method
👀 What to watch next: Independent validation by lenders and regulators' view of transformer credit models.
⏰ Time Machinedrag: 1 → 3 → 5 years (our scenario, not a forecast)
In 1 year: 1 yr (our judgment): More lenders test transaction-based scores
📋 Executive briefing teaser free
Credit scores mostly look at past loans.
Credit scores mostly look at past loans. Cash-flow models read bank transactions to judge people with thin credit files. Plaid's figures are its own internal results, not independent tests.
🔒 Full executive briefingIncluded in Pro & InstitutionalUnlock Premium
🎬 30-second video script Premium
Plaid launches a transformer AI credit score it says predicts repayment 42% better. Like judging a driver by watching how they actually drive every day, not just by their old ticket record. Our judgment: watch. Sources on our page.
🔒 Video script with citationsIncluded in Pro & InstitutionalUnlock Premium
Tracked since 2026-10-30Readiness vs prev: = no change · Updated 2026-10-30
History: 10-30 S2/61 → 10-31 S2/61
Stage 2 · Pilot👀 Too early: keep an eye on itFraud AI / RegTech
49. Lloyds' agentic AI fraud assistant passes 90% decision accuracy on 10,600 live cases
🧩 Like a team of junior detectives who gather every clue before the senior detective decides.
LYGLloyds Banking Group
🏛 Lloyds Banking Group · 📅 2026-10-26
👀 Too early: keep an eye on itOur judgment · Not financial advice
1Research / sandbox
2Pilot
3Live launch
4Scaled & regulated
💡 What it is
🔬 Lloyds says a platform of specialist AI agents helped fraud specialists on more than 10,600 live debit-card fraud cases in 90 days.
🧩 Like a team of junior detectives who gather every clue before the senior detective decides.
🚀 Why it matters
📈 Readiness 61/100 · Pilot
⏳ 2-4 yrs to market (our judgment)
🎯 Banks used rules and single models to flag fraud.
💰 Who gains
LYGLloyds Banking Group
🏷 Large banks with big fraud losses (our judgment)
🏷 Fraud and RegTech software vendors (our judgment)
⚠️ Risks
❌ Accuracy figures are the bank's own; no outside audit
✅ What to do
👀 Too early: keep an eye on it · plan: keep watching
🔎 Watch for: Wider rollout beyond debit-card cases and any reported drop in fraud losses.
🗓 Timeline
1 yrRolled to more fraud types
3 yrAgentic AI common in bank investigations
5 yrLinked with anti-money-laundering checks
Timeline steps are our judgment unless marked as company plan.
What they found: Lloyds says a platform of specialist AI agents helped fraud specialists on more than 10,600 live debit-card fraud cases in 90 days. Overall decision accuracy passed 90% in September, staff use about half as many systems per call, and overrides of its suggestions fell 30%. Humans still make the final decision.
🧒 Like I'm 10: A bank uses a team of AI helpers to check if a strange card payment was a thief, so people get help faster.
🧩 Think of it like: Like a team of junior detectives who gather every clue before the senior detective decides.
Readiness61/100
Years to market: 2-4
Our judgment
🎢 Hype vs Reality
Hype 40
Reality 61
Reality is catching up (our judgment)
⚖️ Patent / IP risk
Low IP risk. (our judgment)
🔒 Patent risk noteIncluded in Pro & InstitutionalUnlock Premium
🏆 Who could win
Large banks with big fraud losses (our judgment)Fraud and RegTech software vendors (our judgment)
💰 Investor view👀 Too early: keep an eye on it
In plain words: A bank uses a team of AI helpers to check if a strange card payment was a thief, so people get help faster.
Indirect: UK bank; fraud AI lowers costs a little (our judgment)
Winner
Low (watchlist)
Other possible winners: Large banks with big fraud losses, Fraud and RegTech software vendors (our judgment)
⚠️ Who could lose
Incumbent banks/payment firms slow to adopt (our judgment)
✅ Why now
Lloyds says a platform of specialist AI agents helped fraud specialists on more than 10,600 live debit-card fraud cases in 90 days. Overall decision accuracy passed 90% in September, staff use about half as many systems …
Readiness 61/100, stage 2 on our ladder.
U=30: ½×readiness 61 + 0 (no big event expected soon)
⛔ Why not yet
Accuracy figures are the bank's own; no outside audit
Still in testing and monitoring before expansion
Timeline to impact: about 2-4 years (our judgment)
⬆️ Upgrade triggers
Concrete date or release: Wider rollout beyond debit-card cases and any reported drop in fraud losses.
A named paying customer or order
Independent replication / outside test results
Readiness reaching 70+ with a dated catalyst within 90 days (our 🔥 rule)
⬇️ Downgrade signals
Delay or missed milestone (our judgment)
Independent tests fail to confirm the claim (our judgment)
A rival leapfrogs or rules/regulators block it (our judgment)
🧭 Simple plan for this item (👀 Too early: keep an eye on it)
Don't buy because of this item yet.
Add the tickers to a watchlist and check the triggers below each week.
Move to Build only if 2+ upgrade triggers happen.
Tiers: 👀 Too early: keep an eye on it = track triggers only · ⏳ Promising = small staged position · 🔥 Act = catalyst near, sized small. No return promises.
🗓 Timeline
1 yr (our judgment): Rolled to more fraud types
3 yr (our judgment): Agentic AI common in bank investigations
5 yr (our judgment): Linked with anti-money-laundering checks
📖 What these words mean
Readiness: our 0–100 score for how close an idea is to real products and sales. Higher = closer.
Conviction: how confident we are in a company's link to the idea (high, medium, low).
Ticker / stock code: the short code used to find a company's share on an exchange, e.g. NVDA.
Catalyst / next big event: a dated event (launch, approval, results) that could move the story.
Urgency: our badge for how time-sensitive it is: 🔥 strong signal, ⏳ promising, 👀 too early.
Our judgment · Not financial advice
🇮🇳 Indian investor angle
NSE: PAYTM, BAJFINANCE, POLICYBZR, CAMS, HDFCBANK are the closest local plays. (our judgment)
Our judgment · Not financial advice. Exposure notes are qualitative; we don't quote % of revenue unless sourced.
🐂 Bull case
Lloyds says a platform of specialist AI agents helped fraud specialists on more than 10,600 live debit-card fraud cases in 90 days.
Who could win: Large banks with big fraud losses (our judgment), Fraud and RegTech software vendors (our judgment)
🐻 What could go wrong
Accuracy figures are the bank's own; no outside audit source
Still in testing and monitoring before expansion source
📐 How we scored this
Criterion
Score
Weight
Points
Evidence level
3/5 — Customer samples / qualification
55%
24.8
Manufacturability
4/5
20%
16.0
Supply chain
4/5
10%
8.0
Corporate backing
4/5
10%
8.0
Independent groups
4/5
5%
4.0
Readiness
61/100
Hype = 10×claim boldness (2/5) + 10×attention (2/5) = 40. Patent/IP risk: Low (crowding 1/5, litigation 1/5). Sub-scores are our judgment from the linked sources. Full method
👀 What to watch next: Wider rollout beyond debit-card cases and any reported drop in fraud losses.
⏰ Time Machinedrag: 1 → 3 → 5 years (our scenario, not a forecast)
In 1 year: 1 yr (our judgment): Rolled to more fraud types
📋 Executive briefing teaser free
Banks used rules and single models to flag fraud.
Banks used rules and single models to flag fraud. Lloyds now uses several AI agents to run the investigation steps. Same month, Bank of Ireland said AI checks about 2.9 million transactions a day and Wells Fargo described a 1B-parameter fraud model (single-talk report).
🔒 Full executive briefingIncluded in Pro & InstitutionalUnlock Premium
🎬 30-second video script Premium
Lloyds' agentic AI fraud assistant passes 90% decision accuracy on 10,600 live cases. Like a team of junior detectives who gather every clue before the senior detective decides. Our judgment: watch. Sources on our page.
🔒 Video script with citationsIncluded in Pro & InstitutionalUnlock Premium
Tracked since 2026-10-30Readiness vs prev: = no change · Updated 2026-10-30
History: 10-30 S2/66 → 10-31 S2/66
Stage 2 · Pilot👀 Too early: keep an eye on itPayments / UPI / e-rupee
50. India delays a 0.4% UPI merchant fee to 'immediately after Diwali'
🧩 Like a free highway adding a small toll only for big trucks, to pay for repairs.
PAYTM.NSOne 97 Communications (Paytm)
🏛 NPCI (National Payments Corporation of India) · 📅 2026-10-13
👀 Too early: keep an eye on itOur judgment · Not financial advice
1Research / sandbox
2Pilot
3Live launch
4Scaled & regulated
💡 What it is
🔬 NPCI said a 0.4% merchant discount rate on person-to-merchant UPI payments above ₹2,000 at medium and large merchants, capped at ₹300, will start 'immediately post Diwali' on a date to be notified; it was due on Oct 15.
🧩 Like a free highway adding a small toll only for big trucks, to pay for repairs.
🚀 Why it matters
📈 Readiness 66/100 · Pilot
⏳ 2-4 yrs to market (our judgment)
🎯 UPI has been free for merchants.
💰 Who gains
PAYTM.NSOne 97 Communications (Paytm)
🏷 UPI payment apps and payment aggregators (our judgment)
🏷 Banks in the UPI chain (our judgment)
⚠️ Risks
❌ Already postponed once, and the Supreme Court is reviewing it
✅ What to do
👀 Too early: keep an eye on it · plan: keep watching
🔎 Watch for: The notified start date and the Supreme Court hearing.
🗓 Timeline
1 yrFee starts or is changed after court review
3 yrPayment apps earn more per transaction
5 yre-rupee used for programmable payments alongside UPI
Timeline steps are our judgment unless marked as company plan.
What they found: NPCI said a 0.4% merchant discount rate on person-to-merchant UPI payments above ₹2,000 at medium and large merchants, capped at ₹300, will start 'immediately post Diwali' on a date to be notified; it was due on Oct 15. UPI handled 24.07 billion transactions worth ₹29.37 lakh crore in September 2026. The Hindu reports the Supreme Court asked for affidavits explaining the fee.
🧒 Like I'm 10: India's phone payment system may start charging shops a tiny fee on big payments, which could help payment companies earn money.
🧩 Think of it like: Like a free highway adding a small toll only for big trucks, to pay for repairs.
Readiness66/100
Years to market: 2-4
Our judgment
🎢 Hype vs Reality
Hype 60
Reality 66
Reality is catching up (our judgment)
⚖️ Patent / IP risk
Policy risk, not patent risk. (our judgment)
🔒 Patent risk noteIncluded in Pro & InstitutionalUnlock Premium
🏆 Who could win
UPI payment apps and payment aggregators (our judgment)Banks in the UPI chain (our judgment)
💰 Investor view👀 Too early: keep an eye on it
In plain words: India's phone payment system may start charging shops a tiny fee on big payments, which could help payment companies earn money.
Direct: UPI payments are core; fee rules hit revenue (our judgment)
Winner/At risk
Medium
Other possible winners: UPI payment apps and payment aggregators, Banks in the UPI chain (our judgment)
⚠️ Who could lose
Incumbent banks/payment firms slow to adopt (our judgment)
✅ Why now
NPCI said a 0.4% merchant discount rate on person-to-merchant UPI payments above ₹2,000 at medium and large merchants, capped at ₹300, will start 'immediately post Diwali' on a date to be notified; it was due on Oct 15. …
Readiness 66/100, stage 2 on our ladder.
U=33: ½×readiness 66 + 0 (no big event expected soon)
⛔ Why not yet
Already postponed once, and the Supreme Court is reviewing it
Traders oppose it; the fee could be cut or dropped (our judgment)
Timeline to impact: about 2-4 years (our judgment)
⬆️ Upgrade triggers
Concrete date or release: The notified start date and the Supreme Court hearing.
A named paying customer or order
Independent replication / outside test results
Readiness reaching 70+ with a dated catalyst within 90 days (our 🔥 rule)
⬇️ Downgrade signals
Delay or missed milestone (our judgment)
Independent tests fail to confirm the claim (our judgment)
A rival leapfrogs or rules/regulators block it (our judgment)
🧭 Simple plan for this item (👀 Too early: keep an eye on it)
Don't buy because of this item yet.
Add the tickers to a watchlist and check the triggers below each week.
Move to Build only if 2+ upgrade triggers happen.
Tiers: 👀 Too early: keep an eye on it = track triggers only · ⏳ Promising = small staged position · 🔥 Act = catalyst near, sized small. No return promises.
🗓 Timeline
1 yr (our judgment): Fee starts or is changed after court review
3 yr (our judgment): Payment apps earn more per transaction
5 yr (our judgment): e-rupee used for programmable payments alongside UPI
📖 What these words mean
Readiness: our 0–100 score for how close an idea is to real products and sales. Higher = closer.
Conviction: how confident we are in a company's link to the idea (high, medium, low).
Ticker / stock code: the short code used to find a company's share on an exchange, e.g. NVDA.
Catalyst / next big event: a dated event (launch, approval, results) that could move the story.
Urgency: our badge for how time-sensitive it is: 🔥 strong signal, ⏳ promising, 👀 too early.
Our judgment · Not financial advice
🇮🇳 Indian investor angle
NSE: PAYTM, BAJFINANCE, POLICYBZR, CAMS, HDFCBANK are the closest local plays. (our judgment)
Our judgment · Not financial advice. Exposure notes are qualitative; we don't quote % of revenue unless sourced.
🐂 Bull case
NPCI said a 0.4% merchant discount rate on person-to-merchant UPI payments above ₹2,000 at medium and large merchants, capped at ₹300, will start 'immediately post Diwali' on a date to be notified; it was due on Oct 15.
Who could win: UPI payment apps and payment aggregators (our judgment), Banks in the UPI chain (our judgment)
🐻 What could go wrong
Already postponed once, and the Supreme Court is reviewing it source
Traders oppose it; the fee could be cut or dropped (our judgment) (judgment)
📐 How we scored this
Criterion
Score
Weight
Points
Evidence level
3/5 — Customer samples / qualification
55%
24.8
Manufacturability
5/5
20%
20.0
Supply chain
5/5
10%
10.0
Corporate backing
4/5
10%
8.0
Independent groups
3/5
5%
3.0
Readiness
66/100
Hype = 10×claim boldness (2/5) + 10×attention (4/5) = 60. Patent/IP risk: Low (crowding 1/5, litigation 2/5). Sub-scores are our judgment from the linked sources. Full method
👀 What to watch next: The notified start date and the Supreme Court hearing.
⏰ Time Machinedrag: 1 → 3 → 5 years (our scenario, not a forecast)
In 1 year: 1 yr (our judgment): Fee starts or is changed after court review
📋 Executive briefing teaser free
UPI has been free for merchants.
UPI has been free for merchants. A small fee on bigger payments could give payment apps and banks a revenue line. S&P's view (Business Today): the digital rupee (e₹) stays a niche settlement tool and UPI stays dominant.
🔒 Full executive briefingIncluded in Pro & InstitutionalUnlock Premium
🎬 30-second video script Premium
India delays a 0.4% UPI merchant fee to 'immediately after Diwali'. Like a free highway adding a small toll only for big trucks, to pay for repairs. Our judgment: watch. Sources on our page.
🔒 Video script with citationsIncluded in Pro & InstitutionalUnlock Premium
Tracked since 2026-10-30Readiness vs prev: = no change · Updated 2026-10-30
History: 10-30 S2/65 → 10-31 S2/65
Stage 2 · Limited preview👀 Too early: keep an eye on itFrontier closed model
51. Google's Gemini 4 Carbon ranks #1 on a new independent AI index, first given to cyber defenders
🧩 Like a new top student first let into the bank's security team before being allowed to tutor everyone.
GOOGLAlphabet
🏛 Google DeepMind · 📅 2026-10-28
👀 Too early: keep an eye on itOur judgment · Not financial advice
1Paper / research
2Limited preview
3Generally available
4Widely adopted
💡 What it is
🔬 Google says Gemini 4 Carbon scores 59, #1 on Artificial Analysis Intelligence Index v5, and leads security tests such as SEC-bench Pro (88.2%) for finding software flaws.
🧩 Like a new top student first let into the bank's security team before being allowed to tutor everyone.
❌ Benchmark claims are Google's; most users cannot test it yet
✅ What to do
👀 Too early: keep an eye on it · plan: keep watching
🔎 Watch for: Date of general developer access and independent security evaluations.
🗓 Timeline
1 yrBroad API release
3 yrAI routinely finds and patches bugs
5 yrSecurity tools rebuilt around AI agents
Timeline steps are our judgment unless marked as company plan.
What they found: Google says Gemini 4 Carbon scores 59, #1 on Artificial Analysis Intelligence Index v5, and leads security tests such as SEC-bench Pro (88.2%) for finding software flaws. Access starts with a subset of cyber defenders, then trusted partners, before developers and consumers. Introductory price: $2 per million input tokens and $10 per million output tokens.
🧒 Like I'm 10: Google made a very smart AI that is great at finding computer weak spots, so it is giving it to the good guys first.
🧩 Think of it like: Like a new top student first let into the bank's security team before being allowed to tutor everyone.
Readiness65/100
Years to market: 2-4
Our judgment
🎢 Hype vs Reality
Hype 80
Reality 65
Some hype; watch for proof (our judgment)
⚖️ Patent / IP risk
Heavy AI patent activity; no specific dispute. (our judgment)
🔒 Patent risk noteIncluded in Pro & InstitutionalUnlock Premium
🏆 Who could win
Alphabet (Google Cloud, Gemini API) (our judgment)Cybersecurity teams using AI (our judgment)
💰 Investor view👀 Too early: keep an eye on it
In plain words: Google made a very smart AI that is great at finding computer weak spots, so it is giving it to the good guys first.
Indirect: AI models and Google Cloud are one part; ads are most of the business (our judgment)
Winner
Medium
Other possible winners: Alphabet (Google Cloud, Gemini API), Cybersecurity teams using AI (our judgment)
⚠️ Who could lose
Rival model labs and paid software that AI can replace (e.g. some IT-services work) (our judgment)
✅ Why now
Google says Gemini 4 Carbon scores 59, #1 on Artificial Analysis Intelligence Index v5, and leads security tests such as SEC-bench Pro (88.2%) for finding software flaws. Access starts with a subset of cyber defenders, t…
Readiness 65/100, stage 2 on our ladder.
U=24: ½×readiness 65 + 0 (no big event expected soon) − 8×1 kill-risk flag(s)
⛔ Why not yet
Benchmark claims are Google's; most users cannot test it yet
Rivals leapfrog every few weeks (our judgment)
Timeline to impact: about 2-4 years (our judgment)
⬆️ Upgrade triggers
Concrete date or release: Date of general developer access and independent security evaluations.
A named paying customer or order
Independent replication / outside test results
Readiness reaching 70+ with a dated catalyst within 90 days (our 🔥 rule)
⬇️ Downgrade signals
Delay or missed milestone (our judgment)
Independent tests fail to confirm the claim (our judgment)
A rival leapfrogs or rules/regulators block it (our judgment)
🧭 Simple plan for this item (👀 Too early: keep an eye on it)
Don't buy because of this item yet.
Add the tickers to a watchlist and check the triggers below each week.
Move to Build only if 2+ upgrade triggers happen.
Tiers: 👀 Too early: keep an eye on it = track triggers only · ⏳ Promising = small staged position · 🔥 Act = catalyst near, sized small. No return promises.
🗓 Timeline
1 yr (our judgment): Broad API release
3 yr (our judgment): AI routinely finds and patches bugs
5 yr (our judgment): Security tools rebuilt around AI agents
📖 What these words mean
Readiness: our 0–100 score for how close an idea is to real products and sales. Higher = closer.
Conviction: how confident we are in a company's link to the idea (high, medium, low).
Ticker / stock code: the short code used to find a company's share on an exchange, e.g. NVDA.
Catalyst / next big event: a dated event (launch, approval, results) that could move the story.
Urgency: our badge for how time-sensitive it is: 🔥 strong signal, ⏳ promising, 👀 too early.
Our judgment · Not financial advice
🇮🇳 Indian investor angle
Nasdaq-100 fund-of-funds/ETFs on NSE (e.g. Nasdaq-100 ETF) hold GOOGL, MSFT, AMZN, META, NVDA; Indian IT is the local 'at risk/adopter' angle. (our judgment)
Our judgment · Not financial advice. Exposure notes are qualitative; we don't quote % of revenue unless sourced.
🐂 Bull case
Google says Gemini 4 Carbon scores 59, #1 on Artificial Analysis Intelligence Index v5, and leads security tests such as SEC-bench Pro (88.2%) for finding software flaws.
Who could win: Alphabet (Google Cloud, Gemini API) (our judgment), Cybersecurity teams using AI (our judgment)
🐻 What could go wrong
Benchmark claims are Google's; most users cannot test it yet source
Rivals leapfrog every few weeks (our judgment) (judgment)
📐 How we scored this
Criterion
Score
Weight
Points
Evidence level
3/5 — Customer samples / qualification
55%
24.8
Manufacturability
4/5
20%
16.0
Supply chain
5/5
10%
10.0
Corporate backing
5/5
10%
10.0
Independent groups
4/5
5%
4.0
Readiness
65/100
Hype = 10×claim boldness (4/5) + 10×attention (4/5) = 80. Patent/IP risk: Medium (crowding 3/5, litigation 2/5). Sub-scores are our judgment from the linked sources. Full method
👀 What to watch next: Date of general developer access and independent security evaluations.
⏰ Time Machinedrag: 1 → 3 → 5 years (our scenario, not a forecast)
In 1 year: 1 yr (our judgment): Broad API release
📋 Executive briefing teaser free
Frontier models usually launch to everyone.
Frontier models usually launch to everyone. Carbon is gated first because it is strong at finding and exploiting software flaws. Wider release date not given.
🔒 Full executive briefingIncluded in Pro & InstitutionalUnlock Premium
🎬 30-second video script Premium
Google's Gemini 4 Carbon ranks #1 on a new independent AI index, first given to cyber defenders. Like a new top student first let into the bank's security team before being allowed to tutor everyone. Our judgment: watch. Sources on our page.
🔒 Video script with citationsIncluded in Pro & InstitutionalUnlock Premium
🏷 Businesses automating back-office work (our judgment)
⚠️ Risks
❌ Benchmarks are OpenAI's own
✅ What to do
👀 Too early: keep an eye on it · plan: keep watching
🔎 Watch for: Independent benchmark results and enterprise adoption figures.
🗓 Timeline
1 yrCommon in office automation
3 yrAI agents handle routine desk tasks
5 yrMost form-filling work automated
Timeline steps are our judgment unless marked as company plan.
What they found: OpenAI says GPT-6.1 Terra's API costs 50% less than GPT-5.6 Terra and GPT-6.1 Sol. On its hard-prompt test the error rate at low reasoning effort fell from 53.6% to 16.7%. It solves 50.3% of Terminal-Bench 4.0 coding tasks at max effort, up from 21.5%, and finishes tasks over three times faster than GPT-6 Astra.
🧒 Like I'm 10: OpenAI made a faster, cheaper AI that can use a computer like a person and gets fewer things wrong.
🧩 Think of it like: Like a cheaper, faster office assistant who now makes far fewer mistakes filling in forms.
Readiness85/100
Years to market: 0-2
Our judgment
🎢 Hype vs Reality
Hype 70
Reality 85
Reality is catching up (our judgment)
⚖️ Patent / IP risk
Heavy AI patent and copyright litigation exposure. (our judgment)
🔒 Patent risk noteIncluded in Pro & InstitutionalUnlock Premium
Indirect: Owns a stake in and sells OpenAI models via Azure (our judgment)
Winner
Low (watchlist)
Other possible winners: Cloud providers hosting OpenAI models, Businesses automating back-office work (our judgment)
⚠️ Who could lose
Rival model labs and paid software that AI can replace (e.g. some IT-services work) (our judgment)
✅ Why now
OpenAI says GPT-6.1 Terra's API costs 50% less than GPT-5.6 Terra and GPT-6.1 Sol. On its hard-prompt test the error rate at low reasoning effort fell from 53.6% to 16.7%. It solves 50.3% of Terminal-Bench 4.0 coding tas…
Readiness 85/100, stage 3 on our ladder.
U=34: ½×readiness 85 + 0 (no big event expected soon) − 8×1 kill-risk flag(s)
⛔ Why not yet
Benchmarks are OpenAI's own
OpenAI is private; listed exposure is indirect via Microsoft (our judgment)
Timeline to impact: about 0-2 years (our judgment)
⬆️ Upgrade triggers
Concrete date or release: Independent benchmark results and enterprise adoption figures.
A named paying customer or order
Independent replication / outside test results
Readiness reaching 70+ with a dated catalyst within 90 days (our 🔥 rule)
⬇️ Downgrade signals
Delay or missed milestone (our judgment)
Independent tests fail to confirm the claim (our judgment)
A rival leapfrogs or rules/regulators block it (our judgment)
🧭 Simple plan for this item (👀 Too early: keep an eye on it)
Don't buy because of this item yet.
Add the tickers to a watchlist and check the triggers below each week.
Move to Build only if 2+ upgrade triggers happen.
Tiers: 👀 Too early: keep an eye on it = track triggers only · ⏳ Promising = small staged position · 🔥 Act = catalyst near, sized small. No return promises.
🗓 Timeline
1 yr (our judgment): Common in office automation
3 yr (our judgment): AI agents handle routine desk tasks
5 yr (our judgment): Most form-filling work automated
📖 What these words mean
Readiness: our 0–100 score for how close an idea is to real products and sales. Higher = closer.
Conviction: how confident we are in a company's link to the idea (high, medium, low).
Ticker / stock code: the short code used to find a company's share on an exchange, e.g. NVDA.
Catalyst / next big event: a dated event (launch, approval, results) that could move the story.
Urgency: our badge for how time-sensitive it is: 🔥 strong signal, ⏳ promising, 👀 too early.
Our judgment · Not financial advice
🇮🇳 Indian investor angle
Nasdaq-100 fund-of-funds/ETFs on NSE (e.g. Nasdaq-100 ETF) hold GOOGL, MSFT, AMZN, META, NVDA; Indian IT is the local 'at risk/adopter' angle. (our judgment)
OpenAI is private; listed exposure is indirect via Microsoft (our judgment) (judgment)
📐 How we scored this
Criterion
Score
Weight
Points
Evidence level
4/5 — Volume production or orders
55%
41.2
Manufacturability
5/5
20%
20.0
Supply chain
5/5
10%
10.0
Corporate backing
5/5
10%
10.0
Independent groups
4/5
5%
4.0
Readiness
85/100
Hype = 10×claim boldness (3/5) + 10×attention (4/5) = 70. Patent/IP risk: Medium (crowding 3/5, litigation 3/5). Sub-scores are our judgment from the linked sources. Full method
👀 What to watch next: Independent benchmark results and enterprise adoption figures.
⏰ Time Machinedrag: 1 → 3 → 5 years (our scenario, not a forecast)
In 1 year: 1 yr (our judgment): Common in office automation
📋 Executive briefing teaser free
Cheaper mid-size models make it practical to automate routine office work such as reading invoices.
Cheaper mid-size models make it practical to automate routine office work such as reading invoices. OpenAI says the most complex coding still needs its bigger models. Release date is our estimate from coverage; the OpenAI page is undated in our fetch.
🔒 Full executive briefingIncluded in Pro & InstitutionalUnlock Premium
🎬 30-second video script Premium
OpenAI's GPT-6.1 Terra: computer-use AI at half the price, with errors cut from 54% to 17%. Like a cheaper, faster office assistant who now makes far fewer mistakes filling in forms. Our judgment: watch. Sources on our page.
🔒 Video script with citationsIncluded in Pro & InstitutionalUnlock Premium
Tracked since 2026-10-30Readiness vs prev: = no change · Updated 2026-10-30
History: 10-30 S3/85 → 10-31 S3/85
Stage 3 · Generally available👀 Too early: keep an eye on itSmall / efficient model
53. Anthropic's Claude Haiku 5.5 costs about 75% less to run than Haiku 4.5
🧩 Like a pocket calculator that now does what a desktop computer did, for a quarter of the price.
GOOGLAlphabetAMZNAmazon
🏛 Anthropic (backed by Amazon and Google) · 📅 2026-10-07
👀 Too early: keep an eye on itOur judgment · Not financial advice
1Paper / research
2Limited preview
3Generally available
4Widely adopted
💡 What it is
🔬 Anthropic released Claude Haiku 5.5 on all platforms, including AWS, Google Cloud and Microsoft Azure, saying it costs about 75% less to run than Haiku 4.5 and is its fastest model.
🧩 Like a pocket calculator that now does what a desktop computer did, for a quarter of the price.
🚀 Why it matters
📈 Readiness 85/100 · Generally available
⏳ 0-2 yrs to market (our judgment)
🎯 Small models handle high-volume work such as summaries, sorting and customer support.
💰 Who gains
GOOGLAlphabetAMZNAmazon
🏷 Amazon (AWS Bedrock) and Google Cloud, both Anthropic investors (our judgment)
🏷 Apps with high-volume AI tasks (our judgment)
⚠️ Risks
❌ Cost saving is Anthropic's own average estimate
✅ What to do
👀 Too early: keep an eye on it · plan: keep watching
🔎 Watch for: Price moves by rivals and open-weight catch-up (Kimi K3.1 Pro weights promised by Nov 4).
🗓 Timeline
1 yrSmall models replace big ones for routine tasks
3 yrAI cost per task keeps falling
5 yrAI in most software by default
Timeline steps are our judgment unless marked as company plan.
What they found: Anthropic released Claude Haiku 5.5 on all platforms, including AWS, Google Cloud and Microsoft Azure, saying it costs about 75% less to run than Haiku 4.5 and is its fastest model. OrigoTech, citing Artificial Analysis v5, puts it at 36, ahead of the best downloadable open-weight models (32).
🧒 Like I'm 10: A smaller, cheaper AI got much smarter, so apps can use AI lots more without paying a lot.
🧩 Think of it like: Like a pocket calculator that now does what a desktop computer did, for a quarter of the price.
Readiness85/100
Years to market: 0-2
Our judgment
🎢 Hype vs Reality
Hype 50
Reality 85
Reality is catching up (our judgment)
⚖️ Patent / IP risk
AI copyright litigation is industry-wide. (our judgment)
🔒 Patent risk noteIncluded in Pro & InstitutionalUnlock Premium
🏆 Who could win
Amazon (AWS Bedrock) and Google Cloud, both Anthropic investors (our judgment)Apps with high-volume AI tasks (our judgment)
💰 Investor view👀 Too early: keep an eye on it
In plain words: A smaller, cheaper AI got much smarter, so apps can use AI lots more without paying a lot.
Indirect: Investor in Anthropic; sells Claude on AWS (our judgment)
Winner
Low (watchlist)
Other possible winners: Amazon (AWS Bedrock) and Google Cloud, both Anthropic investors, Apps with high-volume AI tasks (our judgment)
⚠️ Who could lose
Rival model labs and paid software that AI can replace (e.g. some IT-services work) (our judgment)
✅ Why now
Anthropic released Claude Haiku 5.5 on all platforms, including AWS, Google Cloud and Microsoft Azure, saying it costs about 75% less to run than Haiku 4.5 and is its fastest model. OrigoTech, citing Artificial Analysis …
Readiness 85/100, stage 3 on our ladder.
U=34: ½×readiness 85 + 0 (no big event expected soon) − 8×1 kill-risk flag(s)
⛔ Why not yet
Cost saving is Anthropic's own average estimate
Price wars squeeze margins for model makers (our judgment)
Timeline to impact: about 0-2 years (our judgment)
⬆️ Upgrade triggers
Concrete date or release: Price moves by rivals and open-weight catch-up (Kimi K3.1 Pro weights promised by Nov 4).
A named paying customer or order
Independent replication / outside test results
Readiness reaching 70+ with a dated catalyst within 90 days (our 🔥 rule)
⬇️ Downgrade signals
Delay or missed milestone (our judgment)
Independent tests fail to confirm the claim (our judgment)
A rival leapfrogs or rules/regulators block it (our judgment)
🧭 Simple plan for this item (👀 Too early: keep an eye on it)
Don't buy because of this item yet.
Add the tickers to a watchlist and check the triggers below each week.
Move to Build only if 2+ upgrade triggers happen.
Tiers: 👀 Too early: keep an eye on it = track triggers only · ⏳ Promising = small staged position · 🔥 Act = catalyst near, sized small. No return promises.
🗓 Timeline
1 yr (our judgment): Small models replace big ones for routine tasks
3 yr (our judgment): AI cost per task keeps falling
5 yr (our judgment): AI in most software by default
📖 What these words mean
Readiness: our 0–100 score for how close an idea is to real products and sales. Higher = closer.
Conviction: how confident we are in a company's link to the idea (high, medium, low).
Ticker / stock code: the short code used to find a company's share on an exchange, e.g. NVDA.
Catalyst / next big event: a dated event (launch, approval, results) that could move the story.
Urgency: our badge for how time-sensitive it is: 🔥 strong signal, ⏳ promising, 👀 too early.
Our judgment · Not financial advice
🇮🇳 Indian investor angle
Nasdaq-100 fund-of-funds/ETFs on NSE (e.g. Nasdaq-100 ETF) hold GOOGL, MSFT, AMZN, META, NVDA; Indian IT is the local 'at risk/adopter' angle. (our judgment)
Our judgment · Not financial advice. Exposure notes are qualitative; we don't quote % of revenue unless sourced.
🐂 Bull case
Anthropic released Claude Haiku 5.5 on all platforms, including AWS, Google Cloud and Microsoft Azure, saying it costs about 75% less to run than Haiku 4.5 and is its fastest model.
Who could win: Amazon (AWS Bedrock) and Google Cloud, both Anthropic investors (our judgment), Apps with high-volume AI tasks (our judgment)
🐻 What could go wrong
Cost saving is Anthropic's own average estimate source
Price wars squeeze margins for model makers (our judgment) (judgment)
📐 How we scored this
Criterion
Score
Weight
Points
Evidence level
4/5 — Volume production or orders
55%
41.2
Manufacturability
5/5
20%
20.0
Supply chain
5/5
10%
10.0
Corporate backing
5/5
10%
10.0
Independent groups
4/5
5%
4.0
Readiness
85/100
Hype = 10×claim boldness (2/5) + 10×attention (3/5) = 50. Patent/IP risk: Medium (crowding 3/5, litigation 3/5). Sub-scores are our judgment from the linked sources. Full method
👀 What to watch next: Price moves by rivals and open-weight catch-up (Kimi K3.1 Pro weights promised by Nov 4).
⏰ Time Machinedrag: 1 → 3 → 5 years (our scenario, not a forecast)
In 1 year: 1 yr (our judgment): Small models replace big ones for routine tasks
📋 Executive briefing teaser free
Small models handle high-volume work such as summaries, sorting and customer support.
Small models handle high-volume work such as summaries, sorting and customer support. A small closed model now outscores the best open models on that index, which widens the open-vs-closed gap.
🔒 Full executive briefingIncluded in Pro & InstitutionalUnlock Premium
🎬 30-second video script Premium
Anthropic's Claude Haiku 5.5 costs about 75% less to run than Haiku 4.5. Like a pocket calculator that now does what a desktop computer did, for a quarter of the price. Our judgment: watch. Sources on our page.
🔒 Video script with citationsIncluded in Pro & InstitutionalUnlock Premium
💡 Did you know? Patents are often filed months before the paper appears. When a company files a patent and a paper on the same idea (like IBM here), it usually means they plan to sell it.
⏱ 1 min read
🗳 Quick poll: which breakthrough makes money first?
Tap one. Saved only on your device.
⏱ 1 min read
⏳ Countdown to key dates
AMD Q3 2026 results (after US market close)2026-11-03 · source
FDA comment deadline: individualized gene-editing draft guidance2026-11-27 · source
IEDM 2026 begins (San Francisco, Dec 12-16)2026-12-12 · source
ISSCC 2027 begins (San Francisco, Feb 14-18)2027-02-14 · source
💎 Plans
Read the radar for free. Teams that act on it early get the full briefings.